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C H A P T E R I 
GENERAL INTRODUCTION 
I. 1 ACTH AND a-MSH, OCCURRENCE, BIOLOGICAL 
ACTIVITY AND STRUCTURE 
I. 1.1 ACTH 
The ACTH molecule is secreted by the basophil-
ic fî'-cells of the anterior pituitary gland (ade-
nohypophysis ) and reaches the adrenals via the 
bloodstream. Its principal activity is the stimu-
lation of the adrenal cortex to produce and re-
lease steroid hormones (chiefly Cortisol, corti-
sone and corticosterone). The most important extra-
adrenal activities involve lypolytic and melano-
trophic effects. 
The hormone appears to be a single-chain poly-
peptide, composed of 39 amino acid residues. The C-
terminal portion of the hormone, consisting of the 
last 15 amino acid residues, appears to be зреагев-
spscific, which suggests that this fragment is not 
essential for eliciting the biological response. 
The revised structure of human ACTH, recently re-
1 
ported by Riniker et al. is given in fig. I, 1. 
As a result of studies which were initiated 
2 3 
around 1960 by several groups ' , concerning the 
synthesis and biological activities of partial 
2 
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Fig. I . 1 
ACTH sequences, the peptide hormone can be divided 
into three parts. А, В and C. Fragment С (sequence 
25-39) is the species-specific part, contributing 
to the immunological specificity. The remaining 
chain 1-24 (parts A and B) possesses full biologi­
cal activity. The sequence 1-18 (part A) repre­
sents the shortest fragment of the molecule which 
displays full biological activity, provided that a 
C-terminal amide function is present, as has been 
proven by biological tests employing synthetic 
3 4 
samples of this fragment ' . 
Many ACTH analogues, containing IB to 24 ami­
no acid residues, have been synthesized for struc­
ture-activity relationship studies. The results 
suggest the existence of independent loci with 
different functions. Hofmann and co-workers dis­
tinguished an "active site" and a binding site 
7 S fi 
' * . The information-bearing active site ap­
peared to be located in the sequence 1-10 and was 
confined to fragment II (sequence 5-10) because 
3 
SeMyr-Ser-Metjílu-His-Phe-írg-Trp-Glykys-Pro-Val-Cly-LysHys-Arg-Arg-Pro—Рта 
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4 
L-methionine seemed to have more of a binding 
function (fig. I, 2). They suggested that fragment 
III (sequence 11-14) was the binding site for 
melanotrophic activity whereas fragment IV (se­
quence 15-1Θ) in combination with III had the same 
function in respect of adrenocorticotrophic activ­
ity. 
The most far-reaching attribution of functions 
to regions of the ß-corticotrophin-(1-24)-tetraco-
sapeptide* was presented by Schwyzer and co-workers 
7 fl 4 
' ' . Schwyzer suggested a "sychnologic" composi-
tion of the hormone which means that functional el-
ements ("words" composed of combinations of amino 
acids) are arranged in an uninterrupted way. This 
contrasts with a "rhegnylogic" composition, as in 
insulin, which contains discontinuous words i.e. 
the elements composing these words are separated 
by biologically less relevant peptide regions. 
Sychnologic hormones are always flexible, consist 
of a straight chain and are easily bound to their 
receptors; rhegnylogic hormones should be inflexi-
* Nomenclature of Bell, H.P. (1954) J. Amer. Chem. 
Soa. 76, 5565-5567. According to Li, C.H. (1959) 
Science 129, 969-970, the compound should be 
named o-adrenocorticotrophin. 
4 
g 
ble . According to Schwyzer, receptors recognize 
a hormone by its "address", and receive a stimulus 
from its "message". In ACTH the message is present 
in the 5-10 sequence (fragment II) and the address 
in the (11-24) tetradecapeptide (fragment III + IV 
g 
+ V) which behaves as a competitive antagonist . 
Fragment I functions as the word for "potentiation", 
I. 1.2 a-MSH 
The skin-darkening effect of a-MSH and ß-MSH, 
two melanocyte-stimulating hormones isolated from 
the pituitary glands of several organisms, was 
10 11 
discovered independently by Smith and Allen 
a-MSH is a straight-chain tridecapeptide 
with /^-acetyl-serine as the ЛГ-terminal and valine 
amide as the C-terminal. The amino acid sequence 
is identical with that of the JV-terminal trideca­
peptide of natural ACTH (see fig· I, 1, 2). It 
has the same composition regardless of the 
source. 
It has been suggested that the fragment 
-Met-Glu-His-Phe-Arg-Trp-Gly-, comprising the se­
quence 4-10 in ACTH, a-MSH and 0-MSH, is responsi­
ble for the physiological effect. Li found that a 
synthetic sample of this heptapeptide had about 
1 2 
60% of the activity of a-MSH . The smallest frag­
ment which possessed weak melanocyte-expanding ac­
tivity appeared to be the tetrapeptide H-His-Phe-
1 3 Arg-Тгр-ОН i apparently it contains the "active 
site" for melanocyte stimulation. Extension of the 
5 
peptide chain from either the amino or carboxyl 
terminus increases biological activity, which ap­
pears to reach its maximum at a chain-length of 
13 to 15 amino acid residues and which declines 
again on further elongation. 
Every peptide known to date that possesses 
adrenocorticotrophiс activity has also the abili­
ty to expand melanocytes, although the converse 
is not necessarily true; a-MSH itself exhibits on-
14 15 ly a weak adrenal cortical activity ' 
In view of the close parallelism of these two 
types of biological activities, it is not surpris­
ing to find that amino acid substitutions which 
affect one of these biological functions also al­
ter the other. Substitutions that enhance steroido­
genic activity also enhance melanocyte-stimulating 
activity. Until now all alterations that lower 
adrenocorticotrophic activity have brought about 
a proportional lowering of the melanocyte-stimulat-
, . . . 1Б ing activity 
I. 2 SUBSTITUTIONS AT THE "ACTIVE SITE" OF ACTH 
AND a-MSH 
a 
I. 2.1 Arginine 
A first objective of the structure-activity 
relationship investigations made in our laboratory 
concerned the elucidation of the role of the basic 
amino acids. In order to investigate this all the 
basic amino acid residues in fragment A were sys­
tematically replaced by L-ornithine residues. Some 
6 
of these analogues were investigated with L- as 
17 18 19 
well as D-serine at position 1 * Replace-
. . . 11.,1S,16 . . 17,18 . . . 
ment of Lys * * and Arg * appeared to be 
allowed, and in some cases even resulted in a pro­
longation of biological activity. Replacement of 
a 
Arg by Orn, however, caused almost total loss of 
1 β 
activity , a similar result being found when 
о 2 π 
Arg was substituted by L-lysine . These obser­
vations point to the particular significance of 
the guanidino group of the arginine residue in 
this position. The influence of the length of the 
о 
side-chain of Arg was then investigated by syn-
21 22 
thesizing and testing ACTH analogues contain­
ing the higher homologue of arginine, L-homoargi-
nine, in position Θ. These peptides showed a sur­
prisingly high degree of biological activity: in 
all the tests performed viz. steroidogenesis in 
vivo and in vitro and lipolysis in vivo and in vi­
tro, the loss of activity due to the substitution 
22 did not exceed a factor of about 4 
In view of these results we have now synthe­
sized similar ACTH peptides containing the lower 
homologue of arginine, L-norarginine* (L-a-amino-
γ-guanidinobutyric acid] in position β, in order 
to investigate whether shortening of the arginine 
side-chain with a methylene group again results in 
a product which still fulfils the demands for ac-
* By analogy with the abbreviation Наг for L-homo-
arginine, we will use the three-letter symbol 
Nar for L-norarginine. 
7 
tivating the receptor. 
I. 2.2 Tryptophan 
As early as 1957 Dedman et al. stated that 
the presence of a tryptophan residue at position 9 
in ACTH was probably essential for biological ac-
23 tivity . In order to obtain more information con-
g 
earning the importance of the Trp residue for 
hormonal activity, Hofmann et al. investigated the 
effect of replacement of tryptophan by phenylala-
nine. For [ein , Pbsj-ß-corticotrophin-(1-20)-a-
24 
mide he found a nearly complete loss of steroido-
genic activity; the melanocyte-stimulating activi-
ty of the compound appeared to be about 10 U/g 
(about 108U/g for АСТН-(1-24П. Further investiga­
tions using a particulate fraction from beef adre­
nal cortical tissue which appeared to contain ACTH 
receptors led to the conclusion that the trypto­
phan residue in ACTH had an, as yet undefined, 
"functional" importance in the very process by 
1 Б 
which ACTH exerts its physiological action 
The replacement of tryptophan by N -methyl-
tryptophan is another substitution that eliminates 
25 
adrenocorticotrophic activity almost completely 
The most recent communication concerning the 
role of tryptophan in ACTH comes from Ramachandran 
et al.. Chemical modification of the single tryp­
tophan residue in ACTH by reaction with o-nitro-
8 
phenyl sulphenyl chloride results in the loss of 
the lipolytic activity of the hormone in rat fat 
2 fi 
cells . On the other hand, Nps-ACTH was more po­
tent than ACTH in stimulating lipolysis in rabbit 
2 7 
fat cells and in darkening amphibian skin . The 
steroidogenic potency of the modified peptide was 
reduced to about 1/70-1/Θ028. 
Seelig, Kumar and Sayers have tested 
[trp(Nps) 3-ß-corticotrophin-(1-39) and 
LTrp(Nps) J-0-corticotrophin-(1-24) in the isolated 
29 
rat adrenal cell system of Sayers et al. and 
found that the maximum rate of steroidogenesis is 
less than that induced by the agonists ACTH-(1-39) 
and ACTH-(1-24). Their conclusion was that these 
observations emphasize the importance of unmodified 
tryptophan residue at position 9 in ACTH in the 
process involved in the excitation of the recep-
. 3D tor 
g 
Up to now, replacement of tryptophan in o-MSH 
by another amino acid has not been investigated. 
Substitution of L-tryptophan by its D-isomer, car-
ried out in the pentapeptide sequence 6-10, result-
ed in a compound with a slightly lowered activity 
31 
according to Yajima . Koida, however, found the 
modified peptide to be 17 times more potent than 
32 
the all-L-peptide . Similar pentapeptides with 
several other combinations of L- and D-amino acids 
have been synthesized and tested; the activities 
1 G 
found vary widely . ot-MSH in which histidine, 
phenylalanine, arginine and tryptophan were pres-
ent as D-isomers gave a very low melanocyte-stim-
g 
ulating activity 33 
As a working hypothesis for further investiga-
tions into the specific structural demands of the 
amino acid residue at position 9 in natural ACTH 
and a-MSH, we have supposed that the known elec-
tron donor properties of the indolyl side-chain in 
34 tryptophan might be related to the apparent, but 
as yet undefined, functional importance of this 
anino acid in these hormonal factors. Replacement 
of tryptophan by an amino acid having comparable 
donor properties seemed a useful method to test 
this hypothesis. Schwyzer et al. found that the 
donor properties of tryptophan are comparable with 
35 those of DL-pentarnethyIphenylalanine . Therefore, 
we decided to synthesize this artificial amino 
acid, to resolve it into its antipodes and to in-
corporate the L-enantiomer into ACTH-(1-24). For 
comparison, tryptophan was also replaced by an 
amino acid having no, or almost no, charge-trans-
fer properties, viz. phenylalanine. 
Since the ACTH-(I-IO) sequence is the same as 
in a-MSH, we also decided to synthesized ot-MSH 
9 
analogues with tryptophan replaced by L-penta-
methyIphenylalanine and L-phenylalanine. 
10 
I. г STRATEGY, COUPLING METHODS AVD PROTECTIVE 
GROUPS EMPLOYED HI THE SYNTHESIS OF ACTH 
AND a-4SH PEPTIDES 
The principle of carboxyl activetion of an 
ami no-protected amino acid or peptide followed by 
reaction of the activated derivative with a car-
boxy 1-protected amino acid or peptide, forms the 
basis of almost all peptide syntheses. In order to 
obtain an homogeneous product, all other reactive 
groups than those involved in the formation of the 
new peptide bond have to be blocked temporarily in 
3 fi 
both reacting components 
Surveys of protecting groups and peptide-forming 
agents suitable for the synthesis of corticotro-
2 37 
phic peptides have been given previously ' and 
provided a useful basis for our synthetic investi­
gation . 
The most widely employed amino-protecting 
groups are the benzyloxycarbony1 group, introduced 
3 fi 
in 1932 by Bergmann and Zervas , and the tert. 
butyloxycarbony1 group, first introduced by Car-
39 pino as a general protecting group for nitrogen 
in organic compounds. This was later adapted for 
40 
use in peptide synthesis by McKay and Albertson 41 
and, independently, by Anderson and McGregor 
Since the benzy loxycarbony 1 group is labile t.o ca­
talytic hydrogenolysis and the tert. butyloxycar-
bonyl group resists hydrogenolysis (labile to 
acids), these groups can be used together when a-
mino groups are present in the side-chains. A new­
ly developed acid-stable, alkaline-1abile amino-
11 
protective group, the methyIsulphonylethyloxycar-
42 bonyl (Msc-) group has also been used in our 
syntheses of ACTH peptides. 
The most general method for reversible block­
ing of carboxylic groups is esteri fication. The 
43 
alkali-stable tert. butyl ester (generally used 
for the side-chains of glutamic and aspartic acid) 
44 
and the alkali - labi le methyl (or ethyl) ester 
have found wide employment in the synthesis of 
corticotrophiс peptides. 
As to the sequence in which the various peo-
tide bonds have to be formed, it is generally ac­
cepted that in the syntheses of longer peptides, 
condensation of peptide fragments is preferable 
to stepwise synthesis because the problem of pu­
rification becomes more severe in the latter. 
Because the danger of racemization in coupling 
steps does not exist when the carboxyl activated 
component has a glycine residue as the C-terminal 
end, syntheses of corticotrophiс peptides always 
employ coupling of an .V-terminal decapeptide with 
the desired C-terminal peptide as the final step. 
Both the decapeptide and the relevant C-terminal 
fragments can be built up from smaller fragments 
using procedures which minimize the danger of race­
mization. Such methods include azide coupling, 
45 
which was originally introduced by Curtius and 
46 
modified by Honzl and Rudinger , and the carbo-
47 dumide method with the addition of tf-hydroxy-
12 
4 6 49 
succinimide or 1 -hydroxybenzotnazole . Synthe­
ses of these smaller fragments can then be done 
stepwise as well as by fragment condensation via 
active esters [i.e. p-nitropheny1 ester ) or by 
5 1 
employing the mixed anhydride method . Besides 
these methods we have also employed the triphenyl 
52 phosphite method of Mitin and Glinskaya in the 
synthesis of snail fragments. 
I . 4 SYNOPSIS OF THE THESIS 
In chapter II the synthesis and resolution of 
pentamethyIphenylalanine is described. 
Chapter III deals with the synthesis of two 
tetracosapeptides with pentamethyIphenylalanine 
substituted for tryptophan , гг. |_Pmp J- and 
г 1 On 
|_D-Ser , Pmp J - ß-corti cotrophin- ( 1 -24 ) - tetracosa-
peptides. The latter analogue was synthesized as 
it has been shown that the presence of the D-iso-
mer at the //-terminal position slows down enzymat-
ic degradation of corticotrophins and consequent-
ly can enhance biological potencies in the usual 
4- +. 4- 5 3 
test systems 
г 9~Ì г 1 -^| 
The synthesis of |_PheJ- an^ |_D-Ser , Phe'J-
f5- corticotrophin- ( 1 -24 ) -tetracosapeptides is des­
cribed in chapter IV. 
In chapter V the synthesis of [Pmp 3" and 
[Phe3]-a-MSH is described. 
Chapter VI deals with the electron donor prop­
erties of several tryptophan containing peptides 
and the corresponding pentamethyIphenylalanine and 
phenylalanine compounds. 
13 
In chapter VII the biological properties of 
the four ACTH- and two o-MSH analogues are summa­
rized. 
The synthesis of the ACTH-(7-10)-tetrapeptide 
о 
with arginine replaced by norarginine is des­
cribed in chapter VIII, while the synthesis and 
о 
biological activity of (j\|ar J -0-corti cotrophin-
о 7 7 7 Я 
( 1 -24) -tstracosapeptide and of [JMar , Lys * J-
ß-corticotrophin-С1-1Ö)-octadecapeptide amide are 
given in chapter IX. The octadecapeptide amide 
analogue was synthesized for comparison with the 
previously investigated homoarginine -peptide 
which had the same number of amino acid residues. 
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C H A P T E R I I 
SYNTHESIS AND RESOLUTiniM OF 
•L-PENTAMETHYLPHENYLALANINE 
II. 1 INTRODUCTIOn 
As already msntioned in chapter I, our inten­
tion was to synthesize a new amino acid with elec­
tron donor properties and to replace tryptophan in 
a natural peptide by this amino acid in order to 
investigate the possible role of tryptophan as an 
electron donor in biologically active peptides, 
particularly in the adrenocorticotrophiс hormone. 
1 9 Carrion et al. ' have already pointed out that 
tne side-chain of DL-pentanethyIphenylalanine pos­
sesses charge donor properties comparable with 
those of the indole side-chain of tryptophan. There­
fore, we decided to synthesize this amino acid, to 
resolve it into its enantiomers and to insert the 
L-isomer into ACTH. 
From the host of methods used for the prepara-
3 
tion of amino acids , the most convenient one in 
this case seemed to be the reaction between the ap­
propriate alkyl chloride and diethyl acetamidomalo-
4 
nate . The resulting intermediate can lead either 
to the free amino acid by treatment with hydrogen 
bromide, or to the /7-acetyl derivative by hydroly­
sis of the ethyl ester functions with aqueous so­
dium hydroxide and decarboxylation. 
21 
Enzymatic resolution of acetyl derivatives of 
amino acids is a general method. Chemical resolu-
tion can also be attempted with such compounds but 
then an energie hydrolysis must be employed to af-
ford the free amino acid. 
Finally, the assignment of the configuration of 
new amino acids can be performed with the aid of 
optical rotatory dispersion measurements . 
II. 2 SYNTHESIS OF N-ACETYL-DL-PENTAMETHYLPHENYL-
ALANINE 
For the application of the procedure of Albert-
4 
son and Archer in the synthesis of the amino acid 
derivative, diethyl acetamidomalonate and pentame-
thylbenzyl chloride were necessary as the starting 
compounds; the chloride in its turn was synthesized 
from mesitylene (scheme II, 1]. 
In 1934 Von Braun and Nelles introduced one 
or two chloromethyl groups into aromatic hydrocar-
bons with hydrogen chloride and formaldehyde. Nauta 
and Dienske chloromethylated mesitylene (I) under 
varying conditions. They obtained about 15% of the 
dichloromethy1 compound (II) using equimolar a-
mounts of formaldehyde and mesitylene. Using two 
equivalents of formaldehyde, the yield increased up 
Q 
to 724. Shacklett and Smith , using Von Braun's 
method, found that a second addition of formal-
dehyde and subsequent heating was unnecessary and 
succeeded in obtaining some B0% bis(chloromethy1)-
mesity lene. 
22 
Several procedures have been described for the 
reduction of chloromethylated mesitylene. Vavon and 
g 
Bolle claimed that the chloromethyl group can be 
transformed into a methyl group without hydrogéna-
tion of the ring by limited hydrogénation in the 
presence of platina. 
10 Aitken et al. have tried to reduce bisichlo-
romethy1)mesitylene with hydrogen and palladised 
asbestos in acetone; this method appeared to be 
tedious, however, and gave incompletely reduced 
products. Reduction of the chloromethyl group with 
zinc and aqueous sodium hydroxide solution in ben-
zene by Von Braun and Nelles resulted in some 70% 
of pentamethyIbenzene (III). Zinc and aqueous so-
dium hydroxide gave mainly non-crystalline un-
distillable products however, and the same is true 
on reduction with a nickel-aluminum alloy and aque-
ous sodium hydroxide at 90 С The reaction was most 
readily accomplished by stirring the product in 
toluene with zinc and aqueous sodium hydroxide. The 
yield of pentamethyIbenzene was then higher than 
with benzene as the solvent. 
α 
Finally, Shacklett and Smith obtained poor 
yields in the hydrolysis of the Grignard reagents 
of chloromethylated aromatics, but they obtained 
the reduction product in nearly quantitative yield 
when the halide was treated with lithium hydride or 
lithium aluminum hydride in tetrahydrofuran solu­
tion. 
We obtained a nearly quantitative yield by 
simple hydrogénation of the bis(chloromethy1) com-
23 
pound (II) in acetic acid with palladium on char­
coal which consaquently proved to be the method 
of choice. 
The synthesis of pentanethyIbenzy1 chloride 
(IV) from pentamethyIbenzsne has been carried out 
11 by treatment with chloromethyl methyl ether and 
acetic acid at GO С for about 17 hours ' . Ac-
1 1 
cording to Pepper a much smoother reaction takes 
place with chloromethyl methyl ether and tin tetra­
chloride at low temperature. 
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The other starting compound, diethyl acetamido-
malonate (V), was prepared according to the method 
1 4 
of Zambito and Howe . Coupling of this malonate 
with pentanethyIbenzy1 chloride was performed in 
1 4 
absolute ethanol with sodium ethylate ' . Traces of 
water do not impair the alkylation of the malonate, 
but the product isolated is V-acety1-DL-pentamethy1-
phenylalanine ethyl ester (VII) rather than the ma­
lonate (VI). 
By alkaline hydrolysis and subsequent decar­
boxylation of the diethyl 2-pentamethyIbenzy1-2-
acetamido malonate (VI), the racemic pentamethyl-
phenylalanine derivative (VIII) was obtained. 
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II. 3 RESOLUTION A'JD ASSICV'JENT OF CONFIGURATION 
1 5 According to Greenstein and Winitz resolution 
can be achieved: 
a) by selective crystallization 
b) biologically, by means of specific snzynes, as 
for instance carboxypeptidase, renal and mould 
acylase (carboxypeptidase is to be preferred 
when aromatic amino acids are involved) 
c) by chemical means 
Because method a) can only be used if one of 
the isomers is available we tried the enzymatic 
method b) as applied in the resolution of phenyl­
alanine. L-phenylalanine is obtained in fairly good 
yield by digestion of chloroacetyl-DL-phenylalan ine 
25 
or the acetyl compound with hog renal acylase I or 
carboxypeptidase, respectively 
In our case the turnover rate of the hydrolysis 
1 7 
with carboxypeptidase A proved impracticably slow 
(0.5 pmol/mg/h) for a usable resolution. Enzymatic 
hydrolysis has been used, later on, to corroborate 
the assigned configuration. 
Chemical resolution of acids has mostly been 
carried out with alkaloids such as brucine, ephe-
drine, quinine and cinchonine, or other optically 
active bases such as a-phenylethylamine, dexamphe-
1 ñ 
tamine and a-fenchylamine. Gverby and Ingersoll 
unsuccessfully attempted to resolve Л'-acety 1-DL-
phenylalanine with a-phenylethylamine, ephedrine, 
brucine, cinchonine and quinine. A resolution giv­
ing both forms in the pure state was easily ef­
fected, however, with optically active a-fenchyl-
amines. With the (-)amine mainly the salt of the 
acety1-D-amino acid precipitated and was readily 
obtained in pure form in 80-93% yield. The salt of 
the acety1-L-amino acid proved to be very soluble 
and remained in the mother liquor. On decomposition 
of the separated salts by treatment with alkali, 
the amine was nearly quantitatively recovered and 
pure acety1-D-amino acid and partially resolved 
acety1-L-amino acid were obtained. Pure acetyl-L-
phenylalanine was then obtained from the partially 
resolved material by one or two crystallizations 
from acetone, in which the accompanying DL-form is 
more soluble. In this way complete resolution was 
effected with only one form of the resolving agent. 
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For the resolution of our acety1-DL-pentamethy1-
phenylalanine several optically active bases such 
as (-)ephedrine, ( + )dexamphetamine, quinine and 
brucine were tried. It appeared that only the bru­
cine salts of the acetylated antipodes differed suf­
ficiently in solubility to obtain good resolution. 
A favourable feature of the procedure was the 
independent crystallizability of both diastereome-
ric salts from different solvent systems once they 
had been roughly separated. So ethyl acetate/propa-
nol-2 preferentially dissolves the salt containing 
the dextrorotating acid, and methanol the other. 
Methanol is also an excellent solvent for the mix­
ture of both salts. Thus, the fundamental problem 
in chemical resolutions concerning the stereochemi­
cal purity of the "second, better soluble" fraction 
did not arise in this case. 
Decomposition of both diastereomeric salts was 
carried out with an excess of hydrochloric acid in 
propanol-2. When a primary alcohol was used, par­
tial esterifi cation occurred rapidly. The anti­
podes were isolated in nearly theoretical yield, 
and their absolute specific rotations were equal 
within the limits of experimental error. 
Hydrolysis of the acetylated antipodes was per­
formed by heating their solutions in acetic acid 
with concentrated aqueous hydrochloric acid under 
reflux. In both cases the product crystallized on 
cooling in the form of its monohydrochloride mono-
hydrate. (On drying in a high vacuum at О С over 
P-0,-, efflorescence was observed and an anhydrous 
hydrochloride was left. In moist air the hydrate 
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reconstituted itself.) Treatment of its solution in 
acetic acid with ammonium acetate gave the free ami­
no acid. 
As the deacetylation procedure was rather dras­
tic, the risk of partial racemization at this step 
is not merely theoretical. Perceptible racemization 
could be ruled out by reacetylation of a sample: 
the rotation of the product appeared to be unal­
tered . 
The resolution was performed twice, with dif­
ferent batches of brucine. The results supported 
each other. 
Assignment of the configuration was performed 
by rotatory dispersion measurements . Positive Cot­
ton effects were recorded for dextrorotating N-ace-
ty1-pentamethyIphenylalanine as well as for N-ace-
ty1-L-phenylalanine and L-phenylalanine. The (+)-
enantiomer was also susceptible to enzymatic at­
tack: digestion with carboxypeptidase A, although 
very slow, resulted in precipitation of the free 
amino acid after one day of incubation. The optical 
rotatory dispersion curve of the precipitated amino 
acid also revealed a positive Cotton effect. The 
levorotating enantiomer was not digestible with 
carboxypeptidase A. 
From these observations we attribute L-configu-
ration to С+)-acety1-pentamethyIphenylalanine and 
D-configuration to its enantiomer. As deacetylation 
did not alter the sign of the rotation, dextrorota­
tory pentamethyIphenylalanine has to be looked 
upon as belonging to the class of amino acids 
having "natural" asymmetry. 
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II. 4 EXPERIMENTAL SECTION 
For details concerning abbreviations, thin-layer chro­
matography and performance of measurements, see appendices. 
Scheme II, 1 . 
Bis ( chloromethyDmesitylene (II) 
1 Mole of mesitylene (120 g = 139.5 ml), 2.65 moles of 
formaldehyde (as a 37% solution = 240 g = 220.5 ml) and 
7.36 moles (460 g = 610.5 ml) of a concentrated HCl solu­
tion were mixed together in a three-necked round bottom 
flask, equipped with a stirrer, a condenser and an inlet 
tube for gaseous HCl. While stirring at 65 С HCl was in­
troduced and a precipitate separated. After 5 hours, water 
was added and the precipitate was filtered, thoroughly 
washed with water and dried. Upon recrystallization from 
acetic acid 76% of II was obtained; it still contained a 
small quantity of tri(chloromethyl)mesitylene. 
И.p. 103-105oC. Lit.7 105oC, lit.19 105-106oC. N.M.R. 
(CC14): i 7.15 (s, IH, ф-Н), 4.90 (s, 4Н, СН2С1). 2.76 (s, 
ЗН, р-СН 3), 2.6Θ (s, 6Н, о-СН3). 
Analysis : 
С..Н Cl Caled.: % С 60.65 % H 6.50 % Cl 32.65 
(217.14) Found : % С 61.0 % H 6.3 % Cl 33.9 
Pentamethylbenzene (III) 
Catalytic hydrogénation of II with palladium on char-
coal was performed in acetic acid. On concentration of the 
filtered solution some hexamethylbenzene crystallized. Ad-
dition of water and cooling followed by filtration and 
drying gave 94% of III. 
M.p. 52-530C. Lit.6 51e 
ф-Н), 2.45 (m, 15H, ring CH 3), 
0C. N.M.R. (CCI.): δ 6.96 (s, 1Η, 
29 
Determination of the chlorine content indicated that about 
0·9% Cl remained. 
Pentamethylbenzyl chloride (IV) 
72.1 g of pentamethylbenzene (0.49 moles) were dis­
solved in 200 ml of chloroform (p.a.) and the solution was 
cooled in an ice bath. A solution of 73.3 nl of chlorome-
thyl methyl ether (0.96 moles) and 12 ml of tin tetrachlo­
ride (0.13 moles) (both freshly distilled) was added step­
wise. The solution was stirred for 16 hours at 0-4 С After 
addition of water, the chloroform layer was separated, 
washed with water and saturated NaCl solution, dried over 
Na^SO and evaporated. The residue was recrystallized from 
90% acetic acid yielding 85% of pure IV with m.p. B2-B4 С 
Lit. 1 2 a0oC, 1 9 · 2 0 a0-B2oC, 2 0-82.5оС, a B2-840C, 2 1 990C 
and 1 Э 161-1Б50С. N.U.R. (CDC13): 6 4.64 (s, 2H, CH2C1), 
2.29 (s, 6Н, о-СН3), 2.16 (s, 9Н, m- and р-СН 3). Lit.
20
: 
N.M.R. (CDC13): δ 4.74, 2.37 and 2.25. 
Analysis : 
C 1 2H 1 7C1 Caled.: % С 73.27 Ч Η 8.71 Ч Cl 18.02 
(196.72) Found : Ч С 73.5 Ч H 8.9 Ч Cl 18.1 
Scheme II, 2. 
Diethyl acetamidomalonate (V) 
The malonate was prepared according to the method of 
Zambito and Howe. Recrystallization from water (the hot so­
lution must be stirred vigorously upon cooling) yielded 
72.5% of V, m.p. 94-960C. Lit.14 95-970C. TS: Rf = 0.55 
(A) (I 2). N.M.R. (OMSO-dg): 6 8.95 (d, IH, NH, J N H_ C H * 7 
cps), 5.29 (d, 1H, CH), 4.36 (q, 4H. 0CH2-CH3, J = 7 cps), 
2.11 (s, 3H, CH3-C0-), 1.39 (t, 6H, 0CH 2-CH 3). 
Analysis : 
C9 H15 N 05 Caled.: Ч С 49.76 % H 6.96 % Ν 6.45 
(217.22) Found : % С 49.7 % Η 7.1 % Ν 6.4 
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Diethyl(2-pentamethyІЪепгуІ-2-aoetamido)ma lanate (VI) 
62.5 g of pentamethyIbenzyl chloride (317.2 mmolas) and 
64 g of V (3Θ2.1 mmoles) were added to a clear and colour­
less solution of 8.0 g of sodium in about 1600 ml of dried 
and freshly distilled ethanol. The solution was refluxed 
for 20 hours and then filtered and concentrated. On addi­
tion of some ethyl acetate and petroleum ether about 60% 
of VI precipitated. The product was purified by crystalli­
zation from 70% acetic acid, giving large rectangular 
plates. Yield: 70%. M.p. 133-1350C. Lit.2 (990C) 112-1140C 
(1250C). TS: Rf = 0.60 (A) (R-H). N.M.R. (CC14): δ 6.61 
(s, IH, NH), 4.35 (several quartets (4?) due to hindered 
rotation. 4H, 0CH2-CH3, 3 = 7 cps), 4.00 (s, 2H, ф-СН-), 
2.39 (m, 15H, ring CH 3), 2.12 (s, 3H, CH3-CQ-). 1.48 (t, 
6H, DCH 2-CH 3). 
Analysis : 
C21 H31 N 05 Caled.: % С 66.82 % H 8.28 % Ν 3.71 
(377.48) Found : % С 66.7 % Η 8.3 % Ν 3.7 
fì-Acetyl-DL-pentamethylphenylalanine ethyl ester (VII) 
When the reaction mixture in the preparation of VI con-
tained some water, originating either from the ethanol or 
the malonate, a by-product separated on addition of ethyl 
acetate. M.p. 142-143Ο0. TS: Rf = 0.51 (A) (R-H). N.M.R. 
(CC14): Í 6.94 (d, 1H, NH, Û N H_ C H = В cps), 5.86 (m, IH, 
Сн-сн2. ^сн-снг
 = 0 c p s K 4
·
2 1 ( q
'
 2 H
'
 0£íÍ2-CH3' :]QZH2-ZH2 
= 8 cps), 3.36 (d, 2H, ф-СН2-). 2.48 (s, 6H, o-CH 3), 2.44 
(s, 9H, m- and p-CHg). 2.19 (s. 3H, CHg-CO-), 1.28 (t, 3H, 
осн 2-сн 3). 
Analysis : 
C18 H27 N 03 Caled.: % С 70.79 % H 8.91 % M 4.59 
(305.42) Found : % С 70.6 % H 8.9 % N 4.5 
When tf-acetyl-DL-pentamethylphenylalanine (VIII) was 
dissolved in benzene/ethanol and refluxed for a few hours 
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with some p-toluenesulphonic acid, the same compound was 
produced, as judged from its malting point, Rf value and 
N.n.R. pattern, 
N-Acetyl-DL-pentamethylphenylalanine (VIII) 
By alkaline hydrolysis and decarboxylation of the fore­
going compound, the racemic pentamethylphenylalanine deriv­
ative was obtained. Therefore, diethyl(2-pentamethyIben-
zyl-2-acetamido)malonate was dissolved in a mixture of di-
oxan and water (2:1). A solution of 4 N sodium hydroxide 
(about 20% excess) was added, and the solution refluxed for 
about 18 hours. Dioxan was removed under reduced pressure 
and the resulting solution extracted with ethyl acetate to 
remove some 5% of unreacted starting material which was re­
cycled. The aqueous layer was poured into an excess of 6 N 
hydrochloric acid with stirring, then cooled and filtered. 
After recrystallization from 90% acetic acid, about 96% of 
a chromatographically pure product was obtained, m.p. 247-
24 0С, TS: Rf = 0.67 (В). = 0. 1 (С) (R-H). 
Analysis : 
C16 H23 N 03 
(277.36) 
Caled.: 
Found : 
% С 69.29 
% С 68.9 
% H В.ЗБ 
% H 8.5 
% Ν 5.05 
% Ν 5.0 
Resolution of N-acetyl-DL-pentamethylphenylalanine 
Because of the limited solubility in the solvent system 
used for the resolution, 65.0 g (234.3 mmoles) of tf-acetyl-
DL-pentamethylphenylalanine and 92.3 g (234.3 mmoles) of 
brucine were dissolved in 650 ml of warm methanol. The sol­
vent was removed by evaporation, and evaporation was repea­
ted after the addition of some propanol-2 to eliminate re­
sidual methanol. The residue containing the diastereomeric 
brucine salts was dissolved in 300 ml of warm propanol-2, 
the same volume of ethyl acetate was added and the solution 
stored in a refrigerator for 7-8 days. After filtration and 
washing of the precipitate (A) with ethyl acetate, the com-
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bined filtrates were evaporated to dryness, the residue 
taken up in ethyl acetate and the solvent evaporated again. 
To remove the last traces of propanol-2 this procedure was 
repeated. The residue was dissolved in some 300 ml of warm 
ethyl acetate and the solution was cooled and kept at about 
0 С for 1 week. A small amount of precipitate (B) was fil­
tered and the filtrate evaporated to dryness. Following 
dissolution of the residue in 300 ml of warm methanol im­
mediate crystallization occurred upon cooling, giving frac­
tion C. 
Fractions A and С were recrystallized from ethyl ace-
tate/propanol-2 (1:1) and methanol, respectively. 
Fraction 
A 
В 
С 
Yield 
69.2 g = 43.9% 
2.5 g = 1.6% 
57.a g = 36.7% 
M.p. 
216-21B°C 
130-240oC 
129-1340C 
[a]2D4 (c = 1.0, MeOH) 
-16.0° 
- 2.4° 
- 6.2° 
N-Aoetyl-L-pentamethylphenylalanine 
54.84 g of the brucine salt С (60.3 mmoles) were dis­
solved in 200 ml of propanol-2. Fifty ml of 4 N hydrochlor­
ic acid (200 mmoles) were added with stirring followed by 
about 1300 ml of water. After cooling, the precipitate was 
filtered, washed with dilute hydrochloric acid and dried. 
Yield: 21.05 g = 94.5% of a chromatographically pure 
product; TS: Rf = 0.60 (C) (R-H). M.p. 246-24a0C (the crys­
tals melted at about 222 C, but then suddenly gave long 
thin needles, which melted again at 246-248 C). N.M.R. 
(DMSO-dg): Í 8.39 (d, 1H, NH, 3 N H_ C H = 8 cps), 4.48 (m, IH, 
ÇH-CH2), 3.20 (d, 1H, С
е
Н
д
, J
c н
.
с н
 = 7 cps), 3.28 (d, 
IH. CgHg, J
c н
.
С в Н
 = 9 cps), 2.37 (s, 6H, o-CHg), 2.33 (s, 
9H, m- and p-CHj), 2.00 (s, ЗН, СН,-С0-). 
[a]JJ - -15.8° (с = 1.0, ПеОНЬ [
α
] 5 7 8 = *16.7
0
. [α]
 5 4 В = 
•19.3°, Ы Д З Б = +38.0 ο, [а]з65 • -74.2°. 
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Analysis : 
C,
c
H_,NO- Caled.: % С 69.29 % Η θ.36 % Ν 5.05 16 23 3 
(277.36) Found : % С 69.2 % Η В.5 % Ν 5.0 
W-Acatyl-D-pentamsthyIphenylalanine was obtained from 
its brucine salt (A) in a similar manner in ΘΒ% yield. 
M.p.i 242-2450C. (The crystals melted at about 2180C, giv­
ing long thin needles which melted again at 242-245 C.) 
N.M.R.: identical with that given for the L-compound. 
[ a ] " - -16.0° (c = 0.98, MeOH); [ a ] 5 7 B = -16.5°, M ^ g * 
-19.4°, [a]436 = -38.1°. [ a ] 3 6 5 - -74.4°. 
Analysis: Found: \ С 69.3 % Η 8.5 % Ν 5.0 
L-Pentamethylphenylalanine monohydroahloride monohydrate 
The Ä-acetyl compound (20.03 g = 72.2 mmoles) was dis-
solved in 200 ml of concentrated aqueous hydrochloric acid 
and 200 ml of glacial acetic acid, and the solution was re-
fluxed for 5 hours. When heating was discontinued crystal-
lization started at once, and 20.37 g • 97.5% of 
L-H-Pmp-0H.HC1.H20· could be isolated. TS: Rf - 0.50 (D) 
(R-H). M.p.: 256.5-2580C. 
[a]pJ = +55.2° (c = 0.59, HOAc + 0.1 N HCl (4:1П; [ α ] 5 7 8 
= +57.2°, [ o ] 5 4 6 = •es.a0. [ а ] 4 з 6 = •іго.э 0 . [ α ] 3 6 5 = 
+211.8°. 
Analysis : 
C 1 4H 2 4N0 3C1 Caled.: % С 58.02 % Η 8.35 % Ν 4.83 % Cl 12.23 
(289.80) Found : % С 57.8 % H 8.3 % Ν 4.7 % Cl 12.4 
* Suggested three-letter symbol for L-pentamethyIpheny1-
alanine is Pmp. 
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The same p r o c e d u r e was used t o o b t a i n t h e D - i s o m e r , 
m . p . 2 5 4 . 5 - 2 5 6 0 C . [ a ] p J = - 5 4 . 9 ° ( c = 0 . 6 4 . HOAc • 0 . 1 N 
HCl ( 4 i 1 ) ) ( [ a ] 5 7 B - - 5 7 . 0 ° , [ „ ] „ , . - - 6 5 . 7 ° , [ a ] ^ -
- 1 2 0 . 3 ° , Ы э 6 5 = - 2 1 1 . 3 ° . 
A n a l y s i s : Found : % С 5 7 . 9 % H В.З % Ν 4 . 7 % Cl 1 2 . 4 
L-Pentame thyIphenyI alanine 
The f r e e amino a c i d was o b t a i n e d f r o m i t s h y d r o c h l o r i d e 
upon d i s s o l u t i o n i n h o t a c e t i c a c i d ( 1 0 0 % ) , a d d i t i o n o f an 
e x c e s s o f ammonium a c e t a t e , and d i l u t i o n w i t h w a t e r . Con­
s i s t e n t a n a l y t i c a l d a t a were o b t a i n e d a f t e r t h o r o u g h d r y ­
i n g (Θ0 С i n h i g h vacuum f o r a b o u t В h o u r s ) . M . p . : 2 4 2 -
2 4 5 ° C . 
[ a ] ^ J = + 6 5 . 7 ° ( c = 0 . 4 6 , HOAc + 0 . 1 N HCl ( 4 : 1 ) ) ; [ ο ] 5 7 β -
+ 6 6 . β 0 . [ a ] 5 4 6 - + 7 6 . 5 ° . [ a ] 4 3 6 - + 1 4 4 . 7 ° . [ a ^ -
+ 2 5 4 . 4 ° . 
A n a l y s i s : 
C 1 4 H 2 1 N 0 2 C a l e d . : % С 7 1 . 4 6 % Η 9 . 0 0 Ч Ν 5 . 9 5 
( 2 3 5 . 3 3 ) Found : % С 7 1 . 5 Ч Η 9 . 1 Ч Ν 5.9 
The same p r o c e d u r e was used t o o b t a i n t h e D - i s o m e r , 
m . p . : 2 4 3 - 2 4 6 ° C . [ a ] " » - 6 5 . 4 ° ( c = 0 . 4 7 . HOAc + 0 . 1 N HCl 
( 4 : 1 ) ) ; [ α ] 5 7 Β - - 6 8 . 3 ° , [ α ] 5 4 B = - 7 6 . 1 ° . [ α ] ^ = - 1 4 4 . 0 ° . 
Ы э б з - - 2 5 4 . 3 ° . 
A n a l y s i s : Found : Ч С 7 1 . 2 Ч Η 9 . 0 % Ν 5 . 6 
From t h e f r e e amino a c i d UV s p e c t r a were r e c o r d e d . 
I n HOAc - 0 . 1 N HCl ( 4 : 1 , V / v ) : 
X = 2 7 1 . 5 nm ( ε = 3 7 2 . 0 ) and 2 7 7 . 0 nm ( E = 3 2 7 . 5 ) t 
max 
i n 0 . 1 N NaOH: 
λ - 2 9 6 . 0 nm ( ε - 3 6 1 . 4 ) and λ . - 2 4 9 . 0 nm ( ε - 2 0 2 . 9 ) , 
max m m 
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C H A P T E R I I I 
SYNTHESIS OF TWO ACTH-(1-24) ANALOGUES CONTAINING 
L-PENTAMETHYLPHENYLALANINE IN POSITION G 
JJI. 1 INTRODUCTION 
A widely accepted strategy for the synthesis 
of corticotrophic peptides is that used by Schwyzer 
and coworkers in the synthesis of the natural ACTH 
itself . Applied to the synthesis of corticotrophic 
tetracosapeptides the last step in the formation of 
the protected end-product is a carbodiimide media­
ted coupling generating the glycyl-lysyl bond be­
tween a desired /V-terminal decapeptide and the ap­
propriate C-terminal fragment. 
In our case the desired variation from the nat­
ural sequence consisted of the replacement of tryp­
tophan by pentamethylphenylalanine in the mentioned 
^-terminal part. Therefore, we started by synthesi-
zing 1_Ртр J - ß-corticotrophin-(7-1 0 )-tetrapept ide . 
The peptide was prepared via intermediates bearing 
conventional protecting groups (including the nitro 
function for the protection of the arginine side-
chain) (scheme 111,2), and also along a newly adop-
ted route in which the alkali - labi le methylsulpho-
2 
nylethyloxycarbonyl (Hsc) group was used for amino 
protection and the arginine side-chain was left un-
protected (scheme III, 1). It appeared that the 
latter reaction pathway greatly shortened the pro-
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cedure and gave rise to a purer end-product. In the 
former scheme in particular the deprotection steps 
led to difficultly crystallizable intermediates of 
poor quality, and to unsatisfactory yields. 
The tetrapeptide liberated from protection 
groups was then elongated at the //-terminal end by 
two successive azide couplings using first a di-
and then a tetrapeptide (scheme III, 3). The latter 
was introduced in two different forms with W-termi-
nal L- and D-Serine. Condensation of the zwitter-
ionic decapeptide with the protected natural (11-
1 
24)-fragment produced the desired tetracosapep-
tides which were converted into the free ACTH anal-
ogues by treatment with trifluoroacetic acid. 
III. 2 METHOD OF SYNTHESIS 
H-Phe-Arg-Pmp-Gly-OH 
A. According to scheme III, 1. 
The synthesis of this unprotected tetrapeptide 
was started by the introduction of the Boc group 
into L-pentamethyIphenylalanine. With Schnabel's 
3 
method only a low yield was obtained due to the 
low solubility of Pmp which decreases in solu-
tions of increasing ionic strengths; a precipi-
tate was formed after 20-30% conversion (6 ob-
servations) and the reaction stopped. With a 15-
20 fold excess of the acylating agent (Boc-N·,), 
however, precipitation could be avoided and ex-
cellent yields were obtained. We speculate that 
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Msc-Phe-OH ( I ) 
Шр/ОСС 
Msc-Phe-ONp + H-АІ-д-О® 
imi 
" μ . ® 
Msc-Phe-A^-O® 
І Ж ) 
Boc-Pmp-OH + H-6ly-0Me-HCl ( I ) 
11) I al Mitin 
I Ы mined anhydride 
Boc-Pmp-Cly-OMe | 1 ) 
HCl/EtOAc 
* H-Pmp-Gly-OMe HCl 
ИГ) 
Hoet/Dcc 
Msc-Phe-Arg-Pmp-Gly-OMe-HCl І Ж І 
dioiw-methanol-ÌNNaOHlK 5 2) 
H-Phe-Arg-Pinp-Gly-OH-HCl Ш І 
Scheme I I I , 1 
the organic phase of the reaction mixture is part­
ly solubilized by micelles of the sodium salt of 
pentamethylphenylalanine, thus preventing its 
"salting-out" by a profound alteration in the so­
lution structure. 
Coupling of the protected amino acids I and II 
4 
was carried out via Mitin's method as well as 
via the mixed anhydride method of Anderson . The 
methods gave similar results. Deprotection of the 
dipeptide III with hydrogen chloride in ethyl ace­
tate yielded the hydrochloride IV as a crystalline 
compound. 
Methylsulphonylethyloxycarbonyl-L-phenylalanine, 
a water-soluble compound, was condensed as its p-
nitrophenyl ester with L-arginine (free base). The 
resulting dipeptide was crystallized from water, 
and then directly condensed with the hydrochloride 
IV according to König's method . It gave the pro-
tected tetrapeptide ester VIII in approximately 95% 
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yield. The crude product was completely digesti-
ble with trypsin. Minor impurities in the crude 
product were largely removed by the "short-
column" chromatographic procedure of Hunt and 
Rigby . 
Deprotection of VIII with aqueous sodium hy-
droxide in dioxan appeared to be complete within 
a few minutes; when methanol was added (dioxan-
methanol-4N sodium hydroxide solution = 14:5:1, 
0.2 N in NaOH) the deprotection proved to be on-
ly a matter of seconds and a chromatographically 
pure product could be isolated. 
According to scheme III, 2. 
After introduction of the t-butyloxycarbony1 
group into L-phenylalanine, the 1-succinimidyl 
ester (XI] was prepared according to the method 
of Anderson . This activated ester was added to 
a solution containing the methyl ester of nitro-
arginine after neutralization of the hydrogen 
chloride present in the ester. The resulting di-
peptide ester (XIII) was hydrolyzed with a di-
oxan-aqueous sodium hydroxide solution, yielding 
some 90% of XIV. Coupling of XIV and IV with 1-
hydroxybenzotriazole and dicyclohexyIcarbodiimi-
g 
de gave the fully protected tetrapeptide which 
appeared to be pure after pecrystallization from 
ethanol. 
Treatment with hydrogen chloride in ethyl ace-
tate followed by hydrogénation in the presence 
of palladium on charcoal did not result in the 
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Boc-Phe-OH ( I l 
HONSu/DCt 
», 
H-Arg-OH 
SOClj/MeOH 
NO 
вос-Phe-OHSu + H-Arg-OMe χ HCl ( « = 1-1 5) 
m 1 IM) 
NO: 
Boc-Phe-Arg-OMe І Ж ) 
NaOH/dioian 
NO] 
Boc-Phe-Arg-OH + H-Pmp-Gly-OMf HCl 
(Μ) HOBl/OCC IS) 
HO; 
Scheme I I I , 2 
Boc-Phe-Arg-Pmp-Gly-OMe I U I 
1 1) acidolysis 21 hydrogenolysis 3) hydrolysis 
H-Phe-Arg-Pmp-Gly-OH HCl ( Ш 
pure deprotected ester. Several attempts at im­
provement of the procedure, in order to avoid 
the necessity of a time-consuming purification 
of the ester, were unsuccessful. 
|_Pmp J- and [D-Ser
 3 Pmp J-Q-corticotrophin-( 1-24)• 
tetracosapeptides (scheme III, 3) 
Acylation of the free tetrapeptide IX with 
Z-Glu(OBu )-His-N? was performed according to the 
9 
гп згіи procedure of Honzl and Rudinger using a 
50% excess of the acylating azide. The resulting 
protected hexapeptide XVI was directly subjected to 
hydrogenolysis to give XVII. This intermediate was 
then similarly acylated with one of the azides de­
rived from XVIII a or b. The ensuing decapeptide 
OBu' 
Z-Glu-His-NHNHj + H-Phe-Arg-Pmp-Cly-OH HCl 
OBu1 i 
I 
Z -Glu-His-Phe-A^-Pmp-Cly-OH 
¡%Mt l m l I-
lu1 Τ Boc-Ser-Tyr-Ser-Met-NHNHj + H-Glu-His-Phe-Arg-Pmp-Oly-OH 
( Л ) 
ІШ) 
Η 
ι© OBu' 
Boc-Ser-Tyr-Ser-Met-Clu-His-Phe-Arj-Prnp-Oly-O0 
ІЖІ 
a=L-Ser' 
0=0-5«·' 
lequiv HCl 
OBu' 
Bot Boc Boc Boc 
I H-Lys-Pro-Val -Gly-Lys-Lys-Ar î -Arg-Pro-Val -Lys-Val -Tyr-Pro-OBu' îHCI 
HOBI/DCC 
Boc Boc Boc Boc 
Boc-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Pmp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pra-Val-Lys-Val-Tyr-Pro-OBu' .aHCI 
(ШІ 
a-L-Ser' 
0=0-5»' 
757. Τ FA 
i 
[L-Ser'.Pmp'J-p-corticotrophm-ll-Ztl-telracosapíptide 
[0-Ser',Pmp5]-p-corticotrophm-|1-2t)-tetracosapeptide 
Scheme I I I , 3 
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derivatives (XIX a and b) were purified by crystal-
lization and used for the acylation of the C-termi-
nal, partially protected tetradecapeptide ester XX, 
to give the two tetracosapeptide derivatives XXI a 
and b. These compounds were purified by counter-
current distribution, and then deprotected with 75% 
trifluoroacetic acid. Although the risk of forma-
tion of alkylated by-products is rather small in 
the present case (no tryptophan), the use of 75% 
trifluoroacetic acid was preferred to the higher 
concentrations which are often used. The resulting 
trifluoroacetates were finally converted into ace-
tates by a weakly acidic ion exchanger. 
Amino acid analyses of acid hydrolysates of 
the products gave all amino acids in the expected 
ratios except pentamethylphenylalanine. Either by 
strong adherence to the matrix of the ion exchange 
column or by its extremely low solubility in buffer 
solutions the amino acid is lost during the opera-
tion. (The same was found for a sample of the free 
amino acid.) 
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III. 3 EXPERIMENTAL SECTION 
For details concerning the abbreviations, thin-layer 
chromatography and the performance of measurements, see the 
appendices. 
Scheme III, 1. 
Boc-Pmp-OH (I) 
2.90 g (10 mmoles) of H-Pmp-0H.HC1.Η,Ο were dissolved 
in 300 ml of a 0.1 N NaOH solution by gentle heating in a 
water bath under N7. About 100 ml of dioxan, followed by 
10 
25 ml of t-butyloxycarbonyl azide (180 mmoles), were ad­
ded with stirring. With the aid of an autotitrator (Radio­
meter, Kopenhagen) the pH was kept constant at 11.0 with 
1 N NaOH solution. The reaction was carried out in a ni­
trogen atmosphere to prevent uptake of CO«. After some 16 
hours the slightly turbid solution was extracted twice 
with ether and acidified with 2 N KHSO. solution. (The 
ether extract contained the excess of Boc-N, which was re­
cycled.) The product precipitated but dissolved rapidly on 
adding ether. The water layer was extracted twice with 
ether, the combined ether layers were washed with water 
and saturated NaCl solution, dried and evaporated. See 
table III-1 for the results. (The procedure was worked 
out first with the D-enantiomer.) 
H-Gly-OMe.HCl (II) 
This ester was obtained in the normal way with thio-
11 
nyl chloride and methanol 
Yield: 99%. M.p.: 1//-1780C. TS: Rf = 0.29 (B), = 0.10 (E) 
(ninh. and R-H). 
Analysis : 
C3HaN02Cl Caled.: % С 26.70 % Η 6.42 % Ν 11.16 % Cl 28.23 
(125.55) Found : % С 28.9 % H 6.5 % Ν 11.5 % Cl 28.6 
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Table III-1 
Yield 14) 
M.p. (0C) 
TS: Rf (В) 
(E) 
H " (с -
Na 589 
Hg 578 
546 
436 
365 
W 2 J Co -
Na 589 
Hg 578 
546 
436 
365 
Analysis 
(R-H) 
(R-H) 
2.0, MeOH) 
2.0, HDAc) 
C19 H29 N 04 ί 3 3 5 · 4 4 ) 
% С (68.03) 
% Η ( В.71) 
% Ν ( 4.16) 
Boc-L-Pmp-OH 
92.0 
163.0-165.0 
0.80 
0.80 
-9.6° 
-9.9° 
-11.4° 
-19.5° 
-29.9° 
-27.0° 
-20.2° 
-32.5° 
-58.7° 
-97.9° 
68.1 
8.7 
4.1 
Boc-D-Pmp-OH 
91.2 
163.5-166.0 
0.60 
0.60 
•9.8° 
+10.4° 
•11.8° 
•20.5° 
•30.9° 
•26.8° 
•28.3° 
•32.5° 
•58.8° 
•98.1° 
67.9 
8.8 
4.1 
Boc-Pmp-Gly-OMe (III) 
a) Using triphenyl phosphite according to the method of 
Mitin4. 
To a solution of 1.883 g (15 mmoles) of II and 1.89 
ml (15 mmoles) of ff-ethylmorpholine in 35 ml of DMF 
were added 5.032 g (15 mmoles) of I, 1.532 g (22.5 
mmoles) of imidazole and 6.981 g (22.5 mmoles) of tri-
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phanyl phosphite. The resulting slightly yellow solu­
tion was stirred at 40 С for some IB hours. After cool­
ing, the reaction mixture was poured out into 300 ml of 
cold water with stirring. After cooling for one hour 
the precipitate formed was filtered, thoroughly washed 
with water and diisopropyl ether, and dried. The prod­
uct was analytically pure. Analytical data are given 
in table III-2. 
b) Mixed anhydride procedure . 
Boc-Pmp-OH (1.677 g, 5 mmoles) was dissolved in 25 
ml of DMF and the solution was cooled at -20 C. An 
equimolar amount of W-ethyImorpholine was added with 
stirring, followed by 0.67 ml (5 mmoles) of isobutyl 
chloroformate at -15 C. After 2 minutes a solution of 
0.690 g (5.5 mmoles) of II and 0.77 ml (5.5 mmoles) of 
triethylamine in 10 ml of DMF were added and the reac­
tion mixture was stirred for 10 minutes. (The tempera­
ture rose spontaneously to about 5 C.) The solution was 
concentrated in vacuo, and about 130 ml of water were 
added with stirring. The isolated precipitate appeared 
to contain some unreacted I. Therefore it was dissolved 
in ethyl acetate, washed with NaHCO, solution and water, 
and dried. After evaporation of the solvent, chromato-
graphically pure III remained. 
H-Pmp-Gly-OMe.HCl (IV) 
5.370 g (13.2 mmoles) of III were dissolved in 35 ml of 
a 2 N HCl solution in dry, peroxide-free ethyl acetate with 
stirring. After 20 minutes the solvent was evaporated. Dry 
ethyl acetate was added to the residue and the solution was 
stirred again for half an hour in an open flask. The hydro­
chloride of the dipeptide ester (IV) crystallized sponta­
neously. After cooling, the product was filtered: 4.170 g 
(92.1%) of IV were obtained, fl.p.: 139.5-141 . 0oC. TS: Rf = 
Table I I I - 2 
Yield (%) 
M.p. (DC) 
TS: Rf (E) CR-H) 
(F) (R-H) 
[c]^ 1 (c = 2.0, М ОН) 
(с = 2.0, DMF) 
Analysis 
C22 H34 N2 05 ( 4 0 6 - 5 2 ) 
% С (65.00) 
% H ( 8.43) 
% Ν ( 6.89) 
Boc-L-Pmp 
Mitin's 
method 
93.1 
158.5-160.0 
0.90 
0.76 
•4.4° 
-9.7° 
65.0 
8.4 
6.8 
-Gly-OMe 
mixed 
anhydride 
90.0 
159.0-160.0 
0.90 
•4.2° 
-9.6° 
64.7 
8.4 
6.6 
Boc-D-Pmp 
Mitin's 
method 
91.9 
157.5-159.5 
0.89 
-4.1° 
•9.3° 
64.7 
8.3 
6.7 
-Gly-ОИе 
mixed 
anhydride 
90.4 
159.0-159.5 
0.89 
-4.Q 0 
•9.5° 
65.3 
8.5 
6.7 
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0.46 (E). • 0.59 (G) (ninh. and R-H). [α]ρ1 = -129.1° (с 
2.0, МеОНЬ = +84.4° (с = 2.0. DMFJ. 
Analysis : 
C17 H27 N2 03 C 1 Caled.: \ С 59.55 % Η 7.94 % Ν Β.1/ 
(342.87) Found : % С 59.5 % Η θ.2 % Η 8.2 
Mse-Phe-OH í\l) 
3.300 g (20 mmoles) of L-phenylalanine were suspended 
in 25 ml of a mixture of acetonitrile and water (4:1). In 
the suspension, 5.780 g (20 mmoles) of methyIsulphonylethyl 
p-nitropheny1 carbonate (prepared from 2-methylsuIphonyl-
2 
ethanol and p-nitrophenyl chloroformate ) were dissolved, 
and the reaction was started by the addition of 2.θ ml (20 
mmoles) of triethylamine. The suspension was stirred over­
night and then filtered yielding 210 mg of unchanged phe­
nylalanine (6.4%). The filtrate was concentrated in vacuo, 
diluted with 20 ml of water, acidified to pH 5, and ex­
tracted with ether. The aqueous phase was acidified to pH 
2, and the resulting biphasic system was heated till a 
clear solution was obtained. Upon cooling, crystallization 
set in giving 5.190 g (82.0%) of V. Recrystallization from 
water gave a product melting at 63 C. Upon drying in vacuo 
over phosphorus pentoxide efflorescence was observed and 
the melting point rose to 1130C. TS: Rf = 0.37 (E) (R-H). 
[a]p2 = +6.0° (c = 1.5, HOAch = -2.6° (c = 1.0, HeOH); 
= -4.0 (c • 1.0, pyridine). 
Analysis 
C 1 3H 1 7N0gS Caled.: % С 49.52 % H 5.43 % Ν 4.44 % S 10.17 
(315.34) Found : % С 49.5 h H 5.4 4 N 4.4 % S 10.2 
Meo-Phe-ONp (VI) 
630 mg (2 mmoles) of Msc-Phe-OH were dissolved in 5 ml 
of pure dimethoxyethane, and 306 mg of p-nitrophenol were 
added. The mixture was cooled at 0 С and 413 mg of solid 
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DCC were carefully added. After 30 minutes the reaction 
flask was allowed to attain room temperature, left for 1 
hour and then put in the refrigerator to complete the 
crystallization of DCU. The mixture was filtered and the 
filtrate was evaporated to dryness, giving an oily resi­
due that rapidly crystallized. Recrystallization from meth­
anol gave a product melting at 141-142 C. Yield: 733 mg 
(84%). TS: Rf = 0.78 (E), = 0.76 (H) (UV and R-H). Ы ц 2 = 
-18.7° (с = 1.5, CH3CN). 
Analysis : 
C 1 gH 2 QN 20 8S Caled.: % С 52.29 % H 4.62 % Ν 6.42 % S 7.35 
(436.44) Found : % С 52.1 % H 4.4 % Ν 6.6 % S 7.3 
Msc-Phe-Arg-OH (VII) 
2.530 g (5.8 mmoles) of Nsc-Phe-ONp were dissolved in 
20 ml of acetonitrile, and 0.Э12 g (5.22 mmoles, 90% with 
respect to the activated ester) of arginine, dissolved in 
4 ml of water, were added. The mixture was stirred at room 
temperature, giving a clear solution in about 90 minutes. 
On chromatography only a trace of arginine was found. The 
reaction mixture was evaporated, and the residue was dilu­
ted with water and filtered to remove unreacted Msc-Phe-GNp. 
The pH of the water layer was adjusted to 5 using a strong­
ly acidic ion exchanger (Η-cycle). After extraction with 
ether the aqueous phase was concentrated, giving about 40% 
of pure VII after cooling. A second batch, increasing the 
yield to 65%, was obtained by heating the evaporated fil­
trate with ethanol. H.p.: 170-172 С. 
1.0, H 20). TS: Rf = 0.53 (H) (R-H). 
Analysis : 
C 1 9H 2 7N 50 6S.H 2G 
(471.53) 
Ы 
21 
D •3.3
U
 (c = 
Caled. 
Found 
Caled. 
Found 
% С 46.62 
% С 46.7 
% Ν 14.31 
% Ν 14.4 
% Η 6 
% Η 6 
% S 6 
% S 6 
38 
1 
55 
7 
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The residue from the mother liquor was refluxed with 
6 N HCl (20 ml) for 3 hours. After cooling at 0oC, Msc-Phe-
0H partially crystallized. It had the same optical rota­
tion as the starting compound. Phenylalanine could not be 
detected chromatographically in the hydrolysate. 
Maa-Phe-Arg-Pmp-Gly-OMe. HCl (VII!) 
The best results were obtained with the following 
procedure: 5.5 mmoles (2.692 g) of the hydrate of VII were 
dissolved in 25 ml of DMF. The solution was evaporated to 
dryness and the residue again taken up in 25 ml of DMF. 
After cooling to -50C 5.0 mmoles (1.714 g) of HCl.H-Pmp-
Gly-OMe in 5 ml of DMF and 11 mmoles (1.486 g) of HOBt. 
and subsequently at -10 С 5.5 mmoles (1.135 g) of OCC were 
added. The mixture was stirred for 75 minutes. The tempe­
rature was then allowed to rise to room temperature and 
the mixture was left for another 16 hours. After cooling, 
the DCU was filtered and the filtrate was dripped out in­
to cold, dry ethyl acetate with stirring. After washing 
the precipitate with ethyl acetate, about 95% of crude 
VIII remained. A chromatographically pure product could 
not be obtained with Sephadex LH-20 and elution with DMF/ 
MeOH (1:1), nor by ion exchange chromatography with Dowex 
50X2, nor via several crystallizations. By the short-col­
umn method of Hunt and Rigby , however, the product could 
be sufficiently purified for further use. TS: Rf = 0.35 
(B), = 0.48 (F) (R-H). [а]ц5 = -26.1° (с = 0.5, DMF). 
H-Phe-Arg-Pmp-Gly-OH (IX) 
1.80Θ g (2.27 mmoles) of the hydrochloride VIII were 
suspended in 28 ml of pure dioxan and 10 ml of methanol. 
With vigorous stirring 2.3 ml 4N NaOH (4 equivalents, ex­
cess of one equivalent) were added. After 60 seconds the 
pH was brought to about 2 with HCl, and the reaction mix-
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ture was evaporateci. The residue was taken up in ethanol 
and filtered. The pH of the filtrate was brought to 5 with 
pyridine and the solution was cooled and filtered. Chroma-
tographically homogeneous preparations were obtained when 
the solid was taken up in acetonitrile-water (1:1) and 
precipitated with acetonitrile (5-10 times the volume of 
the solution).Yield: 60-70%. TS: Rf = 0.17 (B), = 0.23 (F), 
= 0.48 (H) (ninh. and R-H). M.p.: 210-214° (dec). Elemen­
tal analysis, after equilibration with air moisture, indi­
cated that the amount of HCl bound by different prepara­
tions varied from 1 to 3 mmoles of HCl per mmole of tetra-
peptide. 
Scheme III, 2. 
Boo-Phe-OH (X) 
This compound was obtained by Schnabel's pH Stat 
method ; recrystallization was achieved from diisopropyl 
ether. 
Yield : 
M.p. : 
[ < • 
TS : 
Analysis : 
C 1 4H 1 gN0 4 
(265.31) 
85% Lit.3 91% 
6-87.50С 84-S60C 
-4.4° -4.0° 
(сИ.О.НОАс) (c=1,H0Ac 
Rf - 0.07 (A), = 0.70 (B), 
Caled.: % С 63.38 % H 7 
Found : % С 63.3 % H 7 
= 0 
22 
2 
12 
29 
% 
% 
73% 
79-80DC 
-0.8° 
(c=4.g6,H0Ac) 
(G) (R-H) 
N 5.28 
N 5.3 
Boc-Phe-ONSu (XI) 
The 1-succinimidy1 ester of X was prepared according 
to Anderson . 
Yield 
M.p. 
r
-i2J 
Wo 
79% 
152-1530C 
ьО 
Lit. 81% 13 
152-153 С 
•,ο 
-21.3" -19.0l 
(c=2.O.dioxan ) (c = 2,dioxan) 
88% 
152-1530C 
-20.7° 
(c=2.2,dioxan) 
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TS : 
Analysis : 
C18 H22 N2 06 
(362.ЗВ) 
Rf = D.74 
Caled.: 
Found : 
(В), = 0. 
Ч С 59, 
% С 59, 
.75 and Ü, 
.66 Ч 
. 3 % 
.24 (dec.: 
H 6.12 
H 6.3 
I (G] (R-
% Ν 7, 
% Ν 7, 
-Η) 
,73 
.5 
14,15 
H-Arg (І10
г
)-0Ме.х HCl (XII) 
In contradistinction to reports in the literature' 
esterification of nitroarginine (obtained by nitration of 
free arginine with nitric acid and fuming sulphuric acid) 
with thionyl chloride and methanol did not result in a 
crystalline compound after working up the evaporated reac­
tion mixture with methanol and ether. The amorphous product 
appeared to contain about 1.5 equivalents of chlorine which 
was present as hydrochloric acid. Therefore, the total a-
mount of HCl was neutralized before addition of the activa­
ted ester in the next step. 
Boo-Phe-Arg(N02)-OMe (XIII) 
After the usual working up of the reaction mixture (a 
10% excess of XII was used) we obtained 76.1% of a chroma-
tographically pure product. M.p. 9D-95CIC. [a] ^  = -12.7° 
(c = 1.0, ΓΊβΟΗ). TS: Rf = 0.73 (В), = 0.6Θ (E), = 0.62 (G) 
(UV and R-H). ε = 14,770 at \ 269.0 nm in DMF-0.2 Η 
HCl (1:1, /ν) and ε = 1,020 at λ = 259.0 nm in TFA. 
max 
Nitroarginine content: 44% (theoretically 45.6%) 
Analysis : 
C21 H32 N6 07 
(480.52) 
Caled.: 
Found : 
% С 52.49 
: % С 52.4 
% Η 6.71 
% h б.а 
% Ν 17.49 
% Ν 17.4 
Boc-Phe-Arg(NO )-ΟΗ (XIV) 
Hydrolysis of XIII in dioxan-aqueous NaOH gave the 
free acid in 90% yield. 
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И . p . : 1 1 4 - 1 l g 0 C L i t . 1 7 115-12G 0 C 
И ц
1
 : - 6 . 0 ° (с = 1 . 0 , DMF) - 8 . 5 ° (с = 1 , DMF) 
- 4 . 2 ° (с = 1 . 0 , МеОН) 
TS : Rf = 0 . 5 7 ( В ) , = 0 . 2 4 (E) (UV and R-H) 
ε : 1 5 , 9 0 0 at λ = 2 6 8 . 5 nm i n DI4F-0.2 N HCl ( 1 : 1 , 
ν
 m a x 
/ν) and 
ε : 1,080 at λ = 259.0 nn in TFA. Nitroarginine 
пах 
content: 4Б% (theoretically 46.9%) . Analysis : 
C20 H 3oV 
(466.49) Found : I С 51.7 % Η 5.8 % Ν 17.7 
o n
H^
n
N
n
0^ Caled.: % С 51.49 % Η 6.48 % Ν 18.02 U JU Ь / 
Boc-Phe-Arg(N02)-Pmp-Gly-OMe (XV) 
Boc-Phe-Arg(NG2)-0H (XIV, 3.163 g = 6.78 mmoles) and 
0.916 g (6.78 mmoles) of HOBt were dissolved in 25 ml of 
•MF and the solution was cooled in an ice/salt bath at 
-13 С. An equimolar amount of DCC (1.401 g) was added with 
stirring. After half an hour the temperature was brought 
to 0 С and the reaction mixture was kept at 0 С for 30 min­
utes. Finally, the mixture was left for one hour at room 
temperature. A solution of 2.325 g (6.78 mmoles) of IV and 
0.855 ml (6.78 mmoles) of ff-ethyInorpholine in 10 ml of 
DMF were then added with stirring. After 4 hours a few 
drops of acetic acid were added, the reaction mixture was 
cooled and filtered, and the filtrate was poured into 300 
ml of water with stirring. After working up, 85% of the 
crude protected tetrapeptide was obtained. Recrystalliza-
tion from ethanol gave XV in a yield of 65%. И.p.: 217-
217.50C. Ы ц 2 = -17.8° (с = 2.0, DMF ) . TS: Rf = 0.91 (E), 
= 0.60 (I) (UV and R-H). ε = 16,600 at λ = 261.5 nm in 
max 
DMF and ε = 1,400 at λ = 259.5 nm in TFA. Nitroarginine 
max
 ь 
content: 28% (theoretically 28.4%). 
Analysis : 
C37 H54 N8 0g - H2 0 C a l c d - : % c 57.50 % Η 7.30 % N 14.50 
(772.90) Found : % С 57.9 % Η 7.4 % Ν 14.7 
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Neither the removal of the protective groups one by 
one by treatment with HCl in ethyl acetate, hydrogénation 
on palladium/charcoal and saponification, nor the elimina-
tion of the protective groups in two steps by hydrogéna-
tion in a methanolic solution of hydrochloric acid yielded 
pure, unprotected IX, because the intermediates resisted 
crystallization, 
Scheme III, 3. 
Z-Glu(OBu.t)-His-Phe-Arg-Pmp-Gly-OH (XVI) 
In several experiments in which H-Phe-Arg-Trp-Gly-OH. 
HCl (or its free base) was used as a model compound for 
the condensation with Z-Glu(OBu )-His-N-,, it was found 
that the presence of one mole of HCl did not influence the 
yield. The use of half an equimolar excess of the azide 
increased the yield however, from 50 to 60%. 
The condensation finally adopted ran as follows: 
Z-GluiOBub-His-N^*18 (1.447 g, 2.24 mmoles) was dissolved 
in 20 ml of DMF. At -150C 4 equivalents of HCl in EtOAc 
were added and the hydrazide was converted into the azide 
by the addition of 0.31 ml (1.2 equiv.) of t-butyl nitrite. 
After 20 minutes at -15 С the added hydrochloric acid was 
neutralized by the addition of /P-ethyImorpholine, and the 
azide solution was mixed with a solution of 942 mg (^  1.49 
mmoles) of IX in 25 ml of DMF. The mixture was stirred for 
one day at 0 С and then concentrated to about one sixth of 
its volume. Dilution with water under stirring gave a ge­
latinous precipitate which was filtered. For chromatogra­
phy the conventional systems (B, F, H, 3, K, L, M) were 
unsuitable because of "tailing"; only system N invariably 
gave well-shaped spots. The product could be purified by 
intensive washings with water, ethyl acetate and methanol, 
yielding 70% of XVI. 
* Gift from Dr. W. Rittel, Ciba-Geigy A.G., Basle. 
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M.p. 
Γ I 2 1 
MD 
TS 
210-212 С (dec.) 
-9.0° (с = 1.0, 90% HDAc) 
Rf = 0.72 (Ν) (R-H, Pauly and Sakaguchi) 
H-Glu(OBu )-Hi8-Phe-Arg-Pmp-aiy-OH (XVII) 
Hydrogénation of XVI was performed in 90% HOAc with 
palladium on charcoal as a catalyst. After some 3 hours 
the catalyst was removed by filtration and the filtrate 
was concentrated. Methanol was added, and the precipitate 
was filtered after cooling. The procedure was repeated to 
complete the deprotection (2 hours). Although a small a-
mount of a by-product of unknown constitution could not be 
removed, the peptide derivative was used as such in the 
next stage. 
Boc-Ser-Tyr-Ser-Met-Glu(OBu )-His-Phe-Arg-Pmp-Gly-OH (XlXa) 
300 mg (0.50 mmoles) of XVIIIa·19 were dissolved in 5 
ml of UHF, and the solution was cooled at about -25 C. To 
the cold solution were subsequently added, with stirring, 
0.75 ml 2N HCl in EtOAc, then 0.07 ml of t-butyl nitrite 
(0.60 mmoles), after 15 minutes 0.19 ml of iV-ethyImorpho-
line (1.50 mmoles) and finally at -30 С a solution of 33B 
mg (about 0.3 mmoles) of XVII in 40 ml of DMF. (The pH of 
the solution of XVII in DMF was brought to about 6 if ne­
cessary.) The temperature was allowed to rise to 0 C, and 
the reaction mixture was stirred for 22 hours. The slight­
ly turbid solution was subsequently filtered and concentra­
ted in vacuo. Precipitation of the product with acetoni-
trile yielded about 95% of the crude decapeptide which was 
recrystallized from acetonitrile-water (3:2). The mother 
liquor was treated in the same way. The decapeptide deri­
vative, obtained in 70% overall yield, contained about 5% 
of the corresponding sulphoxide. 
* Gift from Dr. W. Rittel, Ciba-Geigy A.G., Basle. 
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H.p.: 231-2340C (dec). И р 2 : •12.8° (с = 0.5, 90% HGAc). 
TS : Rf = 0.27 (В). = 0.41 (F), = 0.32 (0) (R-H). 
The decapaptide derivative XVb was obtained in the 
same way using XVIIIb* . After recrystallization the 
yield was about 60%. It also contained a small amount of 
the sulphoxide derivative. M.p.: 236-23Θ С (dec). TS: Rf 
= 0.42 (F), = 0.31 (0) (R-H). [a']^1 = -6.4° (c = 0.5, py-
ridine-water, 1:1). 
Boc-Ser-Tyr-Ser-Met-Glu(OBu )-His-Phe-Arg-Pmp-Gly-Lys(Boc)-
Pro-Val-Gly-Lys(Boa)-Ly8(Boc)-Arg-Arg-Pro-Val-Lya(Boc)-Val-
Tyr-Pro-OBu* (XXIa) 
20 Following the procedure of Riniker and Rittel the 
coupling of XlXa with 1.2 equivalents of XX· was carried 
out in 0MF. Two equivalents of HOBt (instead of HONSu) and 
1.5 equivalents of DCC were added, and the reaction was 
allowed to proceed at 45 С in a H7 atmosphere. After 1Θ 
hours the reaction mixture was cooled and filtered, and 
the filtrate dripped out into peroxide-free ether with 
stirring. Without further treatment the crude material 
(600 mg) was subjected to counter-current distribution in 
the system: irethanol-chloroform-carbon tetrachloride-buf-
fer (7:5:2:4) (buffer composition: 19.25 g of ammonium 
acetate and 28.5 ml of acetic acid, made up to 1000 ml with 
water). After 525 transfers (K = 0.09, г = 42) 237 mg 
(about 40%) of a chromatographically pure product were ob­
tained. TS (Antee SL 254): Rf = 0.38 (J), = 0.17 (C). = 
0.78 (P) (Pauly and R-H). 
M.p. : 205Ο0 (dec) 
[a]2D0: -37.6° (c = 1.037, MeOH) 
UV spectrum: A = 0.67 at λ = 276.5 nm (concentration: 
max 
4.49 mg of XXIa in 5.0 ml 90% HDAc). 
• Gift from Dr. W. Rittel, Ciba-Geigy A.G., Basle. 
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Ths same procedure vas used to obtain the D-Ser anal­
ogue (XXIb). On counter-current distribution with the 
same system some 60% of pure XXIb was isolated. On thin-
layer plates the compound showed the same Rf-values as its 
L-SBr2-isomer. Ы р 0 - -37.4° (с = 0.Θ79, MeOH). 
UV spectrum: A = 0.62 at λ = 276.5 nm (concentration: K
 max 
4.16 mg of XXIb in 5.0 ml 90% HOAc). 
[Pmp ~\-Ъ-corti co trophin- ( 1-24 J-tetracosapeptide 
The protected tetracosapeptide acetate (XXIa, 170 mg) 
was dissolved in 17 ml of 75% trifluoroacetic acid (by vol­
ume). The slightly turbid solution was kept for 3 hours in 
an atmosphere of nitrogen in the dark, then cooled and 
slowly poured into Θ5 ml of dry peroxide-free ether, which 
was vigorously stirred. After some 10 minutes the precipi­
tate was filtered by forcing the suspension through a sin­
tered glass funnel by nitrogen pressure. The sticky tri-
fluoroacetate was then dissolved in 0.1 N acetic acid, and 
the solution was filtered through a column of a weakly ba­
sic anion exchanger (Merck II- acetate form). Eluate frac­
tions were pooled until the Folin-Ciocalteux reaction be­
came negative, and the solution was then lyophylized. ТА: 
Rf = 0.52 (P)i TC: Rf = 0.47 (P), = 0.40 (0), = 0.55 (R) 
(ninh., Pauly and R-H). After equilibration with air mois­
ture the following constants were found: [a]
n
 ш
 -83.6 
(с = 0.506, 1% HOAc), Ы 5 7 В = -B7.7
0
, [a]
 S 4 6 " -100.0°, 
Ы 4 3 6 = - 1 7 5 · 1 0 and [а]з65 - -262.2°. 
Amino acid analysis after complete hydrolysis (6 N HCl, 24 
hours at 110 C) (theoretical values in parentheses): 
Lys 3.76 (4), His 1.06 (1), NH3 1.40, Arg 2.9Θ (3). 
Ser 1.66 (2), Glu 1.02 (1). Pro 3.20 (3), Gly 1.96 (2), 
Val 3.00 (3, standard). Met 0.96 (1), Туг 1.90 (2) and 
Phe 0.93 (1). Peptide content: 75 _+ 1% (mean of 3 analyses). 
UV spectra: in 0.1 N HCl A = 0.560 at λ - 276.5 nm 
max 
(concentration 0.688 mg/ml), 
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i n 0 . 1 N NaOH A = 0.7Θ4 a t λ = 2 9 6 . 0 nm 
max 
(concentration 0.632 mg/ml). 
[p-Ser , Pmp ^-ß-corticotrophin-(1-24)-tetraco8apeptide 
The same p r o c e d u r e was used as i n t h e f o r e g o i n g p r e p -
a r a t i o n . TA: R-F = 0 .52 ( P ) ; TC: Rf = 0 .47 ( P ) , = 0 .40 
( 0 ) . = 0.55 (R) ( n i n h . Pau ly and R-H) . 
H Q 0 = - 6 0 . 7 ° (c = 0 . 4 7 7 , 1% HOAc), [ α ] 5 7 Β • - 8 4 . 5 ° . 
Ы 5 4 6 • - 9 6 . 0 ° , [ α ] 4 3 6 - - 1 6 9 . 0 ° and [ α ] 3 6 5 - - 2 7 1 . 5 ° . 
Amino a c i d a n a l y s i s a f t e r c o m p l e t e h y d r o l y s i s : 
Lys 3.Ö2 ( 4 ) , H i s 1.08 ( 1 ) . NH3 0 . 6 3 . Arg 2 . 7 4 ( 3 ) . 
Ser 1.51 ( 2 ) , Glu 0 .95 ( 1 ) , Pro 3 .12 ( 3 ) . Gly 1.89 ( 2 ) . 
Va l 3 .00 ( 3 , s t a n d a r d ) . Met 0 .90 ( 1 ) , Т у г 1.84 ( 2 ) , 
Phe 0 . 9 7 (1 ) . 
UV a b s o r p t i o n : i n 0 . 1 N HCl A = 0 . 5 3 3 a t λ = 2 7 6 . 3 nm 
^ ^ max 
( c o n c e n t r a t i o n 0 . 6 6 2 m g / m l ) , 
i n 0 . 1 N NaOH A = 0 . 7 7 0 a t λ = 2 9 6 . 0 nm 
max 
( c o n c e n t r a t i o n 0.634 mg/ml). 
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C H A P T E R I V 
SYNTHESIS OF TWO АСТН-И-24) ANALGGUES CONTAINING 
L-PHENYLALANINE IN POSITION 9 
IV. 1 INTRODUCTION AND METHOD OF SYNTHESIS 
The only difference between the synthesis of 
the tetracosapeptides indicated -in the title and 
those described in the previous chapter, concerns 
the preparation of the intermediate consisting of 
the desired sequence 7-10. This compound has been 
synthesized before as its acetate by Hofmann et 
al. in their preparation of [Gin , Phe J-0-corti-
cotrophin-(1-20)-amide in a stepwise procedure in 
8 
which Arg was induced as ω-nitroarginine. 
We preferred the fragment condensation tech­
nique which has also been used in the synthesis of 
the pentamethyIphenylalanine analogue (Chapter 
III). The water-soluble product, Hsc-Phe-Arg-Phe-
Gly-OMe.HCl (III, scheme IV, 1), was deprotected 
without previous purification. The working up of 
the reaction mixture was changed in order to ob­
tain only one mole of hydrogen chloride per mole 
of free tetrapeptide. 
Elongation of the tetrapeptide salt (IV) to 
the protected zwitter-ionic decapeptides (Vila and 
b, scheme IV, 2) was carried out in the same way 
as described in chapter III for the pentamothyl-
61 
Boc-Pht-OH + H-Gly-OMe · HCl 
Mitin 
Boc-Phe-Gly-OMe (I) 
HCl/EtOAc 
H® 1 
Msc-Phe-Arg-0O+ H-Phe-G(y-OMe-HCl 111 
HOBl/DCC 
Msc-Ptie-Arg-Phe-Gly-OMe · HCl ( И ) 
dioian-methanot-lH НгСШОі, 5 2) 
H-Phe-Arg-Phe-Gly-OH · HCl (IT) 
Scheme IV, 1 
phenylalanine analogues. Both decapeptides were 
converted into the corresponding protected tetra-
cosapeptide esters (Villa, b) with 1-hydroxy-
benzotriazole and dicyclohexyIcarbodiimide as the 
condensing agent. After counter-current distribu­
tion followed by deprotection with trifluoroace-
tic acid, the resulting trifluoroacetates of the 
end-products were converted into acetates. 
OBu' 
Z-Glü-His-KHIIHi + H-Phe-Arg-Phe-Gly-OH · ИСІ 
(Ш 
OBu' ,, 
ι " 
Ζ - G l u - H i s - P h « - 4 r g - P t i e - G l y - O H 
(Τ) 
OBu' 
I 
Н
г
/Рі),С 
Boc-Ser-Tyr-Ser-Met-HHNH, + H-Glu-His-Phe-irg-Phe-Gly —DH 
a = l-Ser' 
brO-Sw' 
(IE) 
OBu' H¡® 
1
 I ' PI 
Boc-Ser-ryr-Sw-Met-Glu- His-Pde-Arg-Phe-Gly-O" (Ш) 
a = L-S«1 
bsB-Ser' 
OBu 
lequivHCI 
Вас 
Вое Вас 
HOBt/OCC 
- j . — _ . Вас 
-H-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OBu1 -ZHCl 
Вас-Ser-Туг 
а г І - З е г ' 
6 = 0 - ^ ' 
Вое Вое Вое 
I l i 
Вое 
1
 I I I Ι ι 
-Ser-Met-Glu-His-Phe-Arç-Phe-Gly-Lys -Pro -Val -Gly-Lys-Lys-Arg-Arç-Pro - V a l - Lys-Val - Т у г - Pro- OBu'-ЗНСІ 
inni 
75 V. ÏFA 
[ ι - Ser', Phe'J — β—corticotrophin—( 1 - 2 4 ) - tetracosape ptide 
[o-Ser', Phe9] - β - corticotrophm - ( 1 - 2 1 ) -tetracosapeptide 
Scheme I V , 2 
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IV. EXPERIMENTAL SECTION 
For details concerning the abbreviations, thin-layer 
chromatography and the performance of measurements, see 
the appendices. 
Boa-Phe-Gly-OMe (I) 
Boc-Phe-OH and H-Gly-OMe.HCl (see chapter III) were 
2 
coupled using Mitin's method . 
Yield 
M.p. 
Γ I 2 5 
TS 
Analysis : 
C 1 7H 2 4N 2D 5 
(336.39) 
60.0% 
94-950C 
-5.2° (c = 1.0, MeOH) 
-10.4° (c = 1.57 
Rf = 0.74 (B), 
Lit. 63-86% 
93-95QC 
-5.6° (c = 2.3, 
DMF) -10.5U (c = 
0.79 (G) (R-H) 
Caled. 
Found 
С 60.70 
С 60.6 
Η 7.19 
Η 7.3 
1.3, 
MeOH) 
DMF) 
Η θ.33 
N a.4 
H-Phe-aly-ОМе.НСг (II) 
Deprotection was achieved with HCl in dry EtOAc (com­
pare the Pmp-analogue in chapter I I I ) . 
90.5% Yield 
M.p. 
Γ 1 S 1 
TS ! 
Analysis : 
C12 H17 N2 Q3 C 1 
(272.73) 
137.5-139 С 
id 
•35.3" (с 
,ο 
1.0, MeOH) 
20.9" (с = 1.0, DMF) 
о 
+ 51.7 
Rf = 0.39 (В), 
(с = 1.0, Н20) Lit 1 52 
0.60 (G) (ninh 
3 (с = 1.8, 
and R-H) 
н2о) 
Caled. 
Found 
С 52.Θ5 
С 52.9 
H 6.28 
H 6.3 
Ν 10.27 
Ν 10.2 
Msc-Phe-Arg-Phe-Gly-OMe.HCl (III)
 u
+ 
У
2
 -
5.9 mmoles (2.890 g) of Msc-Phe-Arg-0 .H 20 (see chapter 
III) were dissolved in 25 ml of 0MF and the solution was 
64 
cooled to about -В C. To this solution were added 5.47 
mmoles (1.491 g] of II in 5 ml of DMF and 11.θ mmoles 
(1.594 g] of HOBt, followed by 5.9 mmoles [1.217 g) of 
DCC. The mixture was stirred for one hour and the tempera­
ture was then allowed to rise to room temperature. After 
some 1Θ hours the reaction mixture was cooled and fil­
tered, and the greater part of the filtrate evaporated. 
Addition of dry ethyl acetate resulted in a gum which 
could be transformed into a filterable substance by rub­
bing with ether. 95.0% of III was obtained. The product 
was deprotected without further purification. 
H-Phe-Arg-Phe-Gly-OH.HCl (IV) 
1.626 g (2.23 mmoles) of III were dissolved in 2Э ml 
of pure dioxan and 10 ml of methanol. 4 equivalents (ex­
cess of one equivalent) NaOH were added as a 4 IM solution 
with stirring. After about one minute the pH was brought 
to about 7 and the turbid solution was filtered and evap­
orated. The residue was dissolved in water-acetonitrile 
(1:1) and HCl was added with stirring until pH 5. To this 
well-stirred solution, acetonitrile was slowly added (a-
bout 5 times the volume of the solution). After one hour 
the flask was cooled. By filtering and drying 1.10 g of 
IV were obtained. A chromatographically homogeneous prep­
aration was obtained when the substance was dissolved in 
a small amount of water-acetonitrile (1:1) and acetoni­
trile was slowly added to this solution with stirring. 
Yield: 916 mg of the monohydrate of IV = 70.9%. M.p.: 176-
178° (dec. at about 200OC). TS: Rf = 0.25 (F), = 0.55 (Ν) , 
= 0.40 (P) (ninh. and R-H). [ a ] ^ = +9.6° (c = 1.0Θ, 90^ 
Ac), = • 
Analysis : 
:26 H36 N7 0! 
(5Θ0.09) Found : Ч С 53.6 % H 6.4 
HO +5.8° (с = 1.0, H 20). 
C.,C .,-N,0CC1.H_0 Caled.: % С 53.83 % H 6.60 
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Caled.: 
Found : 
% H 16.90 
Ч H 16.8 
% Cl 6.12 
4 Cl 6.4 
Z-Glu(0Bub)-His-Phe-Arg-Phe-Gly-OH (V) 
The azide coupling leading to V was carried out in ex­
actly the same way as described in chapter III for the 
Pmp-hexapeptide. Dissolution of the crude product (about 
89%) in DI4F and precipitation with water (with stirring), 
followed by cooling, filtering, washings with water and 
ethyl acetate and drying yielded Э mg of the dihydrate 
of V (70.5%). 1.p.: 205-207DC. TS: Rf = 0.41 (F). = 0.6Θ 
(N), = 0.52 (P) (R-H). [o]pJ = -13.4° (c = 1.0, 90% HOAc) 
(Perkin-Elmer 241). 
Analysis : 
C f lnH C QN 4,0 4 <.2H oQ Caled.: % С 57.80 % H 6.63 % Ν 15.13 4У b o l i IT ¿ 
( 1 0 1 ö . 1 4 ) Found : % C 5 7 . 8 % H 6 . 5 % N 15 .0 
H-Glu(0But)-His-Phe-Arg-Phe-Gly-OH (VI) 
Hydrogénation of V was performed in 90% HOAc with pal-
ladium on charcoal as a catalyst. After some 5 hours the 
catalyst was removed by filtration and the filtrate was 
concentrated. By addition of a small amount of methanol 
followed by a larger amount of ether, VI was precipitated 
and isolated by filtration. Dissolution of the substance 
in a small amount of acetic acid and precipitating it in 
the same way yielded some 80% of VI. Tic revealed that a 
trace of an unknown by-product had remained. 
Boo-Ser-Tyr-Ser-Met-GlufOB^J-Hie-Phe-Arg-Phe-Gly-OH (Vila) 
The same procedure as in the synthesis of the corre-
sponding Pmp-analogue was used. Precipitation of the prod-
uct was carried out with peroxide-free ethyl acetate. Re-
crystallization of the crude product (94%) by dissolution 
in water-acetonitrile (1:1) and precipitation with aceto-
66 
nitrile (5-10 times the volume of the solution) yielded 
68% of the decapeptide. И.p.: 205-210OC (dec). TS: Rf = 
0.42 (F), = 0.59 (P) (R-H). [a]^1 = -20.0° (c = 0.41. 90% 
HOAc) (Perkin-Elmer 241). 
The decapeptide derivative Vllb was obtained in the 
same way. The yield, after recrystallization, was 64%. 
M.p.: 200-205OC (dec). TS: Rf = 0.42 (F) (R-H). [a]^1 = 
-14.6° (c = 0.5, pyridine-water, 1:1) (Perkin-Elmer 241). 
Boc-Ser-Tyr-Ser-Met-Glu(OBu i-Hia-Phe-Arg-Phe-Gly-Lys(Boc)-
Pro-Val-aly-Lys(Boc)-Lya(Boc)-Arg-Arg-Pro-Val-Lys(Boa)-Val-
Tyr-Pro-OBu* (Villa) 
The same procedure as described in chapter III was 
followed to obtain the protected tetracosapeptide Villa. 
The crude material (400 mg) was subjected to counter-cur­
rent distribution in the system: methanol-chloroform-car-
bon tetrachloride-buffer (8:5:2:4) (buffer composition: 
19.25 g of ammonium acetate and 2Θ.5 ml of acetic acid, 
made up to 1000 ml with water). After 260 transfers (K = 
0.4, г = 75) 150 mg (40%) of a chromatographically pure 
compound were obtained. M.p.: ig5-200OC. TS: Rf = 0.22 (B), 
= 0.42 (C), = 0.44 (F) (R-H, Pauly and Sakaguchi). [a]Z1 = 
-43.8° (c = 0.74. MeOH) (Perkin-Elmer 241). UV spectrum: 
A = 0.46 at λ = 277.0 nm (concentration: 2.75 me of 
max
 ь 
Villa in 5.0 ml 90% HOAc). 
The D-Ser analogue was obtained in the same way. On 
counter-current distribution with the same system the prod­
uct appeared to move much slower than the L-Ser peptide. 
After 370 transfers a small amount of a by-product was 
still present; another 300 transfers in a closed circuit 
gave pure VHIb (K = 0.22. г = 22) in about 40% yield. 
a r
 max
 J 
The compound showed the same Rf-values on thin-layer 
plates as its L-Ser isomer. Ы п * -44.0° (с = 1.0, 
67 
MeGH) ( P e r k i n - E l m e r 2 4 1 ) . UV s p e c t r u m : A = 0.57 a t λ 
max 
278.0 nm (concentration: 3.50 mg of Vlllb in 5.0 ml 90% 
HDAc). 
[Phe J-S-corti.cotrophin- (1-2 4)-tetraco8apeptide 
Deprotection of Villa with 75% trifluoroacetic acid 
and working up with peroxide-free ether yielded the tri-
fluoroacetate of the free tetracosapeptide; conversion in­
to the acetate was performed with a weakly basic anion ex­
changer (Merck II-acetate form). TC: Rf = 0.46 (M), = 0.53 
(P), = 0.62 (R) (ninh., Pauly and R-H). 
[a]pJ = -84.6° (c = 0.50, 1% HDAc). Ы 5 7 д = -ΘΘ.2
0
, 
Ы 5 4 Б = -100.6°. [ α ] 4 3 6 = -175.0° and [а]з65 - -282.4° 
(Perkin-Elmer 241). 
Amino acid analysis after complete hydrolysis (6 N HCl, 
24 hours at 110 С) (theoretical values in parentheses): 
Lys 3.72 (4), His 1.05 (1), NH3 0.94, Arg 3.01 (3), 
Ser 1.59 (2), Glu 0.98 (1), Pro 3.20 (3), Gly 1.98 (2), 
Val 3.00 (3, standard). Met 0.97 (1), Туг 1.89 (2) and 
Phe 2.03 (2). 
Peptide content: 58 +_ 1.5% (mean of 3 analyses). 
UV spectra: in 0.1 N HCl A = 0.53 at λ = 274.5 nm (con-K
 max 
centration 0.68 mg/ml), 
in 0.1 N NaOH A = 0.83 at λ = 292.3 nm (con-
max 
centration 0.58 mg/ml). 
г 1 Sn 
[D-Ser , Phe _\-ß-corticotrophin-(1-24)-tetracoeapeptide 
The same p r o c e d u r e was used as i n t h e f o r e g o i n g p r e p a -
r a t i o n . TC: Rf = 0 .48 (14), = 0 .51 ( P ) , = 0 .65 (R) ( n i n h . , 
Pau ly and R-H). 
[ a ] " = - 8 4 . 6 ° (с = 0 . 5 0 , 1% HDAc), Ы 5 7 в = - Β 7 . Θ 0 , 
[ а ] 5 4 6 - - 1 0 0 . 2 ° , [ а ] 4 3 6 - - 1 7 4 . 8 ° and [ а ] 3 6 5 - - 2 8 4 . 0 ° 
( P e r k i n - E l m e r 2 4 1 ) . 
Amino acid analysis after complete hydrolysis: 
Lys 3.59 (4), His 0.96 (1). NH3 0.79. Arg 3.16 (3). 
Ser 1.65 (2). Glu 1.01 (1), Pro 2.97 (3), Gly 1.96 Í2) , 
Val 3.00 (3, standard). Met 1.03 [1), Туг 1.91 (2), 
Phe 2.02 (2). Peptide content: 56 _^  1.5% (mean of 3 
analyses). 
UV absorption: in 0.1 N HCl A = 0.55 at λ = 274.4 nm 
r
 max 
(concentration 0.66 mg/ml), 
in 0.1 N NaOH A = 0.69 at λ - 291.θ nm 
max 
(concentration 0.56 mg/ml). 
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C H A P T E R V 
SYNTHESIS OF a-MSH AMALGGUES CONTAINING 
L-PENTA^ETHYLPHENYLALANINE OR 
L-PHENYLALANINE IN POSITION Э 
V. 1 INTRODUCTION 
Since the amino acid sequence of a-HSH is iden 
tical with that of the amino terminal tridecapep-
tide of ACTH, the protecting groups and condensin 
agents employed in the synthesis of ACTH-analogue 
could also be employed in the synthesis of the co 
responding MSH-an a logues. 
A special feature of the composition of a-MSH 
is, however, the presence of an '/-acetyl group at 
the ^-terminal serine residue. Various methods 
have been used far its introduction. They include 
1 
acetylation of the //-terminal dipeptide , tripep-
2 3 4 1 3 
tide or tetrapnptide with acetic anhydride ' 
2 
pentachloropheny1 acetate or p-nitrophenyl acet-
4 
ate , and subsequent coupling of the acetylated 
2 3 
peptide with the remaining C-terminal part ' or 
4 5 
with suitably chosen fragments ' leading to the 
desired acetylated tridecapeptide amide. Only 
Schwyzer has investigated acetylation of the N-
4 
terminal serine at the tndecapeptide stage . A 
protected ACTH-(1-10] decapeptide was coupled 
with the C-terminal tripeptide amide in which the 
lysine side-chain was protected with the acid-
70 
stable phthaloyl group. The acid-labile í-butyl-
oxycarbonyl and t-butyl ester groups on serine 
and glutamic acid , respectively, were removed and 
the resulting tridecapeptide derivative was selec-
tively acetylated at the //-terminal serine with p-
nitrophenyl acetate. Treatment of the resulting 
4 
product with hydrazine acetate gave a-MSH . 
Since we had the protected //-terminal decapep-
tide at our disposal we followed Schwyzer's strat-
egy but employed the methyIsuIphonylethyloxycar-
bonyl group for the protection of the side-chain 
of lysine in position 11. The group has a very 
high acid stability and is not attacked by W-ethyl-
morpholine under the conditions needed for acetyla-
tion of the iV-terminal serine residue. Removal of 
this group was performed in dioxan-methanol-sodium 
hydroxide solution. Due to irreversible adsorption 
of a large amount of the product onto the column, 
purification could not be done by chromatography 
on carboxymethy1 cellulose. This loss of material 
4 
was also found by Schwyzer . Good results were ob-
tained, however, with Sephadex LH-2G equilibrated 
with the upper phase of a butanol-acetic acid-wat-
er system, using the lower phase for the elution . 
V. 2 METHOD OF SYNTHESIS 
Η-Lys(Mso)-Pro-Val-NH .HCl (Scheme V, 1) 
Boc-Val-NH- (II] was prepared from Boc-Val-DH 
^ 4 
(I) with isobutyl chloroformate and ammonia . After 
deprotection with 90% trifluoroacetic acid the re-
71 
H 
I 
H - L y s - O H 
i CuSDt.NaOH 
z-ci 
, ь V 
ζ 
ι 
H-Lys-OH ( Ж ) 
Boe-N,,NaOH 
ι 
Ζ 
I 
Boe-Lys-ОН (Ш) 
Нг/Ріі.С 
г 
H 
I 
Boc-Lys-OH ( I ) 
Msc-ONp 
Msc 
Boc-Lys-OH (IL) 
HONp 
DCC 
Msc 
Boc-Lys-OHp ( Ж ) 
Boc-Val-OH ( I ) 
isobutylchloro formate 
ИН] 
Boc-Pra-OH (H) Boc-Val-NH, ( I ) 
HONSu 
DCC 
a 9 0 % TF4 
b ion exchanger 
Boc-Pro-OHSu + H - V a l - H H 2 · HOAc ( Ж ) 
(71 
Boc-Pro-Val-HH2 (Ж) 
1 907. TF4 
b юп («changer 
H-Pra-Val-HH¡- НОДс (Ш) 
Msc I 
Boc-Lys-Pro-Val-HH j ( Ж ) 
IHCl/EtOAc 
H-Lys-Pro-Val-NHj· HCl ( Ш ) 
S c h e m e V, 1 
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suiting trifluoroacetate was converted into the 
acetate with a weak basic anion exchanger. Since 
4 
it is known that coupling of the product III with 
t-butyloxycarbonyl-L-proline (IV) via the mixed 
anhydride procedure is only possible with low 
yield, the coupling was effected with the 1-succin-
imidyl ester of IV. Deprotection of the dipeptide 
derivative VI with 90% trifluoroacetic acid, fol­
lowed by conversion of the trifluoroacetate into 
the acetate, yielded chromatographically pure pro­
lyl-valine amide acetate (VII). 
The introduction of the t-butyloxycarbonyl 
group into e-benzyloxycarbony1-L-lysine (VIII), 
synthesized by benzyloxycarbonylation of the copper 
complex of lysine, was carried out according to 
η 
the method of Schnabel . After hydrogénation with 
palladium on charcoal as a catalyst, the methyl-
suIphonylethyloxycarbonyl group was introduced in 
9 the e-amino group га its p-nitrophenyl ester , 
and the protected lysine derivative XI was convert­
ed into an activated ester (XII) in the conven­
tional way. 
Coupling of XII with VII gave the water-soluble 
protected tripeptide XIII in fairly good yield. To 
eliminate the t-butyloxycarbonyl group it was 
treated with hydrogen chloride in ethyl acetate 
resulting in the desired product XIV as a hydro­
chloric acid salt. 
[Pmp5J- and [Pfce5]-а-М5Я (Scheme V, 2) 
The synthesis of the decapeptide XVa and b has 
73 
m' Hu 
ι ι 
Boc-Ser -Ty r -S í r -Mr t -G lu -H ie -Phe -Arg -X -6 l y -0H + H - L y s - P r e - V a l - N H j - H C l 
( I T ) » XrPiïip 
b X=Phe 
OBu' 
HOBt/DCC 
(Ш) 
Msc 
Boc-Sír-Tyr-Ser-Mft-Slu-His-Phe-Arg-X-íly-lie-Pfo-Val-IIHj · №1 
(Ш) a X=Pmp 
90·/. TFÄ b X = Ptie 
Msc 
I 
H-Ser-Tyr-Sw-Met-0lu-His-Ptie-Arg-X-Oly-Lys-Pra-Val-l(Hr ТРД 
Дс-ОНо
 ( Ш І
 i X'fmf 
fc X=Phe 
Ac - Ser - Tyr - Ser- Het - Glu -His - Pt» -• Г 
Hsc 
ι 
Arj-X-Gly-Lys-Pra-Val-HHj 
{dioíjn (ПЖ) а Х= Ртр 
methanol ^ χ-ρ^ 
um [Pmp'J-a-MSH 
[Phe'J-a-MSH 
Schsme V, 2 
10 
been described in chapters III and IV, respective 
ly. 
They were coupled with XIV with the aid of 1-
hydroxybenzotriazole and dicyclohexyIcarbodiimide 
in dimethyIformamide as the solvent under nitrogen. 
A chromatographically homogeneous product could not 
be obtained with Sephadex LH-20 (eluent dimethyl-
formamide-methanol 1:1) nor with Kieselgel 60 (chlo 
roform-methanol 1:1 as eluent). However, after 
cleavage of the acid-labile protecting groups from 
XVI (a and b) with 90% trifluoroacetiс acid the re­
sulting products XVIIa and b could well be purified 
74 
by precipitation from a dimethyIformamide solution 
with ethyl acetate. The acetylation was conducted 
with two equivalents of p-nitropheny1 acetate. 
XVIIIa and b could then be precipitated with per-
oxide-free ether. They were converted into the 
crude a-MSH analogues by treatment with a mixture 
containing dioxan, methanol and sodium hydroxide 
solution (3:1:1). Pure [PmpS] - and [PheS]-a-MSH 
were obtained by chromatography on Sephadex LH-2G 
equilibrated with the upper phase of the system 
1-butanol-acetic acid-water (2:1:10), using the 
lower phase for elution. 
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V. г EXPERIMENTAL SECTION 
For details concerning abbreviations, thin-layer chro­
matography and performance of measurements, see appendices. 
Scheme V, 1. 
Boc-Val-OH (I) 
This compound was prepared according to Schnabel's meth-
η 
od and was obtained 
И.p. : 72.5-74.50C 
Γ Τ
 2
^ с -»0 C«] D = -6-7 
(c = 1.3, 
HOAc) 
TS : Rf • 0.36 (G) 
in 
L 
= 
abou 
it 
0 
θ 
42 
t 90% yield. 
72-73QC 1 1 
•6.0° 
(578 nm, 
с • 1, HOAc) 
(S) (R-H) 
77-79DC 
-5.8° 
Cc = 1.2, 
HGAc) 
1 280 oC 
-6.9° 
(c = 2, 
HOAc) 
Boa-Val-NH2 (II) 
The same procedura as described by Schwyzer was used 
for this preparation. 
Yield 
M.p. 
Γ I 2 1 
78% 
155.5-1570C 
-o 
Lit. 6B% 
156-1570C 
-0.5 (c = 1.5, MeOH) 
-13.4° (c = 1.5. HOAc) 
TS : Rf = 0.67 (G), = 0.63 (S) (R-H) 
H-Val-NH-.CH-COOH (III) 
¿ ó 
Treatment of II with 90% TFA at room temperature for 
30 minutes followed by evaporation of the solvent yielded 
a yellow oil which crystallized on trituration with ethyl 
acetate; yield 87%. The white substance had m.p. 123-1240ε 
(Lit.4: 91.6% H-yal-NH2.TFA with m.p. 124-125
0C). TS: Rf = 
0.10 (E) (R-H). Dissolution in 0.1 N acetic acid followed 
by filtration of the solution through a column of a weak 
anion exchanger (Merck II, acetate form) and evaporation 
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of the filtrate yielded III with m.p. 95-100oC, [a]^ 21 
+36.6 (c = 1.0, HOAc). 
Boa-Pro-OH (IV) 
α 
Schnabel's pH Stat method was used to prepare IV. 
TS 
S 11, Yield: 
M.p. : 
г T2J 
94% L: 
135-1360C 
-62.0° 
(c = 1.05, 
HOAc) 
t. ü 96% 
136-137° 
-68.5° 
(57Θ nm, с = 
HOAc) 
"55% 
136-137 
-60.2° 
1. (c = 2, 
HOAc) 
Rf 0.67 (E), = 0.32 (G) CR-H) 
12 
133-134 
-60.6° 
(c = 2.0, 
HOAc) 
Boc-Pro-ONSu (V) 
3.01 g of IV were dissolved in 30 ml of purs dimethoxy-
ethane. 1.61 g of //-hydroxysuccinimide were added with 
stirring and then 3.1Θ g of DCC (10% excess) at 0°. After 
some 15 hours the solution was filtered and the evaporated 
filtrate was crystallized from isopropyl alcohol. 
66% ' "• 1 3 -"' 1 4 Yield 
M.p. 
r -[21 
TS 
Lit. 743 
133-134 С 135-136 
-55.0° (с = 1.0. -55.3° (с = 2, 
dioxan) dioxan) 
Rf = 0.65 and 0.14 (dec.) (A) (R-H) 
= 0.76 and 0.35 (dec.) (E) (R-H) 
67% 
134-136c 
-55° (c 
dioxan) 
1 , 
Boc-Pro-Val-NH (VI) 
Boc-Pro-ONSu (10 mmoles) and H-Val-NH2-H0Ac (10.5 
mmoles) were dissolved in 30 ml of DMF. One equivalent of 
ff-ethylmorpholine was added and the solution was left over­
night at room temperature. After evaporation of the solvent 
the residue was dissolved in ethyl acetate and extracted 
with water, 5% KHSO. solution, water, 5% NaHCO. solution 
and again with water. The organic layer was dried with 
Na^SO,, filtered and evaporated. The residue was crystal­
lized from ether. 
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Yield 
И.p. 
Ы 
TS 
Ö U Lit. 
04- 60С 
-14.θ0 (с = 0.5, OMF) 
Rf = 0.25 (А). = 0.73 (E) CR-H) 
44.i: 
Θ4 0 
H-Pro-Val-HH0.CH-COOH (VII) 
2.24 g of VI (7.2 mmoles) wers dissolved in 90% TFA. 
After 20 minutes at room temperature, the solution was 
evaporated and the resulting oil crystallized from ethyl 
acetate/ether. Yield: B9% of the chromatographically pure 
trifluoroacetate of H-Pro-Val-NH2. M.p. 167-166
0C (Lit.4: 
163-1650C). 
The trifluoroacetate was converted into the acetate as 
described for the preparation of II. After evaporation of 
the solvent the residue was crystallized from ether; the 
product VII was obtained in a quantitative yield. 
M.p. : 126-127 С 
Ы п
1
: -62.4° (с = 0.55, dioxan) 
Lit.4 137-1380C 
'D 
-4 . и ( с = 1 . 0 , HOAc) 
'
І 5 1 3 - 1 4 0 о С 
-54.6° (с = 
1 . 0 2 , d i o x a n ) 
TS Rf 0.15 ( В ) , = 0 . 1 2 (С) ( n i n h . and R-H) 
H-Lys(Z)-0H ( V I I I ) 
ti -carbobenzoxylation of lysine was performed via the 
1 В 
copper complex of the amino acid as described by Tesser 
The blue complex of the product was obtained in 90% yield. 
The removal of copper with hydrogen sulphide was nearly 
quantitative and gave the pure product VIII. 
M.p. : 256-2610C Lit.17 27B-28G0C 1 a aa. 235 С 
Ы ц
2
: +14.8° (с = 1.65, *17.30 (с = 2, +14.0° (с - 2.86, 
2N HCl) 2N HCl) dil. HCl) 
TS : Rf = 0.37 (B), = 0.B6 (L) (ninh. and R-H) 
Boc-Lys(Z)-OH (IX) 
The introduction of the Boc-group in VIII was achieved 
using the pH Stat method . After working up as usual, the 
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product was obtained as a nearly colourless oil in 90% 
yield. TS: Rf = 0.38 (G) (R-H), 
19 24 
Γ I 2 1 
MD 
•11.6 (с = 3.5. 
DMF). Lit. : [α] ρ = -11.5 (с DMF), 
Boc-Lye-OH (Χ) 
IX was hydrogenated in 90% methanol with Pd/C as the 
catalyst. After filtration of the catalyst and evaporation 
of the filtrate, the residue could be crystallized from 
ethanol. 
Yield 
M.p. 
r-,21 
M D 
65% 
200-201OC 
-10.1° 
(c - 1.0, HOAc) 
Lit. 66% 
204-205OC 
20 
201.5-203 С 
-10.7° 
(с = 0.Θ5, HOAc) 
TS : Rf = 0.26 (В), - 0.79 (L) (ninh. and R-H) 
Boc-Lye(Maa)-OH CXI) 
To a suspension of 10 mmoles (2.46 g) of X in 15 ml of 
Q 
acetonitrile-water (4:1), 10 mmoles of Msc-ONp (2.Θ9 g) 
and 10 mmoles (1.4 ml) of triethylamine were added with 
stirring. After 5 minutes another mmole of Msc-ONp and of 
Et„N were added to the now clear solution. The solution was 
left for half an hour and then evaporated. Water was added 
to the thick oil. With a few drops of a 2 N KHSO. solution 
the pH was adjusted to 5 and the water layer was extracted 
three times with ether. On acidification of the colourless 
water layer to pH 3 with 2N KHSO. solution an oil separa­
ted. This was extracted with ethyl acetate, the organic 
layer dried over Na^SO., filtered and evaporated leaving a 
thick, colourless oil which started to crystallize spon­
taneously after a few days. Addition of ethyl acetate/pe­
troleum ether completed the crystallization and gave 92% 
of a white product melting at B4.5-860C. TS: Rf - 0.52 (B), 
= 0.72 (C). = 0.40 (E), - 0.Θ7 (L) (R-H). [a]gJ * -З.б0 (с = 
2.0, EtOAc). 
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Analysis : 
C 1 5H 2 8N 2D BS 
(396.46) 
Caled 
Found 
С 4 5 . 4 4 % H 7.12 % Ν 7 . 0 7 % S В.09 
С 4 5 . 2 % H 7 . 3 % N 7 . 0 % S 8 . 2 
Boa-Lye(M8a)-ONp ( X I I ) 
1.59 g of Boc-Lys(Msc)-OH (XI) (4 mmoles) and 66B mg 
(10% excess) of HONp were dissolved in 20 ml of dry ethyl 
acetate. At 0OC 904 mg of DCC (10% excess) were added and 
the mixture was stirred at 0 С for half an hour and then 
at room temperature for some 15 hours. After filtration of 
the DCU, the filtrate was evaporated and the resulting oil 
crystallized from ether. Recrystallization from isopropyl 
alcohol gave 87% of white XII. M.p.: 104.5-106OC. TS: Rf 
= 0.66 (B), = 0.93 (C), = 0.71 (G) (R-H). [o]pJ - -20.9° 
(c = 1.0, EtOAc). 
Analysis : 
0τ,Η
Ί
.Ν_0,
η
3 Caled.: % С 48.73 % Η 6.04 % Ν 8.12 % S 6.20 21 31 3 10 
(517.55) Found : % С 49.1 % H 6.1 % Ν 8.1 % S 6.2 
Boo-Lys (Msc)-Pro-Val-IiH2 (XIII) 
То a solution of 2.47 mmoles (678 mg) of VII in DMF, 
2.25 mmoles (1.15 g) of XII were added with stirring. The 
yellow-coloured solution was supplied with 220 wl of Et_N 
which intensified the colour. After standing overnight, 
tic revealed that all Boc-Lys(Msc)-ONp had been converted. 
Evaporation of the solvent left a yellow oil which solidi­
fied on addition of dry ether. The product was filtered, 
washed with ether and dissolved in ethyl acetate. The so­
lution was extracted with KHSG. solution and a saturated 
NaCl solution, then dried on Na^SO., filtered and evapora­
ted. Rubbing of the amorphous residue with ether gave a 
water-soluble white, but still amorphous product in 88% 
yield, melting at about 760C. TS: Rf = 0.42 (B), = 0.80 
(C), = 0.61 (E) (R-H). [a]^2 = -57.4° (c = 1.0, MeOH). 
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Analysis : 
C25 H45 N5 [ 
(609.74) 
2 5H 4 5N 50 gS.H 20 Caled. 
Found 
Caled. 
Found 
С 49.98 
С 49.7 
Ν 11.66 
M 11.2 
H 7.ев 
H 7.θ 
S 5.33 
S 5.3 
H-Lys(Msc)-Pvo-Val-NHz. HCl CXIV) 
Removal of the α-amino protecting group from XIII was 
carried out with HCl in dry ethyl acetate. After one hour 
the precipitate was filtered and washed with ethyl acetate. 
A solution in water attained pH 3.5-4 indicating that more 
than 1 equivalent of HCl was present. Therefore, the prod­
uct was recrystallized from propanol-2. After filtration 
and washing with cold propanol-2 and ether a 77% yield of 
0.10 (C), = 0.20 
, 0
 (c = 1.17, 
XIV was obtained with m.p. 73 C. TS: Rf 
\21 (F), = 0.29 (T) (ninh. and R-H). [a]Q 
PleOH). 
Analysis : 
C20 H3B N5 07 S C 1- i H2 0 
(537.0Θ) 
= - 3 6 . В 
Caled.: 
Found : 
Caled.: 
Found : 
% 
% 
% 
% 
С 
С 
S 
s 
44.72 
44.9 
5.97 
6.1 
Ч H 7 . 3 2 % Ν 1 3 . 0 4 
% H 7 . 5 % Ν 1 2 . 5 
% C l 6 . 6 0 
% C l 6 . 5 
Scheme V, 2. 
Boc-Ser-Tyr-Ser-Met-Glu(OBu )-Hie-Phe-Avg-X-Gly-Lys(Maa)-
Pro-Val-NH2 (XVI) 
a) X = Pmp 
To a suspension of ВО mg of XVa (about 0.054 mmoles) 
in 1 ml of pure pyridine were added 0.11 mmoles of XIV 
(59.1 mg) and 0.11 mmoles of HOBt (14.9 mg) followed by 
1.5 equivalents of DCC (0.0B1 mmoles = 16.7 mg). The re­
action mixture was stirred under nitrogen at 45 С during 
19 hours. It was then cooled for some hours to complete 
the precipitation of OCU which was removed by centrifu-
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gation. The desired tridecapeptids was precipitated 
from the supernatant by addition of peroxide-free ether. 
It was washed with ether, then water and again with 
ether. For further purification, the dry peptide was 
dissolved in DMF, the same amount of MeOH was added to 
the solution and the peptide was again precipitated 
with peroxide-free ether. After centrifugation the pel­
let was washed once with ether. Yield: Б9 mg (64%), TS: 
Rf = 0.35 (F). = 0.64 (Ρ). TC: Rf = О.ЯО CM) (R-H). Tic 
revealed that a trace of the corresponding sulphoxide 
was present in the product. 
b) X = Phe 
0.06 mmoles (Θ5 ng) of XVb, 0.12 mmoles (63.4 mg) of 
XIV, 0.12 mmoles (16.2 mg) of HOBt, 0.09 mmoles (1B.6 
mg) of DCC and 1 ml of pure pyridine were stirred under 
nitrogen at 45 С for about 17 hours. The reaction mix­
ture was worked up as described in the previous prepa­
ration, giving 96 mg of crude XVIb. By sequentially 
washing with water, methanol and ether it was partially 
purified. The last traces of the tripeptide derivative 
(XIV) and the sulphoxide of XVIb could not be complete­
ly removed, however, neither by chromatography on 
Sephadex LH-20 nor on Kieselgel 60. Yield: 74%. TS: Rf = 
0.39 (F), = 0.66 (P). TC: Rf = 0.B2 (F), = 0.Θ5 (P) 
(R-H). 
H-Ser-Tyr-Ser-Met-Glu-HiB-Phe-Arg-X-Gly-Lys(Mao)-Pvo-Val-
HH2.TFA (XVII) 
a) X = Pmp 
60 mg of XVa were dissolved in 1 ml of 90% TFA under 
nitrogen. After 15 minutes peroxide-free ether was added 
(10 ml). The precipitate formed was isolated by centrif-
ugation and washed with peroxide-free ether and perox­
ide-free ethyl acetate. It was then dissolved in DMF and 
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precipitated again with peroxide-free ethyl acetate 
(about twice the volume of DPIF). After centrifugation 
and several washings with peroxide-free ethyl acetate 
the product was dried: 54 mg of XVIIa (94%) were ob­
tained. TS: Rf = 0.07 (F), = 0.41 (M). TC: Rf = 0.7R 
(N) (ninh. and R-H). 
b) X = Phe 
83 mg of XVIb were deprotected as described above. 
Before the addition of ether a small amount of DCU was 
removed by centrifugation. The isolation and purifica­
tion of XVIIb were carried out in the same way as de­
scribed for XVIIa. Yield: 60 mg (75%). TS: Rf = 0.06 
(F), = 0.44 (И). TC: Rf = 0.70 (1) (ninh. and R-H). 
Ac-Ser-Tyr-Ser-Met-Glu-Eie-Phe-Arg-X-Gly-Lya(Ms с)-Pro-Val-
ЯН (XVIII) 
a) Χ = Pmp 
Acetylation of the //-terminal serine was carried out 
with p-nitrophenyl acetate according to the method of 
л 
Schwyzer et al. . To that end 48 mg of XVIIa were dis­
solved in 0.5 ml of pyridine and 1.0 ml of DMF. One 
equivalent of ff-ethyImorpholine (3.2 μΐ) was added fol­
lowed by 2 equivalents of Ac-GNp (9.1 mg). After 1Θ h 
at room temperature the product was precipitated by 
addition of peroxide-free ether, isolated by centrifu-
gation and washed with peroxide-free ether and ethyl 
acetate until the supernatant was completely free of p-
nitrophenol. Yield: 46 mg (99%). TS: Rf = 0.14 (F), 
' 0.50 (M) (R-H). 
b) Χ = Phe 
59 mg (0.0Э2 mmoles) of XVIIb were dissolved in 1 ml 
of pyridine and 0.2 ml of DMF. One equivalent (0.004 ml) 
of tf-ethylmorpholine was added followed by 0.062 mmoles 
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(11.2 mg) of Ac-ONp. The product was isolated as de­
scribed for XVIIIa and further purified by dissolution 
in DMF and precipitation with peroxide-free ethyl acet­
ate and ether. 51 mg of XVIIIb (91%) were isolated. 
TS: Rf = 0.26 (F), = 0.50 (M) (R-H). 
[Pmp5]-a-MStf 
45 mg (0.024 mmoles) of XVIIIa were dissolved in a 
mixture of 0.7 ml of dioxan, 0.25 ml of methanol and 
0.25 ml of water. 4 equivalents of NaOH (24 μΐ of a 4N 
solution) were added, an excess of one equivalent. The 
solution became immediately yellow-coloured. After 2 
minutes 2N HCl was added until pH 5 and the reaction 
mixture was then evaporated. The residue was dissolved 
in some ml of the lower phase of the system 1-butanol-
acetic acid-water (2:1:10) and the solution was evapo­
rated again. After dissolution in as little of the lower 
phase as possible, the solution was chromatographed on a 
column (39 χ 2.0 cm) of 31 g of Sephadex LH-20 which was 
equilibrated with the upper phase of the described sol­
vent system before use. Elution with the lower phase 
gave 15.2 mg of pure P^rnp J-a-MSH and 15.2 mg of a not 
quite homogeneous sample containing the product and the 
corresponding sulphoxide (about 20%). Physical constants 
of the pure compound were: ΤΞ: Rf = 0.09 (F), = 0.40 (M) 
(Pauly, ninh. and R-H). TC: Rf = 0.77 (M) (ninh. and R-H) 
H Q 1 = - 49·7 0 (с = 1.0, 10% HOAc), [α]
 5 7 θ = -52.1°, 
Ы54В = 5 9 · 2 0 ' Ы4З6 = - 1 0 3 · Β Ο and Ы з 6 5 • -169.5°. 
Amino acid analysis after complete hydrolysis (6N HCl, 
24 hours at 110 C) (theoretical values in parentheses): 
Lys 1.05 (1), His 0.9S (1), NH3 1.92 (1), Arg 0.95 (1), 
Ser 1.77 (2). Glu 1.05 (1), Pro 1.01 (1), Gly 1.05 (1), 
Val 1.00 (1, standard). Met 1.14 (1), Туг 0.93 (1) and 
Phe 1.05 (1). Pmp was not detectable (see chapter III). 
Peptide content: 73 + 3% (mean of 3 analyses). 
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[Phe92-a-MSH 
1) 37 mg (0.021 tnmoles) of XVIIIb were suspended in 0.7 ml 
of dioxan and 0.25 ml of methanol. 4 equivalents (21 ul) 
of 4N NaOH were added giving instantaneously a yellow 
colour caused by traces of p-nitrophenol or p-nitrophe-
nyl acetate. For complete dissolution 0.4 ml of water 
were then added to the reaction mixture. After 2 minutes 
0.2 ml of Dowex 50X2 (about 100% excess) were added. The 
yellow colour disappeared rapidly. After centrifugation 
the ion exchanger was washed with water and diluted am­
monia (the supernatant of the latter washing was yellow). 
The combined fractions were evaporated, the residue dis­
solved in 0.01 M NH.OAc (pH 6.5) and the solution sub­
jected to chromatography on Carboxymethyl cellulose 
(Serva Feinbiochemica) (Column: 20.5 χ 1.Θ cm). Elution 
with about 550 ml of 0.01 M МНдОАс (pH 6.5) followed by 
150 ml of 0.025 M NH40Ac (pH 6.5) resulted in a consid­
erable loss (about 50%) of material. The purity of the 
tridecapeptide was hardly improved. Washing of the con­
tents of the column with 0.6 Π NH.OAc resulted in a few 
mg of impure [Phe j-a-MSH. 
2) 42 mg (0.024 mmoles) of XVIIIb were deprotected as des­
cribed above. After isolation the crude compound was 
dissolved in the lower phase of the system 1-butanol-
acetic acid-water (2:1:10), the solvents were evapora­
ted and the residue taken up in as little of the lower 
phase as possible. The solution was brought on a column 
of Sephadex LH-20 (32 χ 1.8 cm) which was equilibrated 
with the upper phase of the solvent system. Elution 
with the lower phase resulted in 7.5 mg of pure [Phe J-
a-MSH and 14.9 mg of a chromatographically not quite 
homogeneous product (containing all of the sulphoxide 
derivative). TS: Rf - 0.3Э (M) (Pauly, ninh. and R-H). 
TC: Rf = 0.76 (M) (ninh. and R-H). 
H p * - -55.2° (c = 0.50, 10% HOAc), Η 5 7 8 • -57.6°, 
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Ы 5 4 Б • -66.0°, [а]4з6 - -114.6°, [ α ] 3 6 5 - -137.0°. 
Amino acid analysis after complete hydrolysis (SN HCl, 
24 hours at 110 С) (theoretical values in parentheses] 
Lys 0.94 (1), His 0.98 (1), NH3 1.2Θ (1), Arg 1.06 (1), 
Ser 1.67 (2), Glu 0.95 (1), Pro 0.95 (1). Gly 1.08 (1), 
Val 1.00 (1, standard]. Met 1.05 (1], Туг 1.09 (1) and 
Phe 2.17 (2). Peptide content: 70 ^  2% (mean of 3 ana­
lyses ). 
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C H A P T E R V I 
ELECTRON DONOR PROPERTIES OF TRYPTOPHAN PEPTIDES 
AND CORRESPONDING PENTAMETHYLPHENYLALANINE 
AND PHENYLALANINE PEPTIDES 
YI. 1 GENERAL INTRODUCTION 
According to Foster the term "complex" in or­
ganic chemistry implies substances which are formed 
by interaction of two or more component molecules 
(and/or ions], which may have an independent crys­
tal structure, and which will dissociate into their 
components, at least partially, in the vapour phase 
and on dissolution. The complexes discussed in this 
chapter result from the weak interaction between 
electron donors and electron acceptors (charge-
transfer or electron donor-acceptor complexes), 
When two widely separated molecules are brought 
together, the van der Waals energy (W ) is released 
until an equilibrium distance has been reached. 
When the components are a donor (D) and an acceptor 
(A) molecule the equilibrium distance will be short­
er as a consequence of intermolecular resonance. 
Dependent on the nature of the components the dis­
tance is between 3.2 and 3.5 A. The resulting com­
plex is mainly described by a "no bond" wave func­
tion ψρ д. However, when it absorbs the energy 
hv, an excited state is reached, described mainly 
88 
by a "dative" wave function ψ
π
 +
 .- (fig. VI, 1). 
The energy necessary for this transition is usual­
ly smaller than that for promoting an electron in 
one of the components D and A; the transition 
gives rise to a characteristic charge-transfer 
2 3 band at the long wavelength side of the spectrum ' , 
j - [D~A—O»-A-] or uK-i" 
Energy 
eiciled state 
ground state 
Wg.Van der Waals 
energy 
resonance energy 
hvn 
D + A 
Van der Waals destance 
D—-A 
[θ—A-—D--A'] 
interrnolecular resonance 
F i g . VI, 1 
A number of properties of CT (charge-transfer) 
complexes can be inferred from the UV-visible ab­
sorption characteristics. In our case we are inte­
rested in the association constant К of the squi-
librium D + A , ' D A and the apparent ex­
tinction coefficient E , of the CT absorption. Ac-
4 
cording to Foster et al. , К and ε , for a 1:1 com-da 
plex can be determined with the formula 
da da 
С ..С d a 
К. da 
which is valid when С >>C .. A . is the observed CT 
a d d a 
absorption, corrected for residual absorption of 
donor and acceptor, and С, and С are initial con-K
 d a 
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centraticms of donor and acceptor, respectively, 
corrected for volume expansion. 
д A 
When •=—fr is plotted against •„ a a linear re-
cd-ca cd 
lationship is to be expected with К as the gra­
dient and Κ.ε. as the intercept. In all measure-d a Ada Ada 
ments values for ·=—pr and -p— at five or six wave-
cd' ca Ld 
lengths in the CT area were subjected to least 
squares analysis, without resource to graphical 
evaluation, in order to evaluate К and K.e. . Ex-da 
tinction coefficients (e*) were calculated from 
— ^ (K is the average of K-values found at the 
various wavelengths). A procedure for the evalua­
tion of e* (to be determined from * *max 1 
max £· 
can be deduced from the following 
argument : 
It may be presupposed that the position of the 
maximum in the measured spectra (after correction 
for residual donor and acceptor absorption) 
agrees with λ . The value for Κ.ε at λ can 
ь
 max max 
then be determined by reading the absorption (from 
spectra obtained at the highest concentrations) at 
one of the measuring-points near λ (= A ) and at 
Б r
 max m 
A 
max 
λ (= A ). Then: (Κ.ε). = .(ΚεΚ . 
max max λ . λ 
m a x A
m m 
From this ε* can be calculated with: 
max 
(Κ.ε)
λ 
ε* = (the error in ε* depends on the 
max тг max
 r 
error in Κ). К was also used to determine the maxi­
mum saturation (S ) attained, i.e. the fraction 
max 
of complexed donor at the highest acceptor concen­
tration employed: 
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ртах тт „max 
S
 =
_ Й а 1_а [for C m a x » C J 
max
 c 1 + K<cmax a d 
d a 
VI. 2 THE ELECTRON ACCEPTOR 
In investigations into a possible relationship 
between electron donor properties of corticotro-
phic peptides and their biological activity, meas­
urements of donor properties of the peptides shoul 
preferably be carried out in aqueous solutions in 
order to provide the compounds with a natural en­
vironment. Therefore, we had to choose a water-sol 
uble acceptor for our experiments. 
Most of the well-known acceptors in organic 
chemistry [e.g. chloranil, trinitrobenzenes, picri 
acid, tetrachlorophthalic acid anhydride eta.) are 
nearly insoluble in water, but pyridinium ions wit 
electron-withdrawing substituents such as //-methyl 
nicotinamidium chloride, tf-methylisonicotinamidium 
chloride and tf-methylpicolinamidium chloride com­
bine acceptor properties with high solubility in 
water. 
Other requirements which had to be met by the 
acceptor were: 
a) a high electron affinity, 
b) stability over as large a pH range as possible, 
c) a large gap between the first and second vacant 
molecular orbital to avoid complications aris-
ing from multiple charge-transfer transitions . 
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An acceptor which fulfils all thesa require-
ments very well is N,N' -climethyl-4 ,4 ' -dipyridy lium 
dichloride (paraquat) as found by Verhoeven . 
D 
Paraquat (formerly called methyIviologen ) has 
been shown to form 1:1 charge-transfer complexes 
9-12 
with various anionic and neutral donor species ¡ 
the association constants of such complexes are re-
9 10 latively large ' . The compound is also an inhibi-
13-15 tor of photosynthesis . The mechanism of this 
action is not known, but it may involve an elec-
tron-transfer process in which the paraquat di-
cation is reduced to the free radical mono-cation. 
12 
The observation that paraquat gives complexes 
with porphyrin-liк molecules is of particular in­
terest in this context. 
The almost white paraquat dichloride can be 
prepared from the red di-iodide with freshly pre­
pared silver chloride in water ; N,N'-dimethyl-
4,4'-dipyridylium di-iodide in its turn is easily 
made from 4,4'-bipyridy1 and methyl iodide in di-
g 
methyIformamide . 
Experiments in aqueous solutions with indole 
derivatives as electron donors and various pyridi-
nium chlorides as acceptors revealed that paraquat 
is a much better electron acceptor than the chlo­
rides of ЛР-methylni cotinamide , tf-methy lisonicotin-
amide and tf-methylpicolinamide . Therefore, para­
quat was used as the electron acceptor in all our 
experiments. 
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VI. 3 THE ELECTRON DONORS 
VI. 3.1 Introduction 
All natural amino acids give coloured charge-
1 fi 
transfer complexes with strong electron accep­
tors [e.g. chloranil and tetracyano ethylene). In 
general, the free amino group is responsible for 
the formation of so-called π,π-complexes (see ref. 
2 p. 6). When the amino group is protected by acyl-
ation as in W-acetyl- or tf-t-butyloxycarbony1 amino 
acids, its η-donor properties vanish and only with 
special amino acids do n- or π-donor properties of 
the side-chains remain. 
Donors are present in the side-chains of the 
following amino acids: tryptophan (indole), tyro­
sine (phenol), phenylalanine (benzene), histidine 
(imidazole), methionine (methy1-thioether), cyste­
ine (thiol) and cystine (dialkyl-disulphide). 
Tryptophan is by far the strongest donor among 
these amino acids. It is the only one which gives 
complexes even with weak electron acceptors. 
Since our investigations concern a possible 
donor function of tryptophan in ACTH, some details 
will be given about its donor properties and about 
donor properties of the amino acids which have 
been 
tion, 
о 
been substituted for tryptophan in our investiga-
VI. 3.2 Tryptophan 
Charge-transfer interaction between indole 
residues and pyridinium moieties has been studied 
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intramolecularly in the model compound tf-(B-in-
1 7 dolylethy1)-3-carboxamide pyridinium chloride 
From these results it can be concluded that this 
type of interaction may also occur between tryp­
tophan or tryptophan containing compounds and co­
enzymes derived from nicotinamide [e.g. NAD ). 
Indeed, Cilento and Tedeschi observed a charge-
transfer band in the spectrum of the glyceralde-
hyde-3-phosphate dehydrogenase/diphosphopyridine 
nucleotide complex; it was tentatively ascribed 
to a charge-transfer interaction between an in­
dole side-chain of the enzyme and the pyridinium 
19 
ring of DPN by Kosower . In a similar way the in­
dole ring of a single, solvent-exposed tryptophan 
residue in chicken egg-white lysozyme is consid­
ered to be responsible for the yellow-coloured 
charge-transfer complex with tf-methylnicotinamidi-
. , . . 20 
urn chloride 
Several other investigations with simple model 
compounds have confirmed the good electron donor 
properties of indole and indole derivatives, in­
cluding tryptophan, both in intramolecular ' ' 
j · 4. ι η , 3,5,7,21 ,23.24 
and intermolecular complexes 
Szent Györgyi et al. showed that of the four 
naturally occurring aromatic amino acids, trypto-
phan is the only one which forms an electron 
25 transfer complex with riboflavin . They suggest 
that the donor site of indoles is localized at the 
7 R 
2-3 position in indole 
' Calculation of the formal negative 
Λ 
. „ /г charge distribution shows a high | 44/^N'I 2 7 
' Η density in the 3-position 
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VI. 3.3 Phenylalanine 
Cilento and Tedeschi observed the formation of 
a weak CT complex between a model compound derived 
+ 1 в 
from NAD and phenylalanine . A weak absorption 
band ascribed to an intramolecular complex was al­
so found for Я-{ 0-phenylethyl)-3-carbamoylpyridi-
1 7 
nium chloride . In both cases the corresponding 
indolyl compounds appeared to be much better do­
nors. 
Hofmann et al., studying substitution of phe-
g 
nylalanine for tryptophan in ACTH analogues, 
found a nearly complete loss of steroidogenic ac­
tivity in |Gin , Phe |-B-corticotrophin-(1-20)-
amide and also a lowering of the melanocyte-stim-
2 θ 
ulating activity 
If the charge-transfer properties of trypto-
o 
phan are involved in the biological potency of 
ACTH peptides, it would be understandable that 
phenylalanine analogues should have very low ac­
tivities since phenylalanine seems to be a poor 
25 
electron donor in comparison with tryptophan . 
This has been further substantiated in our in­
vestigations in which donor properties of several 
tryptophan-containing peptides, including ACTH-
(1-24), have been compared with those of corre­
sponding compounds in which tryptophan was ex­
changed for phenylalanine. 
95 
VI. 3.4 Pentamethylphenylalanine 
Since there ars no natural amino acids with 
donor properties comparable to those of tryptophan, 
replacement of tryptophan residues by equally po­
tent electron donors is only possible with unnatu­
ral amino acids. 
3 21 Schwyzer and coworkers ' found that N,N-di-
methyl-p-toluidine and hexamethylbenzene [i.e. see 
1 2 
and ) possess even better donor properties than 
indole towards acceptors like 4-nitrophthalimide 
in organic solvents. When, instead of the simple 
aromatic donors just mentioned, corresponding o-
amino-protected amino acid derivatives were com-
plexed with 4-nitrophthalimide or 4-nitrophthaloy1 
glycine ethyl ester in organic solvents, it ap­
peared that particularly the pentamethylphenylala­
nine derivative had donor properties comparable to 
those of tryptophan derivatives (cf. table VI-1). 
Table VI-1 
Acceptor: 4-nitrophthaloy1 glycine ethyl ester 
Solvent : ethanol (25 С) 
Donor 
Benzyloxycarbonyl-DL-
pentamethylphenylalanine 
^
a
-acetyl-L-p-dimethyl-
ami nophenyl alan ine 
^"-acetyl-L-tryptophan 
K(l/mole) 
2.3 
0.54 
1.56 
Eda 
500 
664 
712 
X
m a x
C n m ) 
370 
460 
355 
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tl -Acetyl-L-p-dirrmthylaminophenylalanine has a 
much lower K-value. Moreover, its introduction in­
to an ACTH-(1-24)-tetracosapeptide can give rise 
to difficulties in the synthetic procedure as a 
consequence of the rather basic side-chain. There­
fore, we thought it advisable to synthesize and 
resolve DL-pentamethylphenylalanine and to use 
this unnatural amino acid in the investigations 
into a possible relationship between donor proper­
ties of the amino acid residue in position 9 and 
the biological activity of corticotrophic pep­
tides. 
VI. 4 COMPARISON OF TRYPTOPHAN CONTAINING PEP­
TIDES WITH THE CORRESPONDING PENTAMETHYL-
PHENYLALANINE AND PHENYLALANINE PEPTIDES 
VI. 4.1 Introduction 
The only peptides from which electron donor 
properties ascribable to an incorporated trypto­
phan residue have been measured, are the ACTH-C5-
10) fragment, ACTH-И-24) and the natural hog ACTH 
30 
with 39 amino acids . The measurements were per­
formed in water and diluted acetic acid with N-
methylisonicotinamidium chloride as the acceptor. 
In view of the scarcity of data about the e-
lectron transfer properties of tryptophan con­
taining peptides, our measurements have not been 
restricted to the tetracosapeptides which have 
been tested for biological activity, but have also 
been performed with some intermediates from the 
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synthesis of the end-products. For these measure­
ments we selected the free ACTH-(7-10) fragments 
and the dipeptides H-X-Gly-OMe.HCl (X = Trp, Pmp 
and Phe, respectively). The three variable amino 
acids at the 9-position were themselves all meas­
ured as their ff-acetyl derivatives in order to ob­
tain corresponding values for comparison within 
the series of Trp, Pmp and Phe derivatives. 
VI. 4.2 Methode 
VI. 4.2.1 Performance of the measurements 
All spectrophotometric titrations were carried 
out with a Zeiss PMQ-II spectrophotometer at room 
temperature in a closed quartz cell of 1 cm (the 
same cell was used in all determinations). 
To the cuvette containing 2.0 ml of a dilute 
-3 
(about 1-2x10 molar) solution of the donor in 
water (except for the ff-acetyl amino acids which 
were measured in acetic acid-water (1:4)) increas­
ing amounts of solid N,N'-dimethy1-4,4'-dipyridyli-
um dichloride (paraquat) were added in 7 steps and 
the increase in the CT-absorption at various wave­
lengths was monitored (550-350 nm) after each step. 
The correction for the concomitant volume expansion 
was calculated from the formula 
V = V + y.0.0008 , where V = volume in ml 
У о > у 
after addition of у mg of the solid acceptor to V 
ml of solution. 
In most cases association constants and extinc­
tion coefficients of the peptide complexes were de-
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termined using the formula's given in section VI.I. 
This was not done for the phenylalanine containing 
compounds, except for ^Phe J-ACTH-(1-24), since the 
complexes of these substances did not show any CT-
absorption. In the figures (VI, 4-7) only the cor-
rected absorption curves for the complexes at the 
highest concentration of acceptor used are given. 
VI. 4.2.2 Influenae of the solvent 
An aqueous solution with the appropriate donor-
-3 
concentration (about 10 molar) could not be ob-
tained with tf-acetyl-pentamethyIphenylalanine in 
contradistinction to tf-acstyl-tryptophan, ^ -acetyl-
phenylalanine and the various peptides. Adequate 
concentrations for all compounds could be obtained, 
however, with solvent mixtures such as acetic acid-
water or acetic acid-dilute hydrochloric acid. 
The solvent influence on the stability of the 
complex between ^-acetyl-tryptophan and tf-methyl-
nicotinamidium chloride has been studied by 
Deranleau and Schwyzer in ethanol-water mixtures. 
They found that an increase in the ethanol concen-
tration markedly decreased the association con-
stant of the complex, without affecting the ex-
tinction coefficient appreciably. 
We investigated a possible solvent influence 
in acetic acid-water mixtures for the very strong 
electron donor 3-methylindole (skatole) in 20% ace-
tic acid, B0% acetic acid and acetic acid-0.1 N 
hydrochloric acid (4:1, /v) using the same end-
concentration of the components. Qualitative ex-
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perinients indicated that in this case the intensi­
ty of the CT-bands was considerably higher when 
water or 20% acetic acid were used as the solvent 
whereas the position of the bands was nearly the 
same in all solvent mixtures employed Cfig. VI, 
2). Probably, water stabilizes the complexes more 
than acetic acid. The influence of these solvent 
systems on the absorption of paraquat differs only 
below 375 nm, as is shown in fig. VI, 3. 
In order to restrict the consequences of the 
solvent influence on К and ε the association con­
stants and the extinction coefficients for the 
complexes formed between paraquat and //-acetyl-
tryptophan and tf-acetyl-pentamethylphenylalanine 
were determined in 20% acetic acid as the solvent. 
In all other measurements, water was used as the 
solvent. 
VI. 4.2.3 Synthesis of the compounds 
tf-Acetyl-L-tryptöphan and tf-acetyl-L-phenyl-
alanine were prepared from the amino acids by 
treatment with acetic anhydride in aqueous sodium 
hydroxide solution according to the method of du 
29 Vigneaud . The synthesis of tf-acetyl-L-penta-
methylphenylalanine has been described in chapter 
II. In chapter III and IV the synthesis of the 
pentamethylphenylalanine and phenylalanine pep-
tides, respectively, have been described. Details 
of the dipeptide H-Trp-Ely-OMe.HCl, with which on-
ly qualitative experiments were carried out since 
it should have about the same electron donor prop-
100 
erties as the previously examined H-Trp-OMe.HCl , 
are given in chapter VIII. 
VI. 4. 3 Experimental Resulte 
In tabel VI-2 the donor and acceptor concen­
trations, after volume correction, in the begin­
ning and at the end of the experiment are given. 
Table І-З summarizes the results obtained from 
the complexing of paraquat with the various do­
nors. Since there was no measurable CT-absorption 
from complexes with phenylalanine containing com­
pounds, no determinations of К and ε . could be 
о a 
carried out, except for the tetracosapeptids. 
The corrected absorption curves for the com­
plexes at the highest concentration of acceptor 
used are given in figures VI, 4, 5, В and 7. 
Table VI-2 
Donor 
^-acetyl-L-Тгр-ОН 
^-ac8tyl-L-Pmp-DH 
tf-acetyl-L-Phe-OH 
H-Trp-Gly-OMe.HCl 
H-Pmp-Gly-Dne.HCl 
H-Phe-Gly-OMe.HCl 
H-Ph8-Arg-Trp-Gly-0H.HC1.2H2D 
H-Phe-Arg-Pmp-Gly-0H.HC1.2H20 
H-Phe-Arg-Phe-Gly-DH.HC1.H2D 
[TrpS]-ACTH-(1-24) 
(peptide content 80.6%) 
[Pmp5] -ACTH-(1-24) 
(peptide content 75%) 
[Phe5]-ACTH-(1-24) 
(peptide content 58%) 
Donor concentration 
(Molar, χ 10 
beginning 
(QO paraquat) 
1.33 
0.B5 
1.76 
1 .90 
1.73 
1 .85 
1.09 
1.14 
2.34 
0.94 
0.82 
0.96 
-
3) 
end 
1.19 
0.76 
1 .59 
1.72 
1.54 
1 .65 
0.97 
1.01 
2.08 
0.83 
0.72 
0.85 
Acceptor concentration 
(Molar, 
beginning 
15.60 
15.62 
-
-
19.10 
-
15.66 
15.62 
-
16.02 
16.56 
16.31 
χ 10"2) 
end 
53.71 
53.77 
46.80 
44.34 
51.00 
52.13 
53.11 
55.59 
53.32 
51.64 
51.93 
52.40 
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Table VI-3 
Calculated data from the measurements of the charge-trans­
fer complexes of paraquat with the ff-acetyl amino acids in 
20% acetic acid and with various peptides in water, at 
room temperature. 
Compound 
tf-acetyl-Trp-OH 
ff-acetyl-Pmp-DH 
H-Trp-DMe.HCl7 
H-Pmp-Gly-OMe.HCl 
λ ( nm) 
36D 
370 
380 
390 
410 
360 
370 
3B0 
390 
410 
370 
400 
420 
450 
360 
370 
360 
390 
410 
К (1/mole) 
2.04 
2.14 
2.21 
2.34 
2.56 
0.17 
0.33 
0.25 
0.26 
0.38 
2.32 
2.8B 
2.64 
2.B6 
1.46 
1.43 
1.29 
1.23 
1.26 
Κ.ε 
1596 
1772 
1875 
1950 
1955 
456 
527 
521 
510 
45Θ 
1640 
2003 
1872 
1522 
1400 
1422 
1355 
1280 
1058 
К. e/K 
694 
770 
815 
847 
850 
1520 
1750 
1737 
1700 
1527 
680 
740 
690 
564 
1052 
1069 
1019 
962 
795 
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ТаЫ І - З , continued 
Compound 
H-Phe-Arg-Trp-Gly-OH.HCl 
H-Phe-Arg-Pmp-Gly-0H.HC1 
[Trp9]-ACTH-(1-24) 
[PmpSJ-ACTH-(1-24) 
[PheflJ-ACTH-(1-24) 
λ (nm) 
360 
370 
380 
390 
410 
360 
370 
3Θ0 
390 
410 
360 
370 
380 
390 
400 
410 
360 
370 
Э 0 
390 
400 
410 
360 
370 
380 
390 
400 
410 
К (1/mole) 
3.59 
3.77 
4.14 
4.43 
4.95 
1.56 
1.46 
1.62 
1.65 
1.64 
1.46 
1.55 
1.81 
1.93 
1.93 
2.21 
1.93 
1.74 
1.79 
1.55 
1.53 
1.6B 
0.26 
0.23 
0.26 
0.30 
0.56 
0.58 
K.e 
2604 
2820 
3075 
4631 
3463 
1235 
1288 
1368 
1369 
1211 
2528 
2732 
2776 
2771 
2634 
2566 
2B13 
2763 
2701 
2475 
2258 
2096 
880 
744 
613 
495 
359 
276 
K.e/K 
620 
671 
732 
1103 
825 
772 
805 
855 
856 
757 
1397 
1509 
1534 
1531 
1455 
1418 
1655 
1625 
1590 
1456 
1328 
1233 
2444 
2067 
1703 
1375 
997 
767 
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οι Ι—ι ι ι ι ι I 
350 U)0 (50 500 550 
λ (nm) 
Fig. VI, 2 - Absorption spectrum of the CT-com-
plex formed between skatols and pa-
-3 
raquat (concentrations 1.4 χ ID M 
-2 
and 41.4 χ 10 M, respectively) as 
measured in 
0 н2о 
@ H0Ac-H20 (1:4,
 V/v) 
0 H0Ac-H20 (4:1,
 V/v) 
0 HDAc-0.1 N HCl (4:1. V/v) 
105 
06 -
05 
Ol 
03 
02 
01 
\ : > 
• " " " ^ « ^ X ^ ^ ^ — · 
360 100 (50 500 
X(nm) 
Fig. VI, 3 - Influence of the solvent systems^?) 
(b) 0and(d) (see fig. VI, 2) on the 
paraquat absorption (concentration 
about 115 mg/ml). 
3S0 ДО) »О 500 550 
λ(ηπι| 
Fig. VI, 4-6 - Correctsd absorption curves for the 
CT-complexBS of several compounds and paraquat at 
the highest paraquat concentration, measured in 20% 
HOAc (fig. 4] or HjD at room temperature. —ο—ο— X = 
Trp, -·-·- X = Pmp, -Δ-Δ- X = Phe. 
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A 
07 
[x'J-Acn-fi-ui 
VI, 7 - Corrected absorption curves for the 
) CT-complexes of [X5]-ACTH-(1-24 ) and 
paraquat at the highest paraquat con­
centration, measured in water at room 
temperature. —o—o— X = Trp, —•—•— X = 
Pmp, -Δ-Δ- X = Phe. 
VI, В - Absorption curves obtained after sub-
tom] tracting curve —Δ—Δ— from curves 
—о—o— and — • — · — in fig. VI, 7. —о—o— 
X = Trp, —·—·— X = Pmp. 
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VI. 4.4 Огваивзгоп 
In table \/I-4 the complex constants for sever­
al tryptophan- and pentamethylphenylalanine con­
taining compounds are summarized. 
CT-absorption for the simple tryptophan con­
taining peptides takes place at a slightly longer 
wavelength than for the corresponding pentamethyl­
phenylalanine peptides, while the small phenyl­
alanine peptides do not show any CT-absorption at 
all. The association constants for the small tryp­
tophan peptides are markedly larger than for the 
pentamethylphenylalanine peptides while the ε* 
values are in general somewhat lower. 
The results found for tf-acetyl-Trp-OH in 20% 
acetic acid agree with the solvent dependence of 
the complex constants as was found by Deranleau 
and Schwyzer in ethanol-water mixtures. The low 
maximum saturation attained in the ff-acetyl-L-Pmp-
OH/paraquat complex indicates that the values 
found for К and e have a larger deviation than in 
the other cases. 
In the dipeptide, the positive charge of the 
+ 
-NhU group may be responsible for the less effi­
cient complexing of paraquat with the side-chain 
(the same was suggested for H-Trp-OMe.HCl by Ver­
hoeven ). 
With the tetrapeptides, where the donor amino 
acids have no free o-amino group, complexing in 
the case of Trp and Pmp is much better (yellow-
Table VI-4 
Characteristic parameters for the charge-transfer complexes of ЛГ-methyInicotinamidium 
chloride (A), paraquat (B) and i/-methylisonicotinamidium chloride (C) with several 
tryptophan- and pentamethyIphenylalanine containing compounds. 
C o m p l e x 
tf-acstyl-L-Trp-OH/A 
/ A 
/ B 
tf-acetyl-L-Pmp-OH/B 
Н - Т г р - 0 М в . Н С 1 / В 
H - P m p - G l y - O M e . H C l / B 
H - P h e - A r g - T r p - G l y - 0 H . H C 1 / B 
H - P h e - A r g - P m p - G l y - G H . H C l / B 
H - G l u - H i s - P h e - A r g - T r p - G l y - O H / C 
[ T r p S ] - A C T H - ( 1 - 2 4 ) / C 
/C 
/C 
/ B 
[ p m p S ] - A C T H - ( 1 - 2 4 ) / B 
[ P h e 5 J - A C T H - ( 1 - 2 4 ) / B 
h o g A C T H - ( 1 - 3 9 ) / C 
S o l v e n t 
н2о 
20% E t O H 
20% HOAc 
Я 
н2о 
» 
η 
η 
η 
0 . 0 1 N HOAc 
λ ( nm) 
max 
-
-
3 8 7 О 
зао_*_2 
З В 3 ^ 2 
3 7 0 + 5 
3 9 0 ^ 5 
3 3 5 ^ 5 
3 6 5 
-
0.2ІЧ A C O ' N H T ^ 3 6 5 
н2о 
η 
η 
η 
0 . 0 1 Ν HOAc 
-
3 7 0 ^ 2 
3 7 0 ^ 2 
no m a x . 
^ 3 6 5 
K ( l / m o l e ) 
5 . 2 
3 . 6 
2 . 3 MD.2 
0 . 3 0 ^ 0 . 0 5 
2 . 7 1 0 . 2 
1 . 3 3 ^ 0 . 1 
4 . 2 ^ 0 . 5 
1 . 6 ^ 0 . 0 4 
3 . 3 0 
Ή . θ 
2 . 0 0 
Ή . Б 
1 . 8 ^ 0 . 3 
1 . 7 ^ 0 . 2 
0 . 3 6 4 3 . 1 3 
1 . 9 
e :max 
B30 
8 0 0 
8 2 0 ^ 7 0 
1 7 9 0 0 0 0 
7 4 0 ^ 5 0 
1 0 7 4 ^ 8 0 
734*_B5 
85 8 ^ 2 1 
4 4 5 
•»-732 
7 7 9 
•^825 
1 5 6 0 ^ 2 5 0 
1 6 3 0 ^ 2 0 0 
-
4 8 0 
w* 
-
-
5 5 
14 
56 
37 
69 
47 
-
-
-
-
4 8 
47 
16 
-
) R e f . 
5 
5 
t h i s w o r k 
Η PI 
7 
t h i s w o r k 
η m 
η я 
3 0 
3 0 
30 
30 
t h i s w o r k 
η tt 
η m 
3 0 
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orange colour). Again, the phenylalanine tetra-
peptide does not show any CT-absorption. 
For the yellow-coloured [Trp\]-ACTH-(1-24)/ 
paraquat complex, the value for К decreases from 
about 4.2 (tetrapeptide) to about 1.6, while on 
the other hand the association constant for the 
yellow [Pmp J-ACTH-(1-24)/paraquat complex does 
not change (about 1.7). A possible explanation is 
that the indole moiety, because of the lower sym­
metry and strong localization of its highest occu­
pied molecular orbital, makes more specific de­
mands for complexing with paraquat than a penta-
methylphenyl residue with a higher symmetrical and 
more delocalized high occupied molecular orbital. 
Complexing of [Phe^-ACTH-(1-24) with paraquat 
results in a very slightly yellow-coloured solu­
tion. From fig. VI, 7 it can be seen that there is 
no maximum in the curve. 
To eliminate possible influences of all the 
other amino acids in the tetracosapeptides on com­
plex formation, especially those of the tyrosine 
residues in positions 2 and 23 which show reasona­
ble CT-absorption , curve 3 in fig. VI, 7 can be 
subtracted from curves 1 and 2. The resulting 
curves (fig. VI, B) have λ at about 400 nm ь
 max 
which is about the same value as found with the 
very good donor skatole (see ref. 7 and fig. VI, 2) 
We conclude that, if the donor properties of 
tryptophan in ACTH are involved in the biological 
activity, the pentamethylphenylalanine analogue 
must exhibit a nearly equal potency, whereas the 
phenylalanine peptide should be almost inactive. 
Ill 
VI. S SYNTHETIC PART 
Ν,Ν '-Dimethyl-4,4'-dipyridylium di chiari de 
100 mmoles (15.6 g) of 4,4'-bipyridy1 (Fluka) were 
dissolved in 250 ml of pure DMF and 250 mmoles (35.4 g) 
of methyliodide were added. The reaction flask was kept 
in the dark for 24 h at room temperature. Then, about 1.5 
1 of ether were added with stirring and the red N,N'-di-
methy1-4,4'-dipyridylium di-iodide was filtered and washed 
with ether (96%). To a suspension of this compound in wa­
ter, an excess (about 4 equivalents) of freshly prepared 
AgCl (from AgNCU and HCl) was added with stirring. After a 
few hours the Agi formed and the excess of AgCl were re­
moved by filtration and the filtrate was evaporated. After 
drying, the residue was dissolved in ethanol and ether was 
added with stirring. The almost white paraquat was ob­
tained in about 96% yield; m.p.: >330 C. 
Analysis : 
C12 H14 N2 C 12 C a l c d ' ! % c 56.05 % H 5.49 % N 10.69 % Cl 27.57 
(257.16) Found % С 5 5.6 H 5.7 % Ν 10.7 % Cl 27.5 
Although it is only slightly hygroscopic it is advisa­
ble to store the product in a desiccator. 
¡i-Ace ty I-L-tryptophan 
The acetylation of tryptophan was carried out with 
29 
acetic acid anhydride in NaOH . The product was recrystal-
lized from water. 
Yield 
M.p. 
Γ I 2 1 
TS 
76% Lit 
175-1770C 
+25.1° (c = 1.0. MeOH) 
(Perkin-Elmer 241) 
Rf = 0.60 (B) (UV and R-H) 
29 
189-190"C 
+30° (1 eq. NaOH) 
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A n a l y s i s : 
C 1 3 H 1 4 N 2 D 3 C a l e d . : % С 63.4D % H 5.73 Ч Ν 1 1 . 3 8 
( 2 4 Б . 2 7 ) Found : % С 6 3 . 1 % Η 5.9 % Ν 1 1 . 4 
Il-Acetyl-L-phenylalanine 
The same method was used t o obta in t h i s compound, 
which was also r e c r y s t a l l i z e d from water. 
Y ie ld 
M.p. 
г - i 2 J 
70% Lit 
165-166.5DC 
+45.3° (c = 1.0, 
EtOH) (Perkin-
Elmer 241) 
29 31 
172 u 
•51.4° 
(c = 1, EtOH) 
171-172 
•47.5° 
(c = 4, EtOH) 
TS : Rf = 0.60 (B) (R-H) 
Analysis : 
C 1 1 H 1 3 N 0 3 Caled.: % С 63.76 
(207.23) Found : % С 63.7 
% Η 6.32 
% Η 6.3 
% Ν 6.76 
% Ν 6.8 
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C H A P T E R V I I 
BIOLOGICAL ACTIVITIES OF THE FOUR ACTH AND TWO 
a-MSH ANALOGUES 
VII. 1 INTRODUCTION 
As already mentioned in chapter I, stimu­
lation of the adrenal cortex to produce and re­
lease steroid hormones and lipolysis in fat cells 
are the main activities of ACTH. 
In structure-function studies measurement of 
1-5 
steroidogenesis can be carried out гп г о and, 
с? 
in the method described by Saffran and Schally or 
modifications of this , also in vitro. Rats are 
preferably used for the determination of the 
steroidogenic potency of ACTH analogues, since 
corticosterone is the main steroid secreted by rat 
adrenals. Steroid determinations are confined to 
measurements of corticosterone using the acid 
)f S 
4,9 
D 
fluorescence technique of Silber et at. as modi­
fied by Guillemin et al· 
For the in vitro determination of the extra-
adrenal activity of ACTH in fat cells, the methods 
10 11 
of Jungas and Ball , and of Rodbell are used. 
The unesterified fatty acids released into the in-
12 
cubation medium are measured by titration and the 
glycerol content is determined according to the 
13 14 
method of Wieland or the method of Korn . Lipo­
lytic activity in vivo can be estimated on the 
116 
basis of the concentration of unesterified fatty 
acids determined colorimetrically in the plasma as 
1 5 described by Duncombe 
Another important extra-adrenal activity of 
ACTH is the stimulation of the melanocytes. This 
skin-darkening effect has mainly been investigated 
with frog skin in the in vitro test of Shizume et 
16 7 
al. or in the procedure of Schuier et al. . 
Lizards have also proved to be very good test ani­
mals for the in vitro examination of the melano-
cyte-expanding activity of a-MSH and ACTH peptides 
17 18 . 19 
' . The ъп ъ о method of Kastin and Ross has 
not found the same wide application as the in 
vitro methods. 
VII. 2 MATERIALS AND METHODS 
Peptides. The compounds that have been tested for 
various biological activities are [Pmp J-ACTH-
(1-24) and its D-Ser analogue (see chapter III), 
[Phe9]-ACTH-(1-24) and its D-Ser2 analogue (chap-
r 9-1 ter IV) , and the two a-MSH analogues, viz. [_Ртр J-
and [Phe ]-a-MSH, described in chapter V. 
Steroidogenesis. In vitro, adrenal slices were in­
cubated for 2 hours according to the method de-
scribed by Saffran and Schally . The corticosterone 
content of the incubation medium was measured by 
9 
acid fluorescence . For г« ь о experiments, rats 
(about 100 g) which had been hypophysectomized 
about 24 hours previously, were used. 
117 
Lipolysis. Lipolytic activity in vitro was deter­
mined essentially as described by Jungas and Ball 
1 0 
. After 2 hours of incubation the unestenfled 
12 fatty acids were measured by the method of Dole 
In vivo experiments were conducted according to 
15 the technique of Duncombe 
Melanocyte-stimulating activity. The tests were 
performed in vitro with the skin of Anolis 
1 fl Carolinensis . Some of the peptides were also 
tested with frog skin . 
VII. 3 RESULTS 
Steroidogenesis in vitro 
g 
The pentamethylphenylalanine ACTH analogues 
had to be tested in doses up to 100 γ/ml since 
there was no noticeable corticosterone release at 
doses lower than 10 γ/ml. Compared with normal 
ACTH-(1-24), the activity of [PmpP] -ACTH-( 1 -24) is 
about 1/600, while [D-SerJ, Pmp5]-ACTH-(1-24) is 
only slightly more active. ([D-Ser ]-ACTH-(1-24) 
is about twice as active as its L-Ser analogue). 
The activity of [PheS]-ACTH-(1-24) is about 
1% of that of the normal peptide, while [D-Ser , 
PheP]-ACTH-(1-24) has an activity of about 1/66 
of the normal ACTH-(1-24). 
9 The in vivo determination of the Phe peptides 
show a reasonable high but short steroidogenic 
response when compared with the normal ACTH-(1-24) 
(dose: 1 mg/kg body weight). 
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Lipolysia 
In in vitro experiments with rats no activity 
at all was found when 10-10D γ/ml doses of the Pmp 
peptides were used. The same experiments with 
ACTH-(1-24) revealed full activity with doses of 
0.01-0.1 γ/ml. 
g 
In in vivo experiments with rats, the Pmp -
analogues showed no lipolytic activity in doses up 
to 300 γ/kg. The same was found when rabbits were 
used as test animals (doses up to 10 γ/kg). The 
rabbit experiments were done because the effect of 
the o-nitrophenylsulpheny1 derivative of ACTH on 
lipolysis in rabbits is quite different from the 
20 
effect on lipolysis in rats 
Melanophore-expanding properties in vitro 
Contrary to the very low steroidogenesis and 
lipolysis found, the melanophore-expanding activi­
ties of the [Pmp "] -ACTH- ( 1 -24 ) peptides were sur­
prisingly high. Table VII-I summarizes the results 
obtained in two tests, on lizard and frog skin, 
respectively; the activity of o-MSH was arbitrari­
ly set at 1 and the values found were corrected 
for variations in the peptide content of the sam­
ples. 
Table VII-1 
Compound 
CTrppJ-ACTH-(1-24) 
[ P m p £ ' ] - A C T H - ( 1 - 2 4 ) 
[ D - S e r 2 , P m p S ] - A C T H - ( 1 - 2 4 ] 
[ P h e p ] - A C T H - ( 1 - 2 4 ) 
[ D - S e r 2 , P h e 5 ] - A C T H - ( 1 - 2 4 ) 
> m p S ] - a - M S H 
[Phe9J-o-MSH 
A c t i v i t y 
l i z a r d s 
•χ-0.05 
0 . 0 1 - 0 . 0 2 
0 . 0 4 - 0 . 1 
0 . 0 0 4 - 0 . 0 1 
0 . 0 1 4 - 0 . 0 5 
0 . 2 5 - 0 . 6 
f r o g s 
0 . 0 1 - 0 . 0 3 
'V.O.05 
} 0 . 1 - 0 . 3 
P e p t i d e 
c o n t e n t 
^ao 
^ 7 5 
^ 7 5 
-vse 
^ 5 8 
^ 7 3 
^ 7 0 
C o r r e c t e d v a l u e s 
l i z a r d s 
0 . 0 5 2 
0 . 0 1 1 - 0 . 0 2 2 
0 . 0 4 5 - 0 . 1 1 
0 . 0 0 6 - 0 . 0 1 5 
0 . 0 2 1 - 0 . 0 7 5 
0 . 2 9 - 0 . 6 9 
f r o g s 
0 . 0 1 1 - 0 . 0 3 4 
•Ю.056 
} 0 . 1 2 - 0 . 3 6 
* The peptide content of the standard was 84%. 
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VII. 4 DISCUSSION 
The results reveal that the steroidogenic and 
г 9-\ lipolytic activity of the two |_Pmp J-ACTH peptides 
on the one hand and the melanocyte-expanding activ­
ity on the other, contrast markedly. While with 
QPmp J-ACTH-(1-24) an almost negligible cortico­
steroid production, no mobilization of unesteri-
fied fatty acids, and no release of glycerol are 
found, the melanocyte-expanding activity tested 
with lizard as well as frog skin, is 20-50% of 
that of normal ACTH-(1-24). 
The influence of the introduction of a D-Ser resi­
due in position 1 on steroidogenesis and lipolysis 
is hardly noticeable but the melanocyte-expanding 
activity increases about fourfold. 
г 9 The observed steroidogenic patency of |_Phe " 
ACTH-(1-24f| (about 1%) agrees very well with the 
2 ι 
data of Hofmann et al. who reported about 24 ac­
tivity for [Gin , Phe J-3-corticotrophin-(1-20)-
amide. The increase in steroidogenesis after the 
introduction of a D-Ser residue in position 1 is 
somewhat lower than the twofold increase caused by 
the same substitution in the corresponding trypto-
22 phan peptide . The melanocyte-expanding activity 
of [Phe5]-ACTH-(1-24) is about 15% of the activity 
g 
of the Trp peptide; this is slightly more than 
that reported by Hofmann for the eicosapeptide. 
The activity is increased by a factor of 4 to 5 in 
the case of [D-Ser2, Phe5]-ACTH-(1-24). 
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Whereas our data on melanocyte-expanding ac-
tivities of the tetracosapeptids suggest that 
l_Pmp J-peptides are significantly more active than 
the corresponding [Phe J-peptides, such a differ-
ence could not be clearly established between 
[Pmp 3" and QPhe J-a-MSH. Both compounds have a 
relative activity between 0.1 and 0.3. The former 
compound might be more active on lizard skin than 
on frog skin. 
It is clear that our results cannot give a 
definite answer to the question as to whether ade-
quate electron donor properties of the amino acid 
residue in position 9 of corticotrophic compounds 
are an essential factor in the determination of 
biological activity. As far as steroidogenesis and 
lipolysis are concerned it is certainly not the 
only decisive factor, but it remains uncertain 
whether charge-transfer interaction between this 
distinct residue and the corresponding receptor 
are at all concerned in the biological activity of 
this type of compound. The comparable donor prop-
erties of Trp and Pmp are attended by rather large 
structural differences, and these differences may 
cause variations in other parameters (which may be 
important for biological activity) on substiution 
9 9 
of Pmp for Trp in ACTH analogues. For this rea-
son further investigations on analogues having 
residues structurally more related to tryptophan, 
e.g. B-(3-benzo \b]thienyl)-alanine, ß-(benzo-
furanyl)-alanine or N -methy1-tryptophan at posi-
tion 9 will be of importance. 
122 
The remarkable melanocyte-stimulating activi-
ty of the Pmp - analogues is an interesting result. 
23 According to Hofmann up to now all alterations 
in the essential part of ACTH-analogues that have 
lowered adrenocorticotrophic activity have also 
brought about a proportional lowering in melano-
cyte-stimulating activity. With our Pmp-deriv-
atives a separation between both types of activity 
could be realized for the first time. 
In the melanocyte stimulation, charge-trans-
fer interaction between the side-chain of the ami-
no acid residue in position 9 is compatible with 
the working hypothesis when the analogues are 
tested with lizard skin. The comparable activities 
of QPmp\] - and [Phe J-ct-PISH in the frog skin test 
however, do not substantiate this result. Future 
investigations must therefore allow for a discrim-
ination between an also possible hydrophobic inter-
action and the anticipated charge-transfer inter-
action in the excitation of the MSH receptor. 
From the beginning of our investigations we 
have realized that studies on the special func-
tion of a tryptophan residue, occurring in the es-
sential part of a peptide hormone, could also be 
conducted with analogues of endocrine factors 
other than ACTH. From cooperation with other re-
search groups during our investigation, some re-
sults became available concerning the effect of 
substitutions of Pmp for Trp in LH-RH and a 
gastrin tetrapeptide. Because some of these re-
sults seem likely to stimulate the continuation 
123 
of such investigations, they will be presented in 
the following section. 
VII. S OTHER HORMONAL PEPTIDES WITH L-TRYPTO-
PHAN REPLACED BY L-PENTAMETHYLPHENYL-
ALANINE 
VII. S.1 Luteinizing hormone-releasing hormone 
(LH-RH) 
The hypothalamus regulates the release of the 
luteinizing hormone (LH) and the follicle-stimu­
lating hormone (FSH) from the anterior pituitary 
gland by means of neurohumoral factors designated 
as LH-releasing hormone (LH-RH) and FSH-releasing 
2 4 hormone (FSH-RH) . The isolation of a polypeptide 
from porcine hypothalamic extracts which has both 
LH-RH and FSH-RH activity, and the finding that 
FSH-RH activity cannot be separated from LH-RH was 
ос тс 
reported by Schally and coworkers ' ; they found 
the hormone to be a decapeptide amide, containing 
one tryptophan residue at position 3: pGlu-His-
2 7 
Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH^ . The synthe­
sis of this decapeptide has recently been des-
.. .28 
cnbed 
From further investigations of Schally's 
group it was found that the tryptophan residue is 
29 
essential for biological activity . Replacement 
of tryptophan by amino acids containing simple 
hydrocarbon side-chains leads to analogues having 
30 
virtually no LH-releasing activity . Replacement 
by phenylalanine or tyrosine , however, results 
in compounds showing significant, though very low, 
124 
levels of LH-RH activity. 
Further investigations concerning the role of 
tryptophan have been carried out in a joint in-
32 
vestigation with Coy et at. in which successive 
substitutions in position 3 were conducted using: 
pentamethyIphenylalanine, 5-fluorotryptophan, p-
aminophenylalanine, p-nitrophenylalanine and 
histidine. In ovariectomized rats pretreated with 
33 
oestrogen and progesterone the LH-RH analogues 
were found to have LH-releasing activities of 69%, 
6%, 0.6%, 0.01% and oa. 0.05%, respectively, when 
compared to LH-RH itself. LH- and FSH-activities 
'T 
of [Pmp 3-LH-RH were also determined by an assay 
34 based on a 4-hour infusion of the peptide into 
immature male rats. In this test the LH-releasing 
potency is 41% and the FSH-releasing potency 34%. 
Since the only observable similarity in the prop-
erties of tryptophan and pentamethyIphenylalanine, 
apart from aromaticity, is their ability to donate 
•iï-electrons, it is probable that similar electron-
ic interactions between tryptophan, or pentamethy1-
phenylalanine, and a suitably oriented electron 
deficient moiety on the pituitary receptor, repre-
sents one of the principal criteria for the main-
tenance of biological function in LH-RH peptides; 
this might occur either by ensuring binding of the 
hormone to the receptor, participation in the mech-
anism promoting LH release, or a combination of 
both factors. 
Introduction of 5-fluorotryptophan, which is 
a poorer donor than tryptophan but structurally 
and chemically much more closely related than 
125 
pentamethylphenylalanine, causes a considerable 
reduction in LH-releasing activity. [p-NOj'Phe J-
LH-RH had diminished activity as compared to 
[Phe3]-LH-RH whereas [p-NH^Phe3] -LH-RH showed a 
slightly higher potency than the latter compound. 
With these peptide:; it is more difficult to at-
tribute changes in biological activity to the 
electronic effects of ring substituents since 
other factors such as size, acid-base behaviour 
and hydrophobicity might have overriding effects. 
However, the p-NC^'Phe analogue, containing the 
strongly electron-withdrawing nitro group, is by 
far the least active of the phenylalanine anal-
ogues. 
VII. 5.2 Gastrin tetrapeptide 
Gastrin is the generic name for certain pep-
tide hormones which can be extracted from the 
antral region of the stomach; they are remarkably 
potent stimulators of gastric secretion, and have 
a wide range of other activities in the alimenta-
ry tract. These were thoroughly investigated by 
35 
Gregory and Tracy , who isolated two pure, close-
ly related compounds from antral mucosa of hogs. 
Degradative studies indicated that both porcine 
hormones are heptadecapeptide amides having the 
same amino acid sequence: pGlu-Gly-Pro-Trp-Met-
(Glu)5-Ala-Tyr-Gly-Trp-net-Asp-Phe-NH2. Gastrin II 
differs from gastrin I by the presence of a phe-
nolic sulphate ester group. Investigations into 
gastrins from other species showed some minor 
126 
37 
variations in the amino acid sequence 5-10 
3 fl 39 
Syntheses of porcine and human gastrin have 
been described. 
It has been shown that the C-terminal tetra-
peptide amide, H-Trp-Met-Asp-Phe-NHL·, is required 
and is sufficient to elicit the whole range of 
physiological actions on gastric and pancreatic 
gland-cells and on gastrointestinal musculature 
40 41 displayed by the natural hormone ' 
Structure-function studies on the active te-
41 42 
trapeptide by Morley et al. ' showed that sub­
stitution of the tryptophan residue by phenyl­
alanine or histidine lowers activity considerably, 
but that substitution by des-amino tryptophan or 
des-amino homotryptophan and also introduction of 
a methyl group at positions 4, 5 or 6, or a hy-
droxyl group at positions 2 or 5 of the indolyl 
group of tryptophan, results in highly active com-
42 
pounds. It was concluded that tryptophan is con­
cerned with binding at the site of action. 
A possible role for the electron donor prop­
erties of the indole moiety in the binding process 
was investigated by replacement of the tryptophan 
residue by L-pentamethylphenylalanine. For this 
purpose the 2,4,S-trichloropheny1 ester of t-bu-
tyloxycarbonyl-L-pentamethyIphenylalanine was pre­
pared according to the method of Pless and 
43 Boissonnas . The active ester (see table \/II-2) 
was coupled with H-Met-Asp[ПВи )-Phe-NH2.HCl·
44 
* Gift from Dr. U.S. Morley (I.C.I. , England) 
Table І І - 2 
Yield Ш 
M.p. (0C) 
Ы о
2
 íc = 1 · 0 ' DMF) 
Analysis (thsoretical 
values in parentheses) 
% С 
% H 
% N 
% S 
% Cl 
Boc-Pmp-OTcp 
60.0 
• 
162-163 
-14.6° 
C25 H30 N 04 C 13 
(514.88) 
58.1 (58.32) 
5.9 ( 5.87) 
2.6 ( 2.72) 
20.6 (20.66) 
Boc-Pmp-Met-
Asp(0But)-Phe-NH2 
72.1 
205.5-206 
-32.6° 
C41H61N50QS.2H20 
(820.06) 
60.2 (60.05) 
7.4 ( 7.99) 
8.6 ( 8.54) 
3.8 ( 3.91 ) 
H-Pmp-Het-
Asp-Phe-NH2.HC1 
79.7 
222-223 
-3.3° 
C32 H46 N5 06 S C : 1- H2 0 
(682.29) 
55.7 (56.33) 
6.9 ( 7.09) 
10.2 (10.27) 
4.3 ( 4.70) 
5.9 ( 5.20) 
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44 
according to the method of Davey et al. and the 
resulting product, after recrystallization from 
ethanol and drying, deprotected with hydrogen 
chloride in acetic acid. Some chemical and physi­
cal data for the intermediates and the end-product 
of the synthesis are given in table \IIl-2. 
The tetrapeptide has been assayed in two 
dogs*. Doses of 1 and Ζ pg/kg/hr were given by 
intravenous infusion in the absence of background 
stimulation. Gastric secretion was collected at 
15 minute intervals for a period of 1ì hours. With 
neither dose was a secretory response observed. 
With the higher dose one dog showed signs of 
nausea. Apparently the compound is inactive at 
these doses since the test would have detected 
even weak activity. Side effects preclude testing 
at higher doses, but the relative activity com-
pared with the natural tetrapeptide amide must be 
very low. 
Therefore, charge donor properties of the side-
chain of the ^-terminal amino acid residue in 
this type of compounds are not involved in binding 
to its receptor. 
* We thank Dr. 3.S. Morley (I.C.I.. England) for 
performing the tests. 
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C H A P T E R V i l i 
SYNTHESIS OF THE ACTH-(7-1D)-TETRAPEPTIDE WITH 
L-ARGININE5 REPLACED BY L-NORARGINIIME 
VIII. 1 INTRODUCTION 
For the synthesis of \ßar 2 -ACTH peptides the 
same strategy was followed as was previously em-
ployed in the preparation of [Pmp "J- and [Pbe J-0-
corticotrophin-(1-24)-tetracosapeptides: the suit-
ably modified (7-10)-fragment was synthesized by 
stepwise or fragment condensations and subjected 
to the usual sequence of coupling reactions lead-
ing to the desired end-products. 
Two practical ways can be envisaged for syn-
thesizing a peptide containing norarginine: direct 
introduction of previously prepared norarginine or 
its nitro derivative, or introduction of L-a,Y-di-
aminobutyric acid with a temporarily masked γ-ami-
no group which can subsequently be uncovered and 
then converted into a guanidino function (cf. 
scheme VIII, 1 and 2). 
By analogy with the preparation of nitroargi-
nine and nitrohomoarginine by treatment of the 
copper complexes of ornithine and lysine, respec­
tively, with 0-methyl nitroisourea in alkaline 
1 2 
solution , L-a,γ-diaminobutyric acid was used as 
the starting compound for the synthesis of the low­
er homologue, nitronorarginine. An improved method 
134 
for the synthesis of the rather expensive L-α,γ-
diaminobutyric acid from L-glutamic acid was worked 
out. 
For the synthesis of all intermediates required 
for the desired [Nar "] - ß-corticotrophin- ( 7-1 0 ) -te-
tracosapeptids, only standard reactions were used. 
VIII. 2 SYNTHESIS AND SOME CHEMICAL PROPERTIES 
OF L-aty-DIAMINOBUTYRIC ACID 
VIII. 2.1 Synthesis 
The first description of the synthesis of di-
3 
aminobutyric acid was given by Fischer . He se-
quentially introduced a phthalimidoethyl residue 
and a bromine atom at the α-carbon of diethyl 
malonate, converted the product into γ-phthalimi-
do-a-bromobutyriс acid and substituted an amino 
group for the bromine. Hydrolysis with concentra­
ted hydrochloric acid led to the isolation of α,γ-
diaminobutyric acid via the crystalline oxalate. 
Kurihara and Ro started with ethyl acetamido-
cyanoacetate and S-bromoethylphthalimide and ob­
tained the oxalate salt of α,γ-diaminobutyric acid 
via ethyl γ-phthalimido-a-acetamido-o-cyanoacetate 
4 
by acid hydrolysis . 
Several authors have employed the Hofmann de-
C _ η 
gradation of glutamine derivatives or the dehy­
dration and subsequent hydrogénation of asparagine 
g 
derivatives , in order to obtain diaminobutyric 
acid. Other reported methods for the synthesis of 
135 
α,γ-diaminabutyric acid include: 
- the reaction between ethyl acrylate and diazo-
methane, followed by hydrogenolysis of the iso­
lated ethyl-2-pyrazoline-3-carboxylate and sub­
sequent acid hydrolysis of the hydrogenated prod-
.10 
uct 
11 
- the Strecker reaction with 0-phthalimidopropal-
dehyde which is prepared from acrylamide and 
1 2 phthalimide in the presence of Triton В 
- the reaction between γ-butyrolactone and potas­
sium phthalimide and the subsequent introduction 
1 3 
of an α-bromo atom , or directly from a-bromo-
1 4 
γ-butyrolactone and potassium phthalimide 
The most simple methods, however, seemed to be 
the reaction between L-glutamic acid and hydrazoic 
1 5 
acid (Schmidt reaction) as described by Adamson 
and the Curtius reaction with the azides of L-glu­
tamic acid derivatives 16,17 
Although the performance of the Schmidt reac­
tion is experimentally simple, yields exceeding 
15 1В 19 
62% have never been reported ' ' , mainly be­
cause of the laborious work up of the reaction 
mixture involved. 
We improved the procedure used by Adamson in 
the preparation of L-a,Y-diaminobutyric acid at 
two points: the reaction could be brought closer 
to completion by very efficient mixing of the re-
actants, and in the work up of the reaction mix­
ture the huge amount of sulphuric acid was neutral­
ized with an ion exchanger instead of barium hy­
droxide, thus avoiding the time-consuming and 
troublesome filtration of the precipitated barium 
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sulphate. The yield of pure L-a,γ-diaminobutyriс 
acid, isolated as its monohydrochloride, was in­
creased to more than 90% by these refinements. 
VIII. 2.2 Chemical properties 
Derivatives of diaminobutyric acid, selective-
ly acylated at Ν , may be obtained from the free 
amino acid by direct acylation ' . They are, 
however, more conveniently obtained by acylation 
21 22 
of the copper complex of the amino acid ' , ana­
logously to the preparation of the corresponding 
ornithine and lysine derivatives. Removal of cop­
per with hydrogen sulphide yields 76-90% of the 
21 22 desired amino acid derivatives ' ; a smoother 
method for elimination of the copper makes use of 
EDTA 2 3' 2 4. 
The yields of the above-mentioned acylated 
copper complexes were in the range of 60-70% which 
is markedly lower than in the case of the corre-
sponding ornithine - and lysine complexes ' 
Gne explanation may be that part of the α,γ-diami-
nobutyric acid binds copper in the same way as a, 
ß-diaminopropionic acid which forms mainly a type 
I complex whereas ornithine and lysine form only 
4. ту τ 27 type II complexes 
This explanation is not supported by the high 
yield (92.2%] of the //"^-phthaloyl-L-a, γ-d iamino-
butyric acid-copper complex obtained by Hase et al. 
Conversion into the free amino acid derivative, 
о Я 
however, yielded only 58.9% 
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L-nitrohomoarginine and L-nitroarginine 
have been prepared by treatment of L-lysine or L-
ornithine with CuCO^, at pH 11, followed by stir­
ring with O-methyl nitroisourea at О С . A first 
attempt to synthesize the as yet undescribed L-
nitronorarginine via a similar procedure was not 
successful. At pH B.5, however, we could isolate 
the copper complex in 56% yield. 
Introduction of a t-butyloxycarbonyl group in­
to ЛМ-benzyloxycarbonyl-L-a.y-diaminobutyric acid 
29 
could be achieved with Schnabel's method . When 
the same method was applied to L-nitronorarginine, 
however, the thin-layer chromatograms of the reac­
tion mixture showed six spots indicating the in­
stability of the compound in alkaline medium. From 
30 the literature it is known that the stability of 
L-nitroarginins is also limited at high pH values. 
In 2N sodium hydroxide solution at room tempera­
ture only about 24 of the decomposition product 2-
nitrimino-4-carboxy-1,3-diazacycloheptane is 
formed, but on treatment with a 250 fold excess of 
sodium carbonate on a steam bath for IJ hour, 34% 
of the cyclic product can be isolated. The more 
pronounced sensitivity of L-nitronorarginine to-
138 
wards bases was shown in the following experiments: 
when a sample of the compound was treated with 1M 
sodium hydroxide solution at room temperature, the 
resulting solution was ninhydrin negative within 
one minute and did not reveal the characteristic 
UV absorption peak for the nitro group at 268 nm. 
On dissolution in 54 sodium carbonate the solution 
also became ninhydrin negative, but still showed 
the quenching for nitro group. The same observa­
tion was made with a solution in 5% sodium hydro­
gen carbonate solution. Obviously, deprotonation 
of the α-amino group of the zwitter-ionic form of 
L-nitronorarginine triggers a decomposition reac­
tion, and since evolution of ammonia was observed, 
ring-closure to 2-nitrimino-4-carboxy-1,3-diaza-
cylohexane may well be envisaged. 
22 31 
In disagreement with the literature ' , pro-
tection of the carboxylic group in iV -benzyloxy-
carbonyl-L-a,γ-diaminobutyric acid via the normal 
32 
procedure with thionyl chloride and methanol did 
not immediately result in a chromatographically 
homogeneous ester hydrochloride. In all experi­
ments, varied in duration, temperature and degree 
of excess of thionyl chloride, a small amount of 
free diaminobutyric acid methyl ester dihydrochlo-
ride was found as a side-product which could be 
removed by chromatography on silica. The physical 
constants of pure methyl // -benzyloxycarbonyl-L-
α,γ-diaminobutyrate monohydrochloride were the 
22 
same as found by Vogler 
139 
Esterification of L-nitronorarginine could be 
carried out without complications. 
VIII. 3 METHOD OF SYNTHESIS 
Boe-Phe-Nar(IW2)-Trp-Gly-0Me (scheme VIII, 1) 
Carbobenzoxylation of L-tryptophan followed by 
coupling with glycine methyl ester hydrochloride 
(II) (see chapter III) using triphenyl phosphite 
and imidazole gave the protected dipeptide III 
in good yield. Catalytic hydrogenolysis (Pd/C) of 
this product in methanol containing one equivalent 
of hydrochloric acid gave the dipeptide hydrochlo­
ride IV without discolouration when pyridine was 
added prior to filtration of the catalyst. 
L-o,γ-diaminobutyric acid (V) (see section 
VIII. 2.1) was converted into L-nitronorarginine 
(VI) in a pH-Stat at pH 8.5 with O-methyl nitro-
isourea. This reagent was prepared by nitration of 
Q-methylisourea hydrogen sulphate at О С . 
L-nitronorarginine methyl ester hydrochloride 
(VII) was coupled with t-butyloxycarbonyl-L-phe-
nylalanine (VIII) according to the method of Mitin 
33 
to yield the protected dipeptide IX. The dipep­
tide ester was also obtained by coupling VII with 
the 1-succinimidyl ester of VIII; both prepara­
tions had the same physical constants and gave the 
correct analysis. Ester hydrolysis of IX with 1.1 
equivalents of base appeared not to be quantita­
tive, but with two equivalents complete conversion 
was obtained. 
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For the final condensation of the products X 
d IV three methods were investigated (1-3): 
Condensation of the fragments with triphenyl 
33 phosphite as the condensing agent gave no 
satisfactory results. There was an indication 
that, as well as some unidentified components 
the lactam of X had been formed. Isolation of 
that product and dissolution in methanol gave 
a product with the same UV spectrum and ele-
mental analysis as was found with the dipep-
tide methyl ester IX. 
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This result is different from that obtained by 
the Mitin coupling of the corresponding nitro-
37 homoarginine peptide with IV . On the other 
hand, when the corresponding nitroarginine pep-
tide was coupled with methyl phenylalanyl-gly-
cinate using triphenyl phosphite and imidazole, 
the physical constants of the resulting tetra-
peptide differed from those found when König's 
Я R 
method was used. 
At the 12 European Peptide Symposium (1972) 
3 fi 
Mitin stated that because of side-reactions 
his method cannot be used for couplings with 
ω-nitroarginine derivatives as had been repor-
33 ted in an earlier paper . The occurrence of 
side-reactions seems to depend on the length of 
the side-chain in the basic amino acid. 
34 3 5 
2) 7га a Wünsch-Weygand coupling ' , about 80% 
of a crude product was obtained. Purification 
achieved by counter-current distribution gave 
61% of a pure compound which gave the correct 
analysis. 
3) Application of the method of König and Geiger 
gave immediately a pure product on recrystalli-
zation from methanol-ether (70%). 
The physical constants such as melting point, 
39 
specific rotation and nitronorarginine content 
of the main products obtained with methods 2_ and 3^  
were different (cf. experimental section). A by-
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product in condensation 2 (about 15%), however, 
behaved identically with the main product from 
method 3, which is, based on the UV data, the 
desired tetrapeptide. 
An odd phenomenon was observed on chromato-
graphy of the main product obtained with method 2_. 
The pure material appeared as a single spot with 
Rf = 0.59 (system I) on thin-layer plates if a 
fresh methanolic solution was employed. On chro-
matography of a solution which had been left for 
15 minutes at room temperature, a second spot ap-
peared on the chromatogram with Rf = 0.4D. After a 
longer period of standing only the latter spot was 
found. On evaporation of a solution from which the 
original compound had disappeared, a residue was 
left which had again Rf = 0.59 on chromatography 
in system I. It underwent the same transformation 
on standing in methanol as described above. Appa-
rently the process is completely reversible and 
repeatable. The compound with Rf = 0.59 gave Ehr-
lich's reaction, whereas the product with Rf = 
0.40 could not be detected with this reagent. Both 
spots gave strong UV fluorescence quenching and 
chlorine/tolidine reactions. 
The product obtained with method 3 and the by-
product in condensation 2 had a Rf value of 0.30 
(system I) and did not change on standing. 
H-Phe-Nar-Trp-Gly-0H.2HCl (scheme VIII, 2) 
tfY-benzyloxycarbonyl-L-a,Y-diaminobutyric acid 
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was obtained via its copper complex by treatment 
with hydrogen sulphide or the disodium salt of 
23 2 4 
ethylenediamine tetraacetic acid ' . The method 
23 
of Kuwata was, in our hands, only successful 
when an excess of EDTA was used instead of an equi-
molar amount. A slight modification of Eckstein's 
24 procedure appeared to give good results. The 
product XII was acylated directly with the t-bu-
tyloxycarbonyl-L-phenylalanine-1-succinimidyl es-
ter in the presence of an organic base and 1-hy-
droxybenzotriazole. The optical purity of the pro-
tected dipeptide XV was demonstrated by comparison 
with samples obtained by a similar acylation of 
the methyl ester XIII (see section VIII. 2.2), 
using KSnig's as well as Mitin's method, and sub-
sequent alkaline hydrolysis of the protected di-
peptide ester XIV. 
The fragment condensation of the partially 
protected dipeptides XV and IV (route (Â)) with N-
hydraxysuccinimide/¿y,tf'-dicyclohexylcarbodiimide 
as the condensing reagent gave a product having 
physical constants differing from those of the 
product obtained by the same fragment condensa-
tion via Mitin's method (see table VIII. 1). 
Therefore, attempts were made to synthesize the 
tetrapeptide derivative via another pathway, to 
find out which of the products from the fragment 
condensation might be desired tetrapeptide XVI. 
An azide coupling ( ( B ) ) between the crystalline 
hydrazide XVII, obtained in good yield from the 
methyl ester XIV and hydrazine provided, however, 
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Scheme V i l i , 2 . 
no solution to the problem (see table VIH. 1]. 
Two other possible synthetic procedures, viz. 
a fragment condensation using 1-hydroxybenzotria-
zole and dicyclohexylcarbodiimide, and a stepwise 
procedure were then investigated. In the latter 
experiment /V-benzyloxycarbonyl-L-a,Y-diaminobu-
tyric acid (XII) was converted into the N^-tert-
butyloxycarbony1 derivative according to the meth-
Table VIII-1 
Physical and analytical data of the protected tetrapeptide 
Boc-Phe-Dab(Z)-Trp-Gly-OMe prepared via different routes 
Yield (%) 
M.p. (°C) 
[a]D(c = 1.0, MeOH) 
(c = 1.0, DMF) 
Analysis : 
C 4 0H 4 6N 6D g (756.86) 
% С (63.46) 
h H ( 6.39) 
% Ν (11.10) 
Fragment condensation 
HDNSu 
DCC 
57 
166-
186 
-33.5° 
-14.0° 
63.4 
6.4 
10.9 
Mitin 
75 
171-
173.5 
-26.0° 
-19.6° 
63.3 
6.6 
10.6 
azide 
53 
183.5-
168 
-29.5° 
-18.4° 
63.2 
6.4 
10.6 
HOBt 
DCC 
75 
181-182 
-33.2°· 
-18.6° 
63.1 
6.6 
11.1 
Stepwise procedure 
via 
ONSu 
75 
179-181 
-33.2°* 
-18.5° 
63.2 
6.6 
10.9 
HOBt 
DCC 
59 
182.5-
164.5 
-33.3° 
-19.6° 
63.2 
6.4 
11.0 
Mitin 
76 
163.5-
165.5 
-32.7° 
-16.6° 
62.9 
6.4 
11.1 
* These rotations were measured with a Perkin-Elmer 241 apparatus, the others 
on a Zeiss Polarimeter. 
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29 
od of Schnabel and the product XVIII was iso-
lated as a dicyclohexyl ammonium salt. The optical 
rotation, in methanol as well as in dimethylforma-
mide, was quite different from that reported by 
40 41 
Vogler and Arold , but it had the same melting 
point as given by Vogler. Coupling of XVIII with 
IV, gave identical products when performed accord-
ing to König or via Mitin's procedure. So, it 
seemed permissible to suppose that the protected 
tripeptide XIX had been formed in both cases. The 
//-terminal protective group was removed with hy-
drogen chloride in ethyl acetate and the resulting 
product (XX) was then coupled with t-butyloxycar-
bony1-L-phenylalanine (route (ç) ). This coupling 
step was performed with the 1-succinimidyl ester 
of VIII and also via König's and Mitin's method. 
Again, identical products were isolated from all 
three procedures (see table VIII. 1). 
The results of this stepwise procedure were in 
good agreement with those obtained via the frag-
ment condensation method using 1-hydroxybenzotri-
azole and dicyclohexylcarbodiimide; therefore we 
feel confident that these products are the pure, 
desired protected tetrapeptide ester XVI. 
Hydrogénation of the protected tetrapeptide 
XVI in the presence of palladium on charcoal as 
the catalyst was carried out in acetic acid as 
the solvent. 
The introduction of the amidino group into the 
side-chain of XXI can be carried out using several 
reagents. Bodanszky used 1-guanyl-3,5-dimethyl-
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42 α 
pyrazole in the synthesis of N -benzyloxycarbonyl-
histidyl-phenylalanyl-arginyl-tryptophyl-glycine 
43 from the corresponding ornithine peptide . For 
this purpose, 2.31 mmoles of the reagent were added 
to a dimethyIformamide solution containing one 
mmole of peptide and about 4.3 mmoles of triethyl-
amine. After 4 hours at about 40 С and BO hours at 
room temperature, addition of water precipitated 
Bö.8% of the desired pentapeptide. Following ex-
actly this procedure, we did not succeed, however, 
in isolating the norarginine-containing tetrapep-
tide ester in reasonable purity and yield. 
Amidination with a large excess (Ή50 equiva­
lents) of O-methylisourea at high pH (10-12) in 
sodium hydroxide solution as applied to large pep-
44 45 
tides and proteins , also failed to give t-bu-
tyloxycarbonylphenylalanyl-norarginyl-tryptophyl-
glycine in reasonable yield and purity. 
Better results were obtained when a freshly 
46 prepared methanolic solution of O-methylisourea 
was added to a solution of the tetrapeptide XXI in 
47 
methanol. In 1934 Kapfhammer and Müller synthe-
sized several a-guanidino amino acids and dipep-
4Θ tides in this way, and Greenstein prepared homo-
arginyl-glutamic acid from lysy1-glutamic acid 
using the same method. 
When 0-methylisourea was liberated from its salt 
and the amidination reaction carried out in metha­
nol, it appeared that the norarginine peptide a-
rose as the free carboxylic acid since alkaline 
hydrolysis of the product after removal of the t-
butyloxycarbony1 group did not modify the peptide. 
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When XXI was treated with 5 equivalents of O-me-
thylisourea in methanol for 2-3 days at room tem­
perature, and water was added to the mixture, some 
60% of crude XXII could be isolated. About 75% was 
obtained when 20 equivalents of the free urea deri­
vative were used and the reaction mixture was held 
at a temperature of 0-4 С for some 20 hours. Puri­
fication of the norarginine tetrapeptide could be 
achieved by chromatography on Kieselgel 60 using 
isopropyl alcohol-ammonia-water (8:1:1) as the e-
luent. 
Removal of the ЛГ -protective t-butyloxycarbo-
nyl group was carried out with hydrochloric acid 
in acetic acid; precipitation with ether gave the 
free tetrapeptide XXIII in good yield. 
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Vili. 4 EXPERIMENTAL SECTION 
For d e t a i l s concerning the a b b r e v i a t i o n s , t h i n - l a y e r 
chromatography and the performance of measurements, see 
the appendices. 
Scheme V I I I , 1 . 
Z-Trp-OH ( I ) 
The synthesis of this compound was carried out using 
Z-Cl and NaOH at 0 C. Recrystallization was achieved with 
ethyl acetate/petroleum ether. 
Yield : 95% Lit.49 85-98% 
M.p. : 124-1250C 1260C 
[aYQ4 : +24.6° (с = 1.0, EtOAc) (Zeiss) -
- 8.9° (c = 1.0, MeOH) 
+ 2.9° (c = 1.0, HGAc) 
TS : Rf •= 0.07 (A). = 0.68 (B), = 0.56 (E) (UV and R-H) 
Analysis : 
C19 H1B N2 04 Caled.: % С 67.45 % Η 5.36 % Ν 8.28 
(338.36) Found : % С 67.3 % H S.3 % Ν 8.3 
Z-Trp-Gly-OMe (III) 
C o u p l i n g o f I and I I (see c h a p t e r I I I ) was c a r r i e d o u t 
33 w i t h i m i d a z o l e and t r i p h e n y l p h o s p h i t e . The p r o d u c t was 
r e c r y s t a l l i z e d f r o m m e t h a n o l . 
Y i e l d : 92% L i t . 3 3 97% 5 0 7 4 % 5 ' l 5 9 % 
M.p. : 1 5 7 . 5 - 1 5 8 . 5 0 C 1 5 7 - 1 5 8 a C 1 5 6 - 1 5 8 0 C 1 5 8 - 1 5 9 0 α 
[ a ] 2 D 4 · . - 1 3 . 7 ° ( c = - 1 2 . 7 ° ( c = - 1 1 . 0 ° ( c - - 1 1 . 0 ° ( c = 
1.0, HOAc) 2, HOAc) Э, HOAc) 2, HOAc) 
(Zeiss) 
TS : Rf = 0.46 (A). = 0.72 (B), = 0.77 (E) (UV and R-H) 
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Analysis : 
C22 H23 N3 05 
(409.44) 
Caled.: 
Found : 
% С 64.54 
% С В4.5 
\ H 5.6Б 
% H 5.7 
Ч Ч 10.26 
% N 10.3 
H-Trp-Gly-OMe.HCl (IV) 
Compound III was suspended in methanol and hydrogena-
ted in the presence of palladium on charcoal and one equi­
valent of aqueous concentrated HCl. During the uptake of 
hydrogen the ester went into solution. Than one equivalent 
of pyridine was added and the catalyst was removed by fil­
tration. The filtrate was evaporated, the residue taken up 
in methanol and evaporated again; after repeating this 
procedure, the off-white non-crystalline salt was isolated 
and kept in the dark. 
Yield 
14.p. 
Γ Ί
2 ? 
TS : 
Analysis : 
C 1 4 H 1 6 N 3 G 3 C 1 Caled. 
(311.77) Found 
52 
Lit. 91% 9 8% 
99-101oC (dec.) 
•48.8° (c = 1.0, M3.6 0 (c = 1.1, 1N HCl) 
IN HCl) (Zeiss) for the hemihydrate 
+29.2° (c = 1.0, MeOH) 
Rf = 0.09 (A), = 0.37 (B) (UV, ninh. and R-H) 
С 53.94 
С 54.4 
Η 5.82 
Η 5.9 
% Ν 13.48 
% Ν 13.6 
H-Dab-OH.HCl (V) 
100 mmoles of L-glutamic acid (14.72 g) and 70 ml of 
H 9S0. (about 100%) were brought into a conical reaction 
flask (370 ml) with a wide, ground joint (B 55) which was 
equipped with a three way adaptor holding a reflux conden-
sor, the stirring rod of a very efficient stirring appara­
tus (Vibro-Mischer, model E 1 from "A.G. für Chemie-Appa-
ratenbau", Switzerland; plunger diameter of 45 mm, 17 mm 
from the walls of the vessel) and a stopper. After the a-
mino acid had been dissolved by stirring and gentle heat-
ing, 70 ml of chloroform were added, followed by one equi-
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valent of NaN, (6.50 g) in one portion. The temperature 
increased within a few seconds to the boiling point of 
chloroform and was maintained between 50 and 62 С during 
the course of the reaction. Another equivalent of NaN. was 
added after one, four and six hours. After eight hours the 
reaction mixture was cooled to room temperature and poured 
into enough distilled water to obtain a half molar H^SO. 
solution. After separating from the CHCl-, layer, the aque­
ous solution was filtered slowly through a column of Dowex 
50X2 (700 ml of wet Dowex with a capacity of O.ä meq/ml 
resin were used). The filtrate appeared to be completely 
free of diaminobutyric acid and was discarded. The column 
was washed with water until the pH of the effluent was a-
bout 5 and the product was then eluted with 4 M ammonia. 
The filtrate was evaporated, the residue dissolved in wa-
ter, treated with charcoal and evaporated again. The resi-
due was then dissolved in a small amount of HCl, the pH 
adjusted to 5 with pyridine and the product precipitated 
with 96% ethanol. 
9 53_ 54 
о 
о 
Yield 
Μ.ρ 
92% Lit.'
226-227 С 225 
-о 
Г Ί
2 β 
TS : 
Analysis : 
C 4 H 1 1 N 2 0 2 C 1 Caled. 
(154.60) Found 
224-226"С 
о 
+22.5 W (с = +25.3 +22.0 
1.0, 6N HCl) (с = 1.1, 
(Zeiss) 5N HCl) 
2251 
+23.θ'
(с = 1.2, 
6Ν HCl) 
Rf 0.30 (L), - 0.25 (W) (ninh. and R-H) 
С 31.06 
С 31.0 
Ч Η 7.17 
% Η 7.0 
% Ν 18.12 
% Ν 18.2 
H-Nar(N02)-0H (VI) 
7.73 g (50 mmoles) of V were dissolved in Б0 ml of wa­
ter. 4.00 g (25 mmoles) of CuSO. were added to the solu­
tion with stirring and the reaction mixture cooled. The 
pH of the solution was adjusted to 8.5 and kept constant 
during the reaction with the aid of an autotitrator loaded 
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with 4N NaOH. Subsequently 6.66 g (56 mmoles) of 0-methyl 
nitroisourea (prepared according to the method of Heyboer 
in 30% yield with m.p. 118.5-119.5 C) were added in the 
course of a few hours. After about 4 hours, the pH was ad­
justed to 7 with acetic acid and the light-blue copper 
complex was filtered, washed with water and acetone and 
dried with ether (57%). 
The complex was dissolved in dilute hydrochloric acid 
and the amino acid was liberated by saturation of the so­
lution with H-S. After filtration of the precipitated CuS 
and concentration of the filtrate, the pH was brought to 
6 and VI was isolated as a white crystalline solid which 
was purified by recrystallization from water. Yield: 62%. 
M.p.: 206.5-20 .5оС (dec. 16D-1750C). TS: Rf = 0. (L). 
- 0.27 (U) (UV and R-H). [a]p3 = +35.6° (c = 1.0, 1N HCl), 
= OS.2° (c - 1.0. 2N HCl) (Zeiss), e = 15, 10 (at λ 
max 
268.0 nm in DMF/0.2 N HCl, 1:1 v / v ) , ε = 1.810 (at λ 
39 m a x 
265.0 nm in TFA) . 
Analysis : 
C5 H11 N5 04' H2 0 C a l c d ' : % c 26.Э1 % Η 5.87 % N 31.38 
(205.17) Found : % С 26.8 % Η 5.8 % Ν 31.3 
H-!Jar(N02)-OMe.HCi (VII) 
Esteri fication of VI with S0C17 and MeOH was carried 
out in the usual way. The white compound was isolated in 
about 99% yield. M.p.: 91-930C. TS: Rf = 0.10 (B), = 0.60 
(U) (UV, ninh. and R-H). [a] 2Q
e
 = +18.1° (c = 1.0, MeOH) 
(Zeiss). A • 0.41 at λ = 268.5 nm (concentration: 
max 
0.008 mg/ml in 0MF-0.2N HCl, 1:1 V/v) and A = 0.70 at 
λ · 260.0 (concentration 0.1 mg/ml in TFA). Elemental 
analysis indicated the presence of a variable amount (up 
to 1.5 equivalents) of hydrochloric acid. 
Boc-Phe-flar(N02)-OMe (IX) 
1) Boc-Phe-0H (VIII, see chapter III) (5 mmoles = 1.327 
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g), VII (5 mmoles = 1.276 g), tf-ethylmorpholine (5 
mmoles + the amount necessary for neutralization of 
the excess of HCl present in VII), imidazole (7.5 
mmoles = 0.511 g) and triphenyl phosphite (7.5 mmoles 
= 2.327 g) were dissolved in about 15 ml of DMF and 
kept at 40 С for 1Θ hours. Then the solvent was evap­
orated and the residue was taken up in EtOAc. The 
solution was extracted with 5% NaHC0_ solution, water, 
5% citric acid solution, water and finally with satu­
rated NaCl solution. The organic layer was dried on 
Na^SO , filtered and evaporated. Crystallization of 
the remaining oil from ether gave IX in 71% yield. 
И.p.: 122-1240C. TS: Rf = 0.21 (A), = 0.70 (B), = 0.45 
(I) (UV and R-H). [ a ] " =• -4.8° (c = 1.0, EtOAc] , = 
-9.5° (c - 1.0, MeOH) (Zeiss), ε = 15,920 (at λ 
max 
269.0 nm in DMF/0.2N HCl, 1:1 /ν), ε - 1,540 (at λ 
max 
= 261.5 nm in TFA). Nitronorarginine content: 45% 
(theoret: 
Analysis ! 
C20 H30 N6 C 
(466.49) Found : % С 51.3 % Η 6.5 % Ν 1Θ.0 
(theoretically 43.9%) , 
C-.
n
H^
n
N
c
0, Caled.: % С 51.49 % Η 6.4Θ % Ν 18.02 
ZU JU b / 
2) Coupling of Boc-Phe-ONSu (see chapter III) with VII 
gave, after purification, the protected dipeptide 
ester IX with the same physical constants, in 69% 
уі ld. 
Boo-Phe-Nar(N02)-OH (Χ) 
The addition of 1.1 equivalents of NaOH to a solution 
of IX in dioxan did not lead to complete hydrolysis. At 
least 2 equivalents were necessary for complete saponifi­
cation which was then accomplished within half an hour. 
Evaporation of the solvents and dissolution of the residue 
in EtOAc was followed by extraction with 5% citric acid. 
The organic layer was washed with water and saturated NaCl 
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solution, and dried on NapSO.. After filtration, evapora­
tion of the solvent and drying, 92% of X was obtained. 
M.p.: 109-113oC (dec). TS: Rf = 0.50 (B) ( UV and R-H). 
[ a ] " = -3.2° (c = 1.0. MeOH) (Zeiss), ε = 13,920 (at X
m a x 
= 268.5 nm in DMF/0.2N HCl, 1:1 V / v ) , e = 1,790 (at λ 
max 
260.5 nm in TFA). Nitronorarginine content: 40% (theoreti­
cally 45.1%). 
Analysis : 
C
<
oH^ QN c0, Caled.: % С 50.44 % Η 6.24 % Ν 1Θ.57 
ТУ Za о / 
(452.47) Found : % С 50.1 % Η 6.2 % Ν 1Θ.2 
Boc-Phe-Nar(N02)-Trp-Gly-OMe (XI) 
HOBt/DCC method 
The procedure finally adopted ran as follows: to a 
solution of 4.26 mmoles (1.937 g) of X in 15 ml of DMF 
were added with stirring 4.2Ö mmoles (1.335 g) of IV, 
0.54 ml (one equivalent) of ЛГ-ethylmorpholine and 6.50 
mmoles (0.678 g) of HOBt. The reaction mixture was cooled 
in an ice bath and 0.972 g (4.71 mmoles) of DCC were ad­
ded. After stirring at 0 С for 2 hours and at room temper­
ature for another 2j hours, the precipitated DCU was fil­
tered and the solvent evaporated. The residue was taken up 
in EtOAc and was washed and dried as described before (see 
IX) 69% of the not quite homogeneous product was obtained. 
Recrystallization from methanol/ethsr gave about 70% of 
pure XI. И.p.: 120-122OC. TS: Rf = 0.74 (B), = 0.30 (I) 
(UV. R-H and Ehrlich). [α]^ β = -20.5° (с = 1.0. MeOH) 
(Zeiss), ε = 22.310 (at λ = 270.0 nm in DMF/0.2N HCl, 
max 
1:1 V / v ) , ε = 7,370 (at λ = 263.5 nm in TFA). Nitronor-
max 
arginine content: 30% (theoretically 26.9%). 
Analysis : 
C33 H43 N9 09* H2 D C a l c d - : % c 54.46 % Η 6.23 % N 17.32 (727.78) Found : % С 54.6 % Η 6.2 % Ν 17.4 
After drying a sample in a high 
the following values were found 
vacuum over Ρ-,Ο, at 60 С 
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C33 H43 N9 0g Caled.: % С 55.Θ4 % Η 6.11 % Ν 17.76 
(709.76) Found : % С 55.5 % Η 6.0 % Ν 17.6 
The first experiments were carried out with HONSu. 
One equivalent of DCC was added, at -20 C, to the reaction 
mixture consisting of equimolar amounts of IV, X and Et„IM, 
and 2 equivalents of HONSu. The temperature was allowed to 
rise spontaneously to room temperature. Working up of the 
reaction mixture as described in the previous preparation 
gave about B0% of a chromatographically inhomogsneous prod­
uct, which could not be purified by recrystallization from 
ethyl acetate/petroleum ether. Counter-current distribution 
with the system methanol-ethyl acetate-petroleum ether-wa­
ter (5:4:6:3) gave, however, a pure product (K = 0.13, 
г =31 after 275 transfers). Yield: 2.247 g (starting 
max 
from 2.299 g of X). M.p.; 94-970C. TS: Rf = 0.59 (I) (UV, 
R-H and Ehrlich) for a fresh solution (see previous sec­
tion). [а]ц7 - -15.6° (с = 1.0, MeOH) at t = о and -14.0° 
after 8 hours (Zeiss). A = 0.6Θ at λ = 274.0 nm (con-
_7 max 
centration 2.04x10 mg/ml DMF-0.2N HCl, 1:1 V/v) and A = 
0.Θ2 at λ • 262.0 nm (concentration 0.09Θ mg/ml TFA). 
max
 ь 
Nitronorarginine content, calculated for XI: 37% (theoret­
ical value 26.9%). 
Analysis for: 
C 3 3H 4 3N g0 g.H 20 Caled.: % С 54.46 % H 6.23 % Ν 17.32 
(727.7Θ) Found : % С 54.1 % Η 6.2 % Ν 17.4 
Some 50 mg of another pure product were obtained from 
the counter-current distribution (K = 0.05, r_ = 14) 
max 
possessing the same properties as the product obtained via 
the H0Bt/0CC method. M.p.: 119-1220C. TS: Rf = 0.30 (I) 
(UV, R-H and Ehrlich), e = 22,250 (at λ = 270.0 nm in 
max 
DMF-O^N HCl, 1:1 v / v ) , ε = 7.475 (at λ - 266.0 nm in 
max 
TFA). Nitronorarginine content: 29% (theoretically 28.9%). 
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Analysis : 
C33H43N909-ÍH2D 
(71β.77) 
Caled.: 
Found : 
% С 55.14 
% С 55.2 
% Η 6.17 
% Η 6.1 
Ч Ν 17.54 
% Ν 17.1 
Scheme Vili, 2. 
H-Dab(Z)-OH (XII) 
50 mmoles (7.74 g) of H-Dab-0H.HC1 (V) and 25 mmoles 
of CuSO. (4.00 g) were dissolved in about 40 ml of l-UCI. 
The solution was cooled and the pH adjusted to 10.5. Sub­
sequently 60 mmoles of Z-Cl (3.53 ml) were slowly added 
with stirring; the pH of the solution was kept constant 
with a pH Stat loaded with 4N NaOH. After completion of 
the addition, stirring and cooling were continued for 5 
hours. Then, the blue copper complex of XII was filtered 
and washed with water, acetone and ether. Yield: 67%. 
Two methods were used for the removal of the copper: 
a) H^S was bubbled through a solution of the copper com­
plex in dilute hydrochloric acid for about 3 hours. The 
precipitated CuS was filtered off with hyflo and the pH 
of the filtrate was then adjusted to about 7 with di-
ethylamine. After cooling and filtering, the compound 
was recrystallized from EtOH-H_0 (1:1). 
70% Lit. 2 2 76% 3 2-Yield 
M.p. 
Γ 12S 
TS 
Analysis : 
C 1 2H 1 6N 20 4 
(252.27) 
55 
226-227.5 С 
,o 
23B-240 С 
•19.9" (с = 1.0, 
1N HCl) (Zeiss) 
Rf = 0.40 (В) (ninh. and R-H) 
Caled.: % С 57.13 % Η 6.39 
Found : % С 57.2 % Η 6.3 
2380C 
+12.5е 
18% 
2350C 
% Ν 11.10 
% Ν 11.3 
b) 7.00 g of the copper complex were suspended in water. 
13.B0 g of EDTA (3 equivalents) were added to the sus-
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pension followed by HCl to a pH of 2.5. Addition of a 
large amount of water with stirring resulted in a clear 
solution which was neutralized by the addition of solid 
NaOH. Concentration of the solution to about 10% of its 
original volume gave a precipitate of XII which was re-
crystallized from EtOH-bUO (1:1), containing a small 
amount of EDTA. Yield: 71%, m.p. 216-2180C, [ a ] ^ = 
+21.0° (c = 0.4, 2N HCl) (Perkin-Elmer 241). The prod­
uct gave the expected elemental analysis. 
H-Dab(Z)-OMe.HCl (XIII) 
When the esterification was carried out according to 
22 
the method of Vogler and Lanz , a small amount of 
Η-Dab(H)-OMe.2HC1 was obtained as a by-product. Changes in 
the excess of SOCI-, used, the temperature or the duration 
of the reaction did not prevent the formation of the by­
product. Removal of the impurity was achieved by filtra­
tion of the reaction mixture through silica gel (Kieselgel 
60) with СНСЦ-ІЧеОН (9:1) as the eluent. The pure product 
precipitated on addition of ether to a concentrated solu­
tion of XIII in methanol. 
Yield : 73% Lit. 2 2 30% 3 2- 5 690% 
M.p. : 157-15ö0C 164-1660C 140^ 166-1680C 
[α]*2 : -15.5°
 +
15.2 0
 +
20.θ Ο -15.4° 
(с = 1.0, МеОН) (с = 2 , (с = 1, (с = 0.48, 
(Zeiss) МеОН) МеОН) МеОН) 
TS : Rf = 0.40 (В), = 0.33 (I), = 0.55 (V) (ninh. and 
R-H) 
Analysis : 
C 1 3 H 1 8 N 2 t V H C 1 C a l e d . : % С 5 1 . 5 7 % Η 6.33 % Ν 9.25 
( 3 0 2 . 7 6 ) Found : % С 5 1 . 4 % Η 6 . 2 % Ν 9 . 2 
Boc-Phe-Dab(Z)-OMe (XIV) 
1) 6.37 mmoles (2.306 g) of Boc-Phe-ONSu were dissolved in 
25 ml of DMF, and 6.37 mmoles (1.930 g) of XIII and 
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6.37 mmoles (0.69 ml) of Et_N wera addBd with stirring. 
After 3 hours water was added and the resulting oil was 
extracted into ethylacetate. The organic layer was 
washed with an aqueous solution of 3-dimethylaminopro-
pyl amine, water, citric acid solution and water. After 
drying on Na_S0. , the solution was concentrated and pe­
troleum ether was added. After cooling and filtration 
81.5% of XIV was obtained. M.p.: 11 7. 5-11 S. 50C. H p 7 = 
-21.7° (c = 1.0. MeOH) (Zeiss). TS: Rf = 0.60 (A), = 
0.74 (B) (R-H). 
Analysis : 
C27 H35 N3 07 Caled.: % С 63.14 % H 6.97 % Ν β.1Β_ 
(513.59) Found : % С 63.0 % Η 7.0 % Ν Θ.1 
2) In 12 ml of DMF were dissolved: 10 mmoles (2.653 g) of 
Boc-Phe-0H, 10 mmoles (3.02Θ g) of XIII, 10 mmoles 
(1.40 ml) of Et3N, 15 mmoles (1.021 g) of imidazole and 
15 mmoles (4.654 g) of triphenyl phosphite. After 20 
hours at 40 C, a small amount of Et-N.HCl was filtered 
off and the filtrate dripped into 150 ml of water. The 
precipitate was filtered, washed extensively with water 
and ether and dried. Yield: 74.3% of a chromatographi-
cally homogeneous material. M.p.: 116.5-117.50C. [a]-
= -22.6° (c = 1.02, MeOH) (Zeiss). 
Analysis: Found : % С 62.8 % Η 6.8 % Ν 8.2 
Boc-Phe-Dab(Z)-OH (XV) 
а) 6.04 mmoles (3.102 g) of XIV were suspended in 37 ml of 
a mixture of dioxan-water (2:1). 12.1 ml of a IN NaOH 
solution were added with stirring. After 20 minutes, 
citric acid solution and EtOAc were added and the or­
ganic layer was washed with water and dried over Na^SO 
Addition of petroleum ether to the concentrated EtOAc 
solution, filtration and drying gave 90.0% of XV. M.p.: 
111.5-112.50C. [CL]^ = -24.9° (c = 1.0, EtOAc) (Zeiss). 
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TS: Rf - 0 . 6 7 (В) ( R - H ) . 
A n a l y s i s : 
C 2 6 H 3 3 N 3 0 7 C a l e d . : % С 6 2 . 5 1 % H 6 . 6 6 % Ν В.41 
( 4 9 9 . 5 6 ) Found : % С 6 2 . 5 % Η 6 . θ % Ν Β.5 
b) 4.0 mmoles (1.450 g) of Boc-Phs-ONSu, 4.0 mmoles (1.009 
g) of XII and 4.0 mmoles (0.505 ml) of ff-ethylmorpho-
line ware suspended in 30 ml of DMF. After the addition 
of 6.0 mmoles (0.Θ11 g) of HOBt, the suspension was 
stirred for 20 hours at room temperature. Then the pH 
of the (now clear) solution was adjusted to 3 with 2N 
KHSO. solution, and EtOAc was added. The organic layer 
was washed with water and dried. After evaporation of 
the solvent the residue was crystallized from EtOAc/pe-
troleum ether: yield 60%. Tic revealed that a small a-
mount of HONSu was still present. Therefore, the prod­
uct was suspended in 100 ml of water and the suspension 
was stirred for some 16 hours. Filtration gave pure XV 
with m.p. 111-112.50C. H p 1 - -26.3° (c = 0.6, EtOAc) 
(Perkin-Elmer 241). 
Analysis : 
C26 H33 N3 07" H2 D C a l c d , ! % c 60·40 % H 6.B2 % Ν θ.13 
(517.56) Found : % С 60.4 % Η 6.6 % Ν β.3 
Boc-Phe-Dab(Z)-NHNH2 (XVII) 
2.56Β g (5.0 mmoles) of Boc-Phs-Dab(Ζ)-ОМв were dis­
solved in 30 ml of methanol. At room temperature, 1.46 ml 
of N7H .H_0 (30 mmoles) were added. After 17 hours, the 
white precipitate was filtered and washed with methanol. 
Yield: 93.7%. M.p.: 166.5-170.50C. [a]^ 3 = -21.6° (c - 1.0. 
DMF) (Zeiss). ΤΞ: Rf = 0.33 (A), = 0.70 (B) (R-H and Bar­
ton ). 
Analysis : 
C
o
_H_
c;
N
c
0
c
 Caled.: % С 60.80 % Η 6.87 % Ν 13.64 
(513.59) Found : Ч С 60.7 % H 7.0 % Ν 13.7 
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Boc-Phe-Dab(Z)-Trp-Gly-OMe (XVI) 
Fragment condensation 
0 1 . HONSu/OCC method 3 4* 3 5 
14.81 mmoles (7.400 g) of XV. 14.61 mmoles (1.63 ml) 
of ЛГ-ethyImorpholine and 29.62 mmoles (3.409 g) of 
HONSu were dissolved in 60 ml of DMF. After cooling 
at -120C, 3.056 g (14.31 mmoles) of DCC were added 
with stirring. The temperatura was allowed to rise 
spontaneously to room temperature. After 2 hours a 
solution of 11.11 mmoles (3.464 g) of IV (3/4 equi­
valents) and 11.11 mmoles (1.22 ml) of .V-ethylmor-
pholine in 10 ml of DMF were added, and stirring was 
continued for 15 hours at room temperature. Then, 
the precipitated OCU was removed by filtration and 
the filtrate was evaporated. Dissolution of the res­
idue in EtOAc and extraction of the organic layer 
with water, 3-dimethylaminopropyl amine solution, 
water, 5% citric acid solution and water, followed 
by drying and evaporation gave XVI which was conta­
minated with a small amount of DCU. Treatment with 
methanol-ether gave pure XVI in about 57% yield. TS: 
Rf = 0.41 (A), = 0.76 (B) (UV, R-H and Ehrlich). For 
physical constants, see table VIII, 1. 
33 
2. Mitin's method 
The same procedure as described for the synthesis of 
XIV (t>ta route 2_) was employed in the preparation of 
the tetrapeptida XVI. The physical and analytical da­
ta (see table VIII, 1) did not change on treatment 
of the product with methanol-ether. 
3. HOBt/DCC method36 
2.20 mmoles (1.099 g) of Boc-Phe-Dab(Z)-OH were dis­
solved in 5 ml of DMF. To this solution were added 
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2.20 mmoles of IV (0.686 g), 2.20 mmoles of ff-ethyl-
morpholine (0.27Θ ml) and 3.30 mmoles (0.446 g) of 
HOBt with stirring. The solution was then cooled at 
0OC and 2.20 mmoles (0.453 g) of DCC were added. Af­
ter 2 hours at 0 С the reaction mixture was stirred 
at room temperature for about 4 hours. The same work 
up of the reaction mixture as described in procedure 
1. yielded 75% of the tetrapeptide XVI. For physical 
and analytical data see table VIII, 1. 
Azida coupling 
4.00 mmoles (2.054 g) of XVII were dissolved in 25 ml 
of DMF and the solution was cooled to -15 C. Then, 11.0 
mmoles of HCl in EtOAc were added (5.67 ml of a 1.94 N 
solution) followed by 4.Θ0 mmoles of t-butyl nitrite 
(0.547 ml). After 15 minutes at -150C, 11.0 mmoles of 
ff-ethyImorpholine (1.21 ml) were added with stirring 
followed by 4.80 mmoles (1.500 g) of IV and 4.80 mmoles 
of ff-ethyImorpholine (0.53 ml). The temperature of the 
reaction mixture was allowed to rise spontaneously to 
0oC. The solution was then kept in the refrigerator for 
about 23 hours. After filtration and evaporation of the 
solvent the residue was taken up in EtOAc and the solu­
tion was extracted as usual. Tic revealed that there 
were still some by-products present. Therefore, the ex­
traction procedure was repeated. Drying and evaporation 
gave a solid which was extracted with a small amount of 
warm EtOAc; the solution was decanted and cooled. The 
insoluble product and the precipitate from the cooled 
solution appeared to be homogeneous on tic. For physi­
cal and analytical data, see table VIII, 1. 
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Boa-Dab(Z)-OH (XVIII) 
H-Dab(Z)-OH (5.DO mmoles = 1.261 g) was suspended in 20 
ml of dioxan and 20 ml of water. The pH was adjusted to 
10.5 and kept constant with a pH Stat loaded with NaOH so­
lution. Boc-N, (0.B2 ml; 25% excess) was added in three 
portions with stirring. Stirring was continued for one 
day. Then the solution was extracted twice with ether and 
acidified with citric acid solution. The amino acid deri­
vative was extracted into ethyl acetate and the organic 
layer was washed with water and with saturated NaCl solu­
tion and dried. Evaporation gave 00% of a colourless oil. 
TS: Rf = 0.67 (B) (R-H). [а]ц3 = -14.7° (с = 2.0, MeOH), 
= -20.5° (с = 1.0, DMF), = -12.5° (с = 1.0, 96% HOAc). 
То a solution of 4.00 mmoles of the oil C1.405 g) in 
10 ml of ether 5.00 mmoles of DOHA (1.0 ml) were added. 
After cooling overnight the white precipitate was filtered, 
dried and recrystallized from ether. 
Yield : 8B% Lit.40 - 4 193% 
M.p. : 99-102oC 9 -101ОС 121-1220C 
[а]ц3 : Λ,Ο0 (с = 1.0, DMF) -6.2° -18.2° 
(Zeiss) (с = 1, DMF) (с = 2. ΜβΟΗ) 
<\,0Ο (с = 1.0, MeOH) 
-8.3° (С = 1.0, HGAc) 
TS : Rf = 0.68 and 0.60 (dec.) (3) (R-H) 
Analysis : 
C29 H47 N3 06 C a l c d ' : % c 65.26 % Η 8.ΘΘ % N 7.88 
(533.71) Found : % С 65.4 % Η 9.2 % Ν 7.7 
Boa-Dab(Z)-Trp-Gly-OMe (XIX) 
1) 3.30 mmoles (1.154 g) of XVIII were dissolved in 10 ml 
of DMF. To this solution were added 3.30 mmoles (1.029 
g) of IV, 3.30 mmoles (0.418 ml) of JY-ethyImorpholine 
and 4.95 mmoles (0.669 g) of HOBt. The reaction mix­
ture was cooled at 0 С and then 3.30 mmoles (0.681 g) 
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of DCC were added with stirring. After 2 hours at О С 
the mixture was stirred for 4 hours at room temperature 
and then cooled; the precipitated DCU was removed by 
filtration. After evaporation of the filtrate, the res­
idue was dissolved in EtOAc and the solution extracted 
with 2N KHSO solution, H 20, 5% NaHCO, solution, H20 
and saturated NaCl solution. After drying on Na^SD. the 
solvent was evaporated and the residue crystallized 
from methanol-ether giving the protected tripeptide XIX 
as a slightly yellow-coloured precipitate in 73.5% 
yield. M.p.: 152-1530C. Ы р 1 = -28.θ0 (с = 0.66, MeOH) 
(Zeiss). TS: Rf = 0.44 (A), = 0.7Б (В) (UV, R-H and 
Ehrlich). 
Analysis : 
C31 H39 N5 D8 C a l c d · ! % c 61.07 4 Η Б.45 % Ν 11.49 
(609.69) Found : % С 60.7 % Η 6.6 % Ν 11.4 
2) The same procedure as described for the synthesis of 
XIV (υΐα route 2) was employed here. Extensive washings 
of the isolated product with ether, water and again with 
ether gave 66.3% of XIX with m.p. 154-155.50C. [a]p2 -
-26.9° (c = 1.0, MeOH) (Zeiss). TS: Rf •= 0.42 (A), = 
0.75 (B) (UV, R-H and Ehrlich). 
Analysis: Found : % С 61.2 % Η 6.3 % Ν 11.2 
H-Dab(Z)-Trp-Gly-OMe. HCl (XX) 
Elimination of the Boe group from XIX was achieved with 
20 equivalents of HCl. Progression of the deprotection was 
followed by tic (system A). As soon as the starting mate­
rial had disappeared, N- was bubbled through the solution 
for about 5 minutes and the solution was concentrated in 
vacuo at room temperature. After cooling, ether was added 
with stirring. The precipitate was filtered, washed exten­
sively with ether and dried. Yield: 85-95%. M.p.: 142-1460C 
(dec. at about 1θ0 οΟ. [α] ^6 = +9.7° (с = 1.0, MeOH), = 
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+ 3 . 6 ° ( с = 1 . 0 , DMF) ( Р е г к і п - E l m e r 2 4 1 ) ; = • 8 . 7 ° ( с » 1 . 0 , 
МеОН) ( Z e i s s ) . TS: Rf = 0 . 5 0 (В) (UV. n i n h . and R-H). 
A n a l y s i s : 
Ο-.Η,,Ν,-Ο-ΟΙ C a l e d . : % С 5 7 . 1 9 % Η 5 . 9 1 % Ν 1 2 . 6 3 
( 5 4 6 . 0 2 ) Found : % С 5 6 . 7 % Η 5.9 % Ν 1 2 . θ 
Boa-Phe-Dab(Z)-Trp-Gly-OMe (XVI) 
Stepwise condensation 
(ç)1. Using Boc-Phe-ONSu 
4.77 mmoles of XX (2.605 g) were dissolved in 20 ml 
of D(1F. (When the pH of the solution dropped below 
4.5 tf-ethyImorpholine was added to bring it back a-
gain). A further equivalent of ff-ethylmorpholine 
(0.60 ml) was then added, followed by 4.77 mmoles 
(1.729 g) of Boc-Pha-ONSu. The reaction mixture was 
kept at room temperature for about 5 hours. Then the 
solution was cooled, water was added with stirring 
and the precipitated tetrapeptide XVI filtered and 
washed with water. Dissolution of the compound in 
methanol and precipitation with ether gave pure XVI 
(see table VIII, 1). 
2a. Via the HOBt/DCC method 
3.00 mmoles (1.638 g) of XX were dissolved in 1Θ ml 
of DMF. tf-ethylmorpholine (0.378 ml) was added, fol­
lowed by 3.00 mmoles (0.796 g) of Boc-Phe-OH and 
4.50 mmoles (0.608 g) of HOBt. At 0oC 3.30 mmoles 
(0.681 g) of DCC were added and the reaction mixture 
was stirred for 1.5 hours at 0 С and for 2 hours at 
room temperature. Then the precipitated DCU was fil­
tered after cooling and the filtrate was evaporated. 
Dissolution of the residue in EtOAc and extraction 
as usual gave nearly homogeneous XVI. Further puri­
fication was achieved by adding a small amount of 
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М ОН to the dried product, filtration of undissolved 
material, and drying. Ether was added to the filtrate 
and the precipitated product was filtered and dried. 
The combined yields amounted to 59%. The first crop 
was used to determine the physical and analytical da­
ta (see table VIII, 1 ) . 
2b. Via Mitin's method 
2.60 mmoles (1.414 g) of XX, 2.60 mmoles (0.690 g) of 
Boc-Phe-OH, 2.60 mmoles (0.32 ml) of ff-ethylmorpho-
line, 3.90 mmoles (0.266 g) of imidazole and 3.90 
mmoles (1.210 g) of triphenyl phosphite were dissolved 
in 10 ml of 0MF and kept at 40DC for about 22 hours. 
Then the solution was poured into water and the result­
ing precipitate filtered after cooling. Washing with 
water and ether, followed by recrystallization from 
methanol-ether gave XVI (see table VIII, 1). 
Boo-Phe-Dab-Trp-Gly-OMe.HOAc (XXI) 
Hydrogen was bubbled through a solution of XVI in 90% 
HDAc for about half an hour. Then the catalyst (Pd/C) was 
filtered off with hyflo and the solvent was evaporated. 
The residue was freed from acetic acid by evaporation with 
isopropyl alcohol. Dissolution of the residue in as little 
isopropyl alcohol as possible and addition of diisopropyl 
ether gave XXI in yields varying between 8 and 95%. ΤΞ: 
Rf = 0.44 (B). = 0.17 (E), = 0.55 (F) (UV, ninh., R-H and 
Ehrlich). In nearly every preparation traces of one or two 
unknown by-products were found which were almost impossible 
to remove. It appeared to be desirable to use the product 
in the following preparation without delay. 
Boc-Phe-Nar-Trp-Gly-OH (XXII) 
To 7.5 ml of a freshly prepared methanolic solution 
(about 4 mmoles/ml) of O-methylisourea obtained from the 
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hydrogen sulphate according to the method of Stieglitz and 
McKee46 in about 70% yield, were added 961 mg of XXI (1.41 
mmoles). The solution was kept at 0-4 С for about one day, 
then concentrated and cooled. Water was added slowly (a-
bout 7-10 times the volume of the solution) with rubbing. 
The precipitate was removed by centrifugation, washed once 
with water and dried. Yield of impure XXII: 717 mg. For 
purification the product was subjected to chromatography 
on Kieselgel 60 using isopropyl alcohol-ammonia-water (B: 
1:1) as the eluent. The combined fractions containing the 
Sakaguchi positive XXII were evaporated, the residue dis­
solved in methanol and the turbid solution filtered through 
hyflo. Addition of ethyl acetate to the concentrated metha-
nolic solution gave the pure tetrapeptide in 40% yield. 
П.р.і about 1850C (dec). Ы д 2 = -17.6° (с = 0.5В, MeOH) 
(Perkin-Elmer 241). TS: Rf = 0.52 (F), = 0.32 (Τ), = 0.50 
(W) (UV, R-H, Sakaguchi and Ehrlich). Amino acid analysis 
(6N HCl, 110°, 24 hours): Тгр 0.77 (1), Nar 1.04 (1), 
Gly 1.09 (1), Phe 1.00 (1). 
Analysis : 
C32 H42 Ne C I7 , 2 H2 D C a l c d - ! % c 55.96 % Η 6.75 % N 16.32 
(666.77) Found : % С 56.3 % Η 6.θ % Ν 16.0 
H-Phe-Nar-Trp-Gly-OH.2HCI (XXIII) 
Removal of the N -protective group was performed in 
1.6N HCl/HOAc (about 15-20 equivalents of HCl). After 10 
minutes ether was added. The precipitate formed was fil­
tered after cooling and extensively washed with ether. 
Yield: about 92%. M.p.: 187-190oC. [a]^1 = +5.4° (c = 1.23, 
90% HOAc) (Perkin-Elmer 241). TS: Rf = 0.24 (F), - 0.4Θ (W). 
(UV, ninh., R-H and Ehrlich). After drying a sample in a 
high vacuum over Рт^с at BD С, the substance was equilibra­
ted with air moisture. UV spectrum: A = 0.621 at λ = 
max 
280.0 nm (concentration: 3.92 mg in 50 ml 0.1N HCl). Pep-
с α 
tide content: about 78% 
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Analysis : 
C27 H36 N8 Q5 C 12- 4 H2 0 C a l c d - : 
(695.60) Found : 
Caled.: 
Found : 
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C H A P T E R I X 
SYNTHESIS AND BIOLOGICAL ACTIVITY OF TWO ACTH ANAL-
OGUES CONTAINING L-NORARGININE IN POSITION S 
IX. 1 INTRODUCTION AND METHOD OF SYNTHESIS 
Two possible rsaction pathways leading to the 
corticotrophin-(5-1D)-hexapeptide, H-Glu(0Bu )-His-
Phe-Nar-Trp-Gly-OH, can be envisaged. One of them 
starts from the fully protected tetrapeptide Boc-
Phe-Nar(N02)-Trp-Gly-OMe, described in chapter 
VIII, from which the o-amino protective t-butyl-
oxycarbonyl group is cleaved with hydrogen chlo-
ride. Acylation with the dipeptide Z-Glu(0Bu )-His-
N^ does indeed give the pure protected hexapeptide 
ester in reasonable yield, but subsequent saponifi-
cation of the methyl ester with sodium hydroxide in 
aqueous dioxan results in a product which stubborn-
ly resists complete catalytic hydrogénation. It 
seems that only purification by counter-current 
distribution prior to the hydrogénation step guar-
antees a slow but complete conversion of such a 
hexapeptide . 
The alternative pathway starts from the correspond-
ing free tetrapeptide which is likewise acylated 
with 2-С1и(0Ви )-Ніз-и
з
 (scheme IX, 1]. The par­
tially protected hexapeptide II underwent hydro-
genolytic cleavage of the N -protective function 
without difficulties. The resulting product (III) 
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OBu' 
Ζ —GÎu-His-HHNH2 + H-Ph«-Nar-rrp-Gly-OH • 2HCI 
(I) 
OBu1 ,, 
Z-Glu-His-nte-Nar-Trp-Gly-OH 
(Ж) 
OBu' 
Hj/Pd.C 
Boc-Ser-Tyr-Ser-Met-HHNH, + H-Glu-His-Phe-Har-Trp-Gly-OH 
|Ш| Ш) 
OBu1 H 2 ® 
Boc-Ser-Tyr-Ser-Met-Glu-His-Phe-Kar-Irp-Gly-O0 
(I) 
Schema I X , 1 
was used in the now familiar reaction sequence 
(cf. chapters III and IV) leading to the desired 
end-products: the azide coupling with the tetra-
peptide IV was done according to the method of 
Honzl and Rudinger (scheme IX, 1). 
The partially protected, zwitter-ionic deca-
peptide was then extended to a tetracosapeptide 
as well as an octadecapeptide amide by coupling 
with the relevant protected peptides VI and IX, 
respectively (see scheme IX, 2). In both cases 
3 
König's method was used. In the latter case the 
amino acid sequence of the resulting octadecapep-
tide amide differed not only at position β but 
also at the positions 17 and 1B from the natural 
sequence in ACTH. It is known, however, that sub­
ît 
4 
17 18 
stitution of Arg and Arg by Lys does not low-
er the biological potency of ACTH analogues 
The products obtained from these couplings 
were purified by counter-current distribution, 
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IX. 2 EXPERIMENTAL SECTION 
For details concerning the abbreviations, thin-layer 
chromatography and the performance of measurements, see 
the appendices. 
Z-GlufOBu*i-His-Phe-Nar-Trp-Gly-OH (II) 
A sample of I was completely freed from hydrochloric 
acid by addition of sufficient ЛГ-ethyImorpholine and then 
supplied with an excess (1.5 equivalents were used) of 
Z-Glu(0Bu )-His-NHNH.-,. The coupling was performed as des­
cribed in chapter III. After standing at О С for about 40 
hours, the reaction mixture was concentrated and cooled, 
and water was added with stirring. The precipitate was 
filtered and recrystallized from acetic acid/ether giving 
58% of a chromatographically homogeneous product. TS: Rf 
0.41 (F), = 0.Б4 (L), = 0.53 (W) (UV, R-H, Pauly and Ehr­
lich). M.p.: 20a-210OC (dec). 
[α]^1 = -17.0° (с = 1.0, 90% HOAc). 
Analysis : 
C
cn
H
co
N.
o
0,,.H0Ac.H_a Caled.: % С 57.55 % Η 6.32 % Ν 15.4 50 62 12 11 2 
(1085.19) Found : % С 56.5 % Η 6.1 % Η 15.5 
H-Glu(OBu*)-His-Phe-Nar-Trp-Gly-OH (III) 
Hydrogénation of II was carried out in 90% HOAc with 
palladium on charcoal as the catalyst. After 3 hours the 
catalyst was removed by filtration and fresh Pd/C was ad-
ded; hydrogénation was continued for another 3 hours. The 
the reaction mixture was filtered, the filtrate was con-
centrated and cooled, and ether was added dropwise with 
stirring. The isolated product (85% yield) had an Rf of 
0.10 (F) and 0.59 (L) (UV, R-H and Ehrlich). It was con-
taminated with a trace of a slower-running by-product of 
unknown constitution. 
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Boa-Ser-Tyr-Ser-Met-GluCOBu*)-His-Phe-t!ar-Trp-Gly-OH {У) 
The azidB coupling between the acetate of III and an 
excess of IV (1.5 equivalents) was carried out as de­
scribed before. After 20 hours at Q0C the reaction mixture 
was concentrated and acetonitrile was added with stirring. 
After cooling, the precipitate was filtered, washed with 
acetonitrile and dried giving 90% of V. For further puri­
fication, the compound was dissolved in DMF and precipita­
ted with acetonitrile with stirring. Yield: 7B.3%. M.p.: 
1B3-ia70C. IS: Rf = 0.26 (B), - 0.10 (C), = 0.37 (F), = 
0.60 (P) (UV, R-H, Pauly, Sakaguchi, Barton and Ehrlich). 
[α]ρ: = -16.1° (с = 1.05, DMF), = -19.0° (с = 0.7, 90% 
HOAc). 
Boa-Ser-Tyr-Ser-Met-Glu(OBu J-His-Phe-Nar-Trp-Gly-Lye(Boo)-
Pro-Val-Gly-Lya(Boa)-Lya(Boc)-Arg-Arg-Pro-Val-Lys(Boa)-Val-
Tyr-Pro-OBu* (VII) 
244 mg of V were condensed with 443 mg (1.2 equiva­
lents) of VI with the aid of 2 equivalents of HOBt and 1.5 
equivalents of DCC as described in chapter III. After 21 
hours the reaction mixture was concentrated and cooled, 
and the precipitated DCU filtered. Peroxide-free ether was 
added to the filtrate with stirring. After cooling, the 
resulting precipitate was filtered giving 60Θ mg of crude 
VII. The product was purified by counter-current distribu­
tion with the system methanol-chloroform-carbon tetrachlo-
ride-buffer (8:5:2:4) (buffer composition: 19.25 g of 
NH.OAc and 2Θ.5 ml of HOAc made up to 1000 ml with H 20). 
After 243 transfers 260 mg (about 45%) of pure VII were 
obtained (K = 0.47, г - 78). TS: Rf = 0.29 (В), = 0.16 
max 
(С), = 0.43 (F), = 0.74 (Ρ) (R-H, Pauly, Sakaguchi, Ehr­
lich and Barton). M.p.: 175-1в0ОС (dec). 
[а]ц7 = -52.7° (с = 0.60, MeOH). UV spectrum in 90% HOAc 
(concentration 0.18 mg/ml): A * 0.385 at λ = 277.6 nm. 
ь
 max 
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{liar 3 -ß-corti co trophin- ( 1-24 )-te traeos apepti.de 
Deprotection of VII was carried out with 75% TFA under 
N9 in the dark for 3 hours. The solution was then cooled 
at about -30 С and peroxide-free ether was added dropwise 
with stirring. After 10 minutes the precipitate was fil­
tered, washed with ether and dried. Conversion of the tri-
fluoroacetate into the acetate was carried out with a 
weakly basic ion exchanger (Merck II -acetate form). The 
filtrate was lyophilized. 
ТА: Rf = 0.60 (P) CR-H). TC: Rf = 0.49 (P), = 0.Б0 (R) 
(ninh. and R-H). 
[ o ] ^ 1 = - 0 5 . 0 ° ( c - 0 . 6 0 . 1% HOAc), Ы 5 7 в = - 8 6 . 7 ° , 
H 5 4 B " - 1 0 1 . 2 ° , Ы 4 з 6 - - 1 7 6 . 2 ° and [ а ] э 6 5 = - 2 9 5 . 0 ° . 
Amino a c i d a n a l y s i s a f t e r c o m p l e t e h y d r o l y s i s (6N H C l , 
24 h o u r s a t 110 C) ( t h e o r e t i c a l v a l u e s i n p a r e n t h e s e s ) : 
Trp 0 . 6 4 ( 1 ) , Lys 3 . 6 7 ( 4 ) , H i s 0 .99 ( 1 ) , NH3 0 . 5 5 , Nar + 
Arg 3 . 0 3 ( 3 ) , S e r 1.56 ( 2 ) , Glu 1.00 ( 1 ) . Pro 2 . 9 4 ( 3 ) , 
Gly 2 . 0 0 ( 2 ) , V a l 3 . 2 0 ( 3 ) , Het 1.18 ( 1 ) , Т у г 2 . 0 2 ( 2 ) , 
Phe 1.01 ( 1 ) . 
UV s p e c t r a : i n 0 . 1 N H C l : A = 0 . 6 6 1 a t λ = 2 7 5 . 9 nm 
r
 max 
( c o n c e n t r a t i o n 0 . 3 0 7 m g / m l ) , 
i n 0 . 1 NaOH : A = 0 . 7 1 6 a t λ = 2 6 6 . 5 nm and 
max 
A = 0.691 at λ = 2B2.0 nm (concentration 
0.245 mg/ml), 
Tyr/Trp ratio: 2.0 . Peptide content: 72.5 ^ 
0.08% (mean of 2 values) as determined spec-
trophotometrically according to Beaven and 
g 
Holliday . 
H-Lye(Boc)-Pro-Val-Gly-Lys(Boc)-Ly8(Boc)-Lya(Boc)-Lye(Boc)-
NH2 (IX) 
Compound IX was obtained from the benzyloxycarbonyl 
derivative according to the method of Riniker and Rittel . 
The product IX was precipitated by the addition of water 
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to a concentrated methanolic solution of IX 
7 Yield 
M.p. 
TS 
63% Lit.' as? 
about 1950Ε (dec.) 'ь220ОС (dec.) 
-33.6° (с = 1.0, МвОН) -33° (с = 1, ІЧеОН) 
Rf = 0.60 (F), = 0.Б9 (I) (ninh. and R-H). 
Boc-SeT-Tyr-Ser—Met-Glu(OBu )-His-Phe-l/ar-Trp-Gly-Ly3(Boo)-
Pro-Val-Gly-Lys(Boa)-Lys(Воо)-Ьуз(Boa)~Lys(Boo)-llH (X) 
The octadecapeptide amide X was synthesized according 
to the method of Riniker and Rittel using HOBt instead of 
HONSu. The crude material was subjected to counter-current 
distribution using the system methanol-chloroform-carbon 
tetrachloride-buffer (10:7:4:3) (buffer composition: 7.7 g 
of NH.OAc and 57.1 ml of HOAc made up to 1000 ml with H 20). 
After 160 transfers 135 mg of a pure product (about 46%) 
were obtained (K = 0.66, г
 =
 = 74). TS: Rf = 0.46 (C), = 
ГПЗХ 
0.61 (F), = 0.76 (P) (R-H, Pauly, Sakaguchi, Ehrlich and 
Barton). 
M.p.: 195-200OC (dec). [YJp1 = -29.7° (c = 0.43, 90% 
HOAc). UV spectrum in 90% HOAc: A = 0.393 at λ = 278.2 K
 max 
nm (concentration 0.217 mg/ml). 
\ßar , Lya ' ^-^-oorticotrophin-(l-18)-oatadecapeptide 
amide (XI) 
The same deprotection procedure as described for the 
preparation of the tetracosapsptide VIII was employed. Tic 
and electrophoresis of the resulting product revealed the 
presence of a by-product which could be completely separa-
ted, however, from XI by preparative high voltage paper 
electrophoresis*. 
* We should like to thank Dr. W. de Jong (Biochemistry 
Department, Nijmegen) for performing the electrophoresis 
experiment· 
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Thin-layer chromatography of the acid hydrolysate of the 
isolated by-product revealed that it was unreacted octa-
peptide amide IX. 
TA: Rf = 0.25 (P); TC: Rf = 0.44 (P) (ninh. and R-Hb 
[ о ] " = -5Б.4 0 (c = 0.50, 1% HOAc), [a]
 5 7 a = -53.8°. 
И 546 = " 6 7 - D 0 a n d И 436 = - 1 16.4 0. 
Amino acid analysis after complete hydrolysis (6N HCl, 
24 hours at 110 C) (theoretical values in parentheses): 
Lys 4.40 (5), His 1.06 (1), NH 3 1.55 (1). Nar 0.97 (1), 
Ser 1.46 (2), Glu 0.95 (1), Pro 1.03 (1), Gly 2.00 (2), 
Val 1.02 (1), Met 0.97 (1), Туг 0.90 (1), Phe 0.94 (1). 
UV spectra: in 0.1 N HCl: A = 0.627 at λ = 27Θ.Θ nm 
r
 max 
(concentration 0.291 mg/ml). 
in 0.1 N NaOH: A = 0.526 at λ = 281.5 nm 
max 
and A = 0.516 at λ = 288.2 nm (concentration 
0.227 mg/ml). Tyr/Trp ratio: 0.95. 
IX. 3 BIOLOGICAL ACTIVITY 
The results of preliminary in vivo experiments (see 
chapter VII) with [Nar0]-ACTH-(1-24) are given in table 
IX-1. 
Table IX-1 
Plasma corticosterone (γ/100 ml blood) in 24 hours hypo-
physectomized rats, corrected for blanc value (4 rats/ 
group) . 
ACTH-(1-24) 
[NarS]-ACTH-(1-24) 
Dose 
(mg/kg) 
1.0 
1.0 
Time following injection 
15 min. 
1 9 ^ 2 
17 _•_ 2 
30 min. 
34 +_ 4 
1 5 ^ 2 
60 min. 
33 +_ 5 
1 3 ^ 3 
90 min. 
16 *_ 3 
1.6^ 2 
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Although in vivo experiments are less reliable than in 
о experiments, one can cone] 
has a significant ACTH activity. 
о 
vitro experiments, one can conclude that the Nar - peptide 
о 
The rielanacyte-stimulating activity of the two Nar -
peptides has been investigated with lizard skin (see chap­
ter VII), [Narfl]-ACTH-(1-24) had an activity of 0.003-0.01 
(α-ΓΊΞΗ was set at 1) and [NarS, Lys J 7'18~\ -ACTH- ( 1 -1 Θ) -NH 2 
of 0.006-0.01. Compared with the normal tetracosapeptide, 
both compounds possess about 20-30% of the MSH activity of 
ACTH-(1-24). 
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Appendix A 
ABBREVIATIONS 
The abbreviations used for the amino acid residues 
and the notation of peptides are those recommended by the 
lUPAC-IUB Commission on Biochemical Nomenclature, Biochem. 
3. (1972) 126. 773-7B0. 
List of other abbreviations: 
ACTH 
Boc 
1-BuOH 
Dab 
DCC 
DCHA 
DCU 
DMF 
DMS0-dE 
E t 3 N 
EtOAc 
EtOH 
GOMP 
Наг 
HOBt 
HDNp 
HDNSu 
m 
MeOH 
Msc 
a-MSH 
Nar 
OBu 
adrenocorticotrophic hormone 
t-butyloxycarbonyl 
1-butanol 
L-a,Y-diaminobutyric acid 
tfj/Z'-dicyclohexylcarbodiimide 
dicyclohexylamine 
N,N '-dicyclohexylurea 
ff.if-dimethylformamide 
deuterated dimethylsulphoxide 
triethylamine 
ethyl acetate 
ethyl alcohol 
1-guanyl-3,5-dimethylpyrazóle 
L-homoarginine 
1-hydroxybenzotriazole 
p-nitrophenol 
ff-hydroxysuccinimide 
meta 
methyl alcohol 
methylsulphonylethyloxycarbonyl 
o-melanocyts-stimulating hormone 
L-norarginine (L-a-amino-y-guanidinobutyric 
acid ) 
ortho 
t-butyloxy 
181 
ОМв 
ОТср 
Ρ 
Pmp 
і-РгоОН 
вес. 
t 
ТА 
TC 
TFA 
Tic 
TMS 
TS 
Ζ 
methoxy 
2,4,5-trichlorophBnoxy 
para 
L-pentamethylphenylalanine 
isopropyl alcohol 
secondary 
tertiary 
thin-layer chromatography 
thin-layer chromatography 
trifluoroacetic acid 
thin-layer chromatography 
trimethylsilane 
thin-layer chromatography 
benzyloxycarbonyl 
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Appendix В 
TLC DATA 
For thin-layer chromatographical analyses, рге-coated 
silica gal (TS), alumina (TA) and cellulose (TO plates 
with a fluorescence indicator of Merck (F. 254) were used, 
unless otherwise stated. 
To develop the chromatograms, the following solvent 
systems were used: 
A = benzene-acetone (1:1) 
В = 1-butanol-acetic acid-water (10:1:3) 
С = ethyl acetate-pyridine-acetic acid-water (62:21:6:11) 
D = acetic acid-0.1 N hydrochloric acid (4:1) 
E • chloroform-methanol-acetic acid (95:20:3) 
F = 1-butanol-acetic acid-water (4:1:1) 
G » chloroform-methanol (4:1) 
H = 2-propanol-formic acid-water (20:1:5) 
I = chloroform-methanol (9:1) 
J = вес.-butyl alcohol-acetic acid-water (67:10:23) 
К = вес.-butyl alcohol-isopropy1 alcohol-9% monochloro-
acetic acid (56:8:34) 
L = chloroform-methanol-17% ammonia (5:5:1) 
M = 1-butanol-pyridine-acetic acid-water (4:1:1:2) 
N • 1-butanol-acetic acid-water (1:2:1) 
0 = 1-butanol-pyridine-acetic acid-water (16:3:1:4) 
Ρ = 1-butanol-pyridine-acetic acid-water (36:24:6:30) 
Q » 1-butanol-pyridine-acetic acid-water (42:24:4:30) 
R - 1-butanol-pyridine-formic acid-water (40:24:6:30) 
S = chloroform-methanol-acetic acid (40:10:0.15) 
Τ » isopropyl alcohol-25% ammonia-water (8:1:1) 
U • phenol-water (3:1) 
V » chloroform-methanol (1:1) 
W = 1-propanol-25% ammonia (3:2) 
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The pyridine present on plates developed in the 
pyridine containing systems was removed by spraying the 
dried plates with concentrated ammonia solution and sub­
sequent heating at about 10Q C. 
Methods used for the detection of components 
UV quenching of fluorescence after exposure of 
the plates at 254 nm. 
ninh. ninhydrin reagent for detection of free 
amino groups. 
R-H Reindel-Hoppe test (chlorine/o-tolidine 
reagent) for -NH- groups. 
Pauly colouration of histidine containing compounds. 
Ehrlich specific reagent for tryptophan containing 
compounds. 
Sakaguchi detection of free guanidino groups. 
Barton colouration of hydrazides and tyrosine. 
Reagents and experimental techniques 
Ninh. : 240 mg of ninhydrin in 400 ml of 1-butanol and 
16 ml of acetic acid. After spraying, the plates were 
heated in an oven at 80-100 С for 5-10 minutes. 
R-H : silica gel plates were exposed to chlorine for 
about 15 seconds and the excess of chlorine was removed 
by spraying with ethanol; alumina and cellulose plates 
were sprayed with acetic acid followed by a dilute so­
dium hypochlorite solution. The spots could be visual­
ized by spraying with a reagent composed of a solution 
of 4 g of o-tolidine in B0 ml of acetic acid and 320 ml 
of water, mixed with a solution of 3.36 g of potassium 
iodide in 400 ml of water. 
Pauly : a freshly prepared solution of diazotized aul-
phanilic acid (about 50 mg of the moist compound) in 
10 ml of 5% Na-jCO, was used. 
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Ehrlich : the plates were sprayed with a solution of 1 g 
of 4-dimethylaminobenzaldehyds in 25 ml of concentrated 
HCl and 75 ml of methanol and then heated. 
Sakaguchi: the chromatograms were sprayed with a solution 
of 0.02 g of a-naphtol, 2.5 g of NaOH and 4 g of urea 
in 50 ml of water and dried. Then, a solution of 0.33 
ml of bromine and 2.5 g of NaOH in 50 ml of water was 
used as the second spray reagent. 
Barton : equal volumes of a solution of 30 g of FeCl,. in 
170 ml of water and of a solution of 2 g of К Fe(CN) 
in 198 ml of water were mixed just before use. 
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Appendix С 
MEASUREMENTS 
Malting points given in chapters II and VIII were 
determined with a Heiztisch Microscope (Leitz), those in 
oth,er chapters with a Totolli apparatus (Buchi). They are 
uncorrected. 
Specific rotations were measured with a Perkin-Elmer 
141 Polarimeter unless otherwise stated. In chapter IX 
only a Perkin-Elmer 241 apparatus was used. 
The UV spectfa mentioned in chapters II, III and VIII 
were recorded with a Beekman DK.-2A apparatus. The tetra-
cosapeptidas in chapter III were measured with a Perkin-
Elmer 402 spectrophotometer. А Сагу 15 apparatus was used 
for recording the spectra mentioned in chapters IV and IX. 
In all measurements, closed quartz cells of 1 cm pathlength 
were used. 
Amino acid analyses were carried out with a Technicon 
TSM 1 apparatus at the laboratories of Ciba-Geigy Ltd., 
Basle, Switzerland. 
N.M.R. spectra were recorded on a Varian HA-100 appa­
ratus with TMS as internal reference. 
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SAMENVATTING 
Omvangrijke onderzoekingen betreffende struk-
tuur-funktie relaties van het adrenocorticotrope 
hormoon hebben aan het licht gebracht, dat van dit 
39 aminozuren omvattende peptide-hormoon niet min-
der dan 21 aminozuren vanaf het carboxyl uiteinde 
verwijderd kunnen worden zonder verlies van de bi-
ologische werkzaamheid. Het resterende oktadeka-
peptide vertoont volledige ACTH-aktiviteit. 
Daarnaast is vastgesteld dat op diverse plaat-
sen in dit verkorte peptide vervanging van het nor-
maal aanwezige aminozuur door één of meer andere, 
natuurlijke aminozuren mogelijk is zonder volledig 
verlies van de werkzaamheid. Dergelijke substitu-
ties in het aktieve centrum van het hormoon, de 
aminozuren 5-10 omvattend, hebben steeds geleid 
tot veel ingrijpendere verlagingen van de biologi-
sche aktiviteit. 
Aan ons onderzoek ligt de gedachte ten grond-
slag, dat inzicht in de specifieke funkties van 
aminozuren in het aktieve centrum bij de interak-
tie tussen het hormoon en zijn receptor zou kunnen 
ontstaan door vervangingen, waarbij een niet-na-
tuurlijk aminozuur wordt geïntroduceerd, dat een 
zelfde chemische of fysische karakteristiek ver-
toont als het normaal aanwezige aminozuur. 
Uitgaande van deze gedachte is allereerst 
aandacht besteed aan het aminozuur tryptophaan 
(positie 9 in ACTH), waarvan bekend is dat het 
elektron donor eigenschappen bezit die aanzienlijk 
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groter zijn dan die van alle andere natuurlijke 
aminozuren. Omdat tevens bekend was dat het niet-
natuurlijke pentamethylphenylalanine (Pmp) onge-
veer gelijke donor-eigenschappen bezit, zijn sub-
stituties door dit aminozuur en door de zeer zwak-
ke elektron donor phenylalanine onderzocht. 
Omdat verbindingen met ACTH-aktiviteit tot nu 
toe steeds ook een melanocyten-stimulerende werking 
(MSH-aktiviteit) vertoonden is niet alleen het ef-
fekt van de substituties op karakteristieke ACTH-
werkzaamheid (steroidogenese in de bijnier, lipo-
lyse in vetcellen) onderzocht maar ook op MSH-ak-
tiviteit. 
Eenzelfde type onderzoek is gewijd aan argi-
nine (positie B) waarvan reeds bekend was dat het 
niet door andere natuurlijke, basische aminozuren 
(lysine, ornithine) kan worden vervangen. Wij heb-
ben nagegaan of de biologische aktiviteit behouden 
blijft na substituties, waarbij de sterk basische 
guanidino funktie in de zijketen behouden blijft, 
maar de lengte van de zijketen wordt gevarieerd. 
De synthese van pentamethylphenylalanine 
(hoofdstuk II) is uitgevoerd via een bekende pro-
cedure. De splitsing van het verkregen racemaat 
langs enzymatische weg verloopt te traag voor 
praktisch gebruik. Met behulp van brucine kunnen 
de L- en D-enantiomeren echter in goede opbrengst 
zuiver worden verkregen. De natuurlijke L-configu-
ratie kon worden toegewezen aan het rechtsdraaiend 
isomeer op grond van rotatie-dispersie metingen 
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aan het vrije aminozuur en het overeenkomstige N-
acetyl derivaat, en de, weliswaar langzame, enzy-
matische hydrolyse van laatstgenoemde verbinding 
door carboxypeptidase A, die echter niet optrad 
bij de enantiomeer. 
De synthese van de onderzochte ACTH-(1-24) 
g 
analoga Ctwee Pmp -derivaten in hoofdstuk III en 
g 
twee Phe derivaten in hoofdstuk IV) is uitge-
voerd volgens het schema dat door Schwyzer in de 
ACTH synthese wordt gebruikt: het tetrapeptide 
dat de, in ons geval gewijzigde, sequentie 7-10 
omvat wordt door successieve fragmentcondensaties 
met een di- en een tetrapeptide aan het amino uit-
einde en een tetradekapeptide aan het carboxyl 
uiteinde tot het gewenste eindprodukt opgebouwd. 
De synthese van de tetrapeptiden (7-10) waarvan 
men uitgaat is in beide gevallen door middel van 
een fragmentcondensatie verricht. Door gebruik te 
maken van een nieuwe, alkali-labiele maar uiterst 
zuur-stabiele amino beschermgroep, de methylsul-
fonylethyloxycarbonyl group (Msc), waarbij de ar-
ginine zijketen onbeschermd wordt gelaten, werd 
het gewenste tetrapeptide veel sneller en zuiver-
der verkregen dan bij gebruik van conventionele 
beschermgroepen. Bij de aminozuuranalyse van da 
Pmp-derivaten bleek dat pentamethyIphenylalanine 
niet geè'lueerd wordt, zoals op grond van het ge-
drag van het vrije aminozuur verwacht kon worden. 
Een overeenkomstige procedure kon uiteraard 
gebruikt worden voor de synthese van twee a-MSH 
analoga, omdat de aminozuur sequentie van het 13 
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aminozuren omvattende α-MSH geheel gelijk is aan 
die van het amino-eindstandige tridekapeptide uit 
ACTH. In deze synthese is de Msc groep opnieuw ge­
bruikt, nu voor de zijketen bescherming van lysine 
op plaats 11. Anders dan bij ACTH is in a-MSH het 
amino uiteinde geacetyleerd. Wij voerden deze ace­
tyl groep in nadat de synthese van het gehele tri­
dekapeptide amide was voltooid (hoofdstuk V). 
Voor een vergelijking van elektron donor ei­
genschappen tussen overeenkomstige Trp, Pmp en Phe 
derivaten zijn diverse karakteristieke parameters 
voor ladingsoverdrachtskomplexen met N.N'-dime-
thyldipyridylium dichloride (paraquat) onderzocht. 
Met deze sterke acceptor, die stabiel is in een 
groot pH interval, kan water als oplosmiddel ge­
bruikt worden (hoofdstuk VI). Uit de resultaten 
van deze metingen bleek, dat van de gesyntheti-
g 
seerde ACTH-(1-24) analoga het Pmp -derivaat bijna 
even goede donor-eigenschappen heeft als de natuur-
9 9 
lijke Trp -verbinding, terwijl het Phe -derivaat 
vrijwel geen donor eigenschappen bezit. 
Voor het onderzoek naar de biologische werk­
zaamheid van de gesynthetiseerde analoga zijn de 
steroidogenese, lipolytische aktiviteit en melano-
cyten-stimulerende werking onderzocht (hoofdstuk 
o 
VII). Van de tetracosapeptiden bleken die met Pmp 
geen lipolyse, een zeer zwakke steroidogenese 
maar een verrassend hoge MSH aktiviteit te bezit­
ten. Voor zover bekend is hiermee voor het eerst 
een duidelijke scheiding tussen ACTH en MSH wer­
king bij een ACTH analogon waargenomen. De over-
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g 
eenkomstige Phe -peptiden vertonen eveneens een 
zwakke steroidogenese maar ook een duidelijk af-
genomen MSH aktiviteit. 
Bij de a-MSH analoga (trïdekapeptide amidan) werd 
geen duidelijk verschil in MSH aktiviteit tussen 
9 9 
het Pmp -en Phe -analogon gevonden. 
Omdat deze resultaten vooralsnog geen duide-
lijke konklusie toelaten over een mogelijke bete-
g 
kenis van Trp in ACTH en a-MSH als elektron donor 
in de interaktie van deze hormonen met hun recep-
tor, is het interessant te vermelden dat de ver-
vanging van Trp in het hormoon LH-RH (dat het 
luteïniserend hormoon vrijmaakt) door Pmp, in sa-
menwerking met ons door Coy en medewerkers onder-
zocht, een produkt oplevert met een zeer hoge LH-
RH aktiviteit, terwijl vervanging van Trp door 
Phe en door diverse andere aminozuren, met zeer 
zwakke donor eigenschappen, de LH-RH werkzaamheid 
nagenoeg verloren doet gaan. 
Ons onderzoek naar het effekt van vervanging 
o 
van arginine in ACTH sluit aan bij de reeds be-
o 
kende substitutie van Arg door een aminozuur met 
grotere ketenlengte. De invoering van norarginine 
(een CH-, groep minder) levert vrij grote synthe-
tische problemen op. De algemene chemische karak-
teristiek van norarginine verschilt duidelijk van 
die van arginine (hoofdstuk VIII). Hetzelfde alge-
mene schema volgend als voor de hierboven genoemde 
analoga is voor de synthese van het benodigde (7-
10) tetrapeptide een tweetal wegen gevolgd. In een 
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hiervan wordt L-a,Y-diaminoboterzuur, dat volgens 
een aanzienlijk verbeterde en vereenvoudigde me-
thode uit glutaminezuur werd bereid, eerst omge-
zet in norarginine waarna dit, in de zijketen be-
schermd door een nitro funktie, in het gewenste 
peptide werd ingevoerd met behulp van conventio-
nele methoden uit de peptide chemie. 
Bij de andere methode werd het diamïnoboterzuur 
zelf ingebouwd en de γ-amino groep pas in het te-
trapeptide door amidinering in een guanidino -Funk­
tie omgezet. Beide methoden leverden een bruikbaar 
resultaat op. 
Uitgaande van het vrije tetrapeptide konden 
met de conventionele fragmentcondensatie twee ACTH 
analoga verkregen worden (hoofdstuk IX). 
Bij oriënterende biologische aktiviteitsbepalingen 
•in vivo met het ( 1-24 )-analogon bleek dat het dui-
delijk steroidogenese kon induceren. Uit vroeger 
onderzoek is reeds gebleken dat substitutie van 
o 
Arg door homoarginine (een CH-, groep meer) in 
ACTH eveneens duidelijk ACTH aktiviteit oplevert. 
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